Sample records for md phd associate

  1. Clinical Investigation Program, Reports Control Symbol MED-300(R1), Fiscal Year 1988

    DTIC Science & Technology

    1988-10-01

    Dr. Venkataraman Balaraman, M.D. Department/Section: Clinical Investigation Key Words: arginine vasopressin (AVP); vascular smooth muscle responses...Kullama, Ph.D. Associate Investigators: Dr. Venkataraman Balaraman, M.D.; Dr. Kenneth T. Nakamura, M.D.; John R. Claybaugh, Ph.D. Department/Section...Harrison Hassell, MC Associate Investigators: John R. Claybaugh, Ph.D.; Arnold Siemsen, MD; Jon Streltzer, MD Department/Section: Medicine/ Nephrology

  2. Clinical Investigation Program Annual Progress Report

    DTIC Science & Technology

    1989-10-01

    Investigators: Linda K. Kullama, Ph.D., Dr. Kenneth T. Nakamura,MD; Dr. Venkataraman Balaraman, MD, Wayne M. Ichimura, Biomedical Engineer. Department/Section...Investigators: John R. Claybaugh, Ph.D.; Kenneth T. Nakamura, MD; Dr. Venkataraman Balaraman, M.D. Department/Section: Clinical Investigation/Physiology Key...Pigs and Rats Principal ’Investigator: Linda K. Kullama, Ph.D.; John R. Claybaugh, Ph.D. Associate Investigators: Dr. Venkataraman Balaraman, M.D.; Dr

  3. 2017 JOSPT Award Recipients.

    PubMed

    Simoneau, Guy G

    2018-05-01

    During the American Physical Therapy Association's Combined Sections Meeting in New Orleans, LA in February 2018, JOSPT recognized the authors of the most outstanding research and clinical practice manuscripts published in JOSPT during 2017. The 2017 George J. Davies-James A. Gould Excellence in Clinical Inquiry Award was presented to Noa Ben-Ami, PT, PhD; Gabriel Chodick, MHA, PhD; Yigal Mirovsky, MD; Tamar Pincus, MPhil, MSc, PhD; and Yair Shapiro, MD, PhD, for their February 2017 article "Increasing Recreational Physical Activity in Patients With Chronic Low Back Pain: A Pragmatic Controlled Clinical Trial." The 2017 JOSPT Excellence in Research Award was presented to Sanneke Don, PT, MPT; Margot de Kooning, PT, PhD; Lennard Voogt, PT, MT, PhD; Kelly Ickmans, PT, PhD; Liesbeth Daenen, PT, PhD; and Jo Nijs, PT, MT, PhD, for their March 2017 article "The Effect of Visual Feedback of the Neck During Movement in People With Chronic Whiplash-Associated Disorders: An Experimental Study." J Orthop Sports Phys Ther 2018;48(5):348. doi:10.2519/jospt.2018.0104.

  4. Prostate Cancer Research Training in Health Disparities for Undergraduates (PCaRT)

    DTIC Science & Technology

    2010-03-01

    management Program Mentors Carlton Adams, M.D. LaMonica Stewart, Ph.D. Ben Ogunkua, M.D., Ph.D. Alphonse Pasipanodya, M.D. Jay Fowke, Ph.D., MPH...African-Americans Alphonse Pasipanodya, MD. (Primary Mentor) Flora A. M. Ukoli, MD., MPH. (Principal Investigator) Derrick Beech, M.D. (Co-PI...my goals is to be a successful black woman influencing and touching the lives of all those I come in contact with daily. Alphonse Pasipanodya

  5. Hemangioma

    MedlinePlus

    ... 38. Review Date 10/24/2016 Updated by: David L. Swanson, MD, Vice Chair of Medical Dermatology, Associate Professor of Dermatology, Mayo Medical School, Scottsdale, AZ. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the ...

  6. Spider angioma

    MedlinePlus

    ... 650. Review Date 10/24/2016 Updated by: David L. Swanson, MD, Vice Chair of Medical Dermatology, Associate Professor of Dermatology, Mayo Medical School, Scottsdale, AZ. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the ...

  7. Rhinophyma

    MedlinePlus

    ... 7. Review Date 10/24/2016 Updated by: David L. Swanson, MD, Vice Chair of Medical Dermatology, Associate Professor of Dermatology, Mayo Medical School, Scottsdale, AZ. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the ...

  8. Fungal nail infection

    MedlinePlus

    ... 268. Review Date 10/24/2016 Updated by: David L. Swanson, MD, Vice Chair of Medical Dermatology, Associate Professor of Dermatology, Mayo Medical School, Scottsdale, AZ. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the ...

  9. [MD PhD programs: Providing basic science education for ophthalmologists].

    PubMed

    Spaniol, K; Geerling, G

    2015-06-01

    Enrollment in MD PhD programs offers the opportunity of a basic science education for medical students and doctors. These programs originated in the USA where structured programs have been offered for many years, but now German universities also run MD PhD programs. The MD PhD programs provided by German universities were investigated regarding entrance requirements, structure and financing modalities. An internet and telephone-based search was carried out. Out of 34 German universities 22 offered MD PhD programs. At 15 of the 22 universities a successfully completed course of studies in medicine was required for enrollment, 7 programs admitted medical students in training and 7 programs required a medical doctoral thesis, which had to be completed with at least a grade of magna cum laude in 3 cases. Financing required scholarships in many cases. Several German universities currently offer MD PhD programs; however, these differ considerably regarding entrance requirements, structure and financing. A detailed analysis investigating the success rates of these programs (e.g. successful completion and career paths of graduates) would be of benefit.

  10. Discovering and Developing Successful Cardiovascular Therapeutics: A Conversation With James N. Topper, MD, PhD.

    PubMed

    Topper, James N; Rutherford, John D

    2016-11-15

    Dr James (also known as Jamie) N. Topper, MD, PhD, serves as Managing General Partner at Frazier Healthcare Partners, where he leads the Life Science Venture practice. In 2011, and 2016, he was named to the Midas List of leading venture capitalists, and, in 2013, he was recognized by Forbes as one of the top 10 healthcare investors. He has >25 years of experience working with entrepreneurs to found and build successful therapeutics-focused companies. Dr Topper holds a BS from the University of Michigan. He received an MD and PhD (in biophysics) from Stanford University School of Medicine. He completed postgraduate training in internal medicine and cardiovascular disease at the Brigham and Women's Hospital in Boston and is board certified in both disciplines. © 2016 American Heart Association, Inc.

  11. Essential Hypertension—Where Are We Going?

    PubMed Central

    Ives, Harlan E.

    1990-01-01

    This discussion was selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from a transcription, it has been edited by Homer A. Boushey, MD, Professor of Medicine, and Nathan M. Bass, MD, PhD, Associate Professor of Medicine, under the direction of Lloyd H. Smith, Jr, MD, Professor of Medicine and Associate Dean in the School of Medicine. Images PMID:2244377

  12. NCI intramural research highlighted at 2014 AACR meeting

    Cancer.gov

    This year’s American Association for Cancer Research meeting featured plenary talks by two NCI scientists, Steven Rosenberg, M.D., and Louis Staudt, M.D., Ph.D., that highlighted the challenges in developing varied and potentially synergistic treatments f

  13. Cancer Data and Statistics Tools

    MedlinePlus

    ... Joseph Jacqueline W. Miller Mona Saraiya Judith Lee Smith Sherri L. Stewart Mary C. White Debra Younginer ... MD, MPH Simple Singh, MD, MPH Judith Lee Smith, PhD Sherri L. Stewart, PhD Eric Tai, MD, ...

  14. 1492--the medical consequences.

    PubMed

    Camargo, C A

    1994-06-01

    This discussion was selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from a transcription, it has been edited by Nathan M. Bass, MD, PhD, Associate Professor of Medicine, under the direction of Lloyd H. Smith Jr, MD, Professor of Medicine and Associate Dean in the School of Medicine.

  15. High Surplus Energy Status Blocks Protective Breast Cancer Gene | Center for Cancer Research

    Cancer.gov

    High caloric intake, weight gain, and obesity are associated with increased risk of postmenopausal breast cancer, but little is known about the molecular processes through which these metabolic factors contribute to cancer. Li-Jun Di, Ph.D., and Alfonso Fernandez, Ph.D., postdoctoral fellows working with Kevin Gardner, M.D., Ph.D., in CCR's Laboratory of Receptor Biology and

  16. Summary of the 2016 Partners Against Mortality in Epilepsy (PAME) Conference.

    PubMed

    2016-01-01

    Authors: Kevin D Graber, MD, Jeffrey Buchhalter, MD, PhD, Elson So, MD, Rainer Surges, MD, Detlev Boison, PhD, Franck Kalume, PhD, Cyndi Wright, Brian Gehlbach, MD, Jeff Noebels, MD, PhD, Vicky Whittemore, PhD, Elizabeth J. Donner, MD, MSc, Tom Stanton, MPP, Henry Smithson, MD, Jane Hanna, Masud Seyal, MD, PhD, Philippe Ryvlin, MD, PhD The third biannual Partners Against Mortality in Epilepsy (PAME) conference was held in Alexandria, VA from June 23-26, 2016. This was an intimate meeting of clinical and basic scientists, clinicians, people affected by Sudden Unexpected Death in Epilepsy Patients (SUDEP) in a loved one, people living with epilepsy and patient advocate organizations. Plenary sessions have been summarized by moderators, including: 1) Mortality in people with epilepsy: epidemiology and surveillance. 2) Mortality in children. 3) What do we know about the factors that predispose certain people to die from a seizure? 4) What are the events that occur during and after a seizure that cause a death in SUDEP? 5) What are the options for prevention now and in the future? 6) Advocacy perspectives: how can we speed up awareness and prevention? 7) Updates and discussion on select programs in mortality research. Breakout sessions allowed for a more focused audience. Those summarized here are: Frequent non-SUDEP causes of mortality in people with epilepsy; Mechanisms of SUDEP; Lessons learned in grief and how to better support families; Future directions for research to impact prevention; and How do we improve SUDEP risk disclosure? While significant progress has been made with review of human mortality in epilepsy and study of animal models, this meeting emphasized the need for: better understandings of the epidemiology of SUDEP, advances in the understandings of mechanisms, continued search for biomarkers and preventative measures, patient education, increased awareness, continued advocacy for patient and family support and research funding.

  17. 1492—The Medical Consequences

    PubMed Central

    Camargo, Carlos A.

    1994-01-01

    This discussion was selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from a transcription, it has been edited by Nathan M. Bass, MD, PhD, Associate Professor of Medicine, under the direction of Lloyd H. Smith Jr, MD, Professor of Medicine and Associate Dean in the School of Medicine. Images PMID:7519808

  18. Development of a Free-Electron Laser Center and Research in Medicine, Biology and Materials Science,

    DTIC Science & Technology

    1992-05-14

    Elastin Production in Tissue Culture", Debra A.Gonzalez MD, David L. Zealear, PhD., J.M. Davidson, PhD., Robert H. Ossoff, MD, DMD , August 1990...Otolaryngoloty-Head and Neck Surgery. K. "CO2 Laser Micromanipulator Parallax Error Resolved, Jay Werkhaven,MD, Jerri Tribble, and Robert H. Ossoff, MD, DMD ...of the Upper Aerodigestive Tract, Robert H. Ossoff, MD, DMD , Al Aly, MD, Nick Houchin, AAS, and Debra Gonzalez, MD, Vanderbilt University, Nashville

  19. 76 FR 38405 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-06-30

    ..., 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Michael H Chaitin, PhD... (Virtual Meeting). Contact Person: David L Williams, PhD, Scientific Review Officer, Center for Scientific... Health, 6701 Rockledge Drive, Bethesda, MD 20817 (Virtual Meeting). Contact Person: David L Williams, PhD...

  20. Colorectal Cancer—A New Look at an Old Problem

    PubMed Central

    Toribara, Neil W.

    1994-01-01

    This discussion was selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from a transcription, it has been edited by Nathan M. Bass, MD, PhD, Associate Professor of Medicine, under the direction of Lloyd H. Smith Jr. MD, Professor of Medicine and Associate Dean in the School of Medicine. Images PMID:7810127

  1. 76 FR 66075 - Center for Scientific Review Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-10-25

    ... applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting..., Bethesda, MD 20892, (Virtual Meeting). Contact Person: Michael H. Chaitin, PhD, Scientific Review Officer... Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: John C Pugh, PhD...

  2. Development of EBM-CDSS (Evidence-Based Clinical Decision Support System) to AIG Prognostication in Terminally Ill Patients

    DTIC Science & Technology

    2016-03-01

    Mbah, PhD2*, Ambuj Kumar, MD, MPH3, Kim Sehwan, PhD4*, Ronald Schonwetter, MD5* and Benjamin Djulbegovic, MD, PhD6 1Center for Evidence - Based Medicine , University...of South Florida, Tampa, FL 2USF, Tampa, FL 3University of South Florida, College of Medicine, Center for Evidence Based Medicine , Tampa...4HPC healthcare, Tampa, FL 5HPC Healthcare, Tampa, FL 6Center for Evidence - Based Medicine & Health Outcomes Research, University of South

  3. Management of Suicide-Related Events during Deployment

    DTIC Science & Technology

    2014-02-01

    progress on site tasks. In addition, Emily Biggs , a Master’s level Research Assistant is assisting with site-specific study activities. At the...Bowles, Ph.D., ABPP; John Bradley, M.D.; Russell B. Carr, M.D.; Charles C. Engel, M.D., MPH; David A. Jobes, Ph.D., ABPP; Chris Martin, LCDR; Kim Ruocco

  4. 75 FR 12766 - National Center on Minority Health and Health Disparities; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-03-17

    ..., Bethesda, MD 20892. (Virtual Meeting) Contact Person: Prabha L. Atreya, PhD, Chief, Office of Scientific... Health, 6706 Democracy Blvd. 800, Bethesda, MD 20892. (Virtual Meeting) Contact Person: Prabha L. Atreya... Democracy Boulevard, Suite 800, Bethesda, MD 20892. (Virtual Meeting) Contact Person: Prabha L. Atreya, PhD...

  5. Tranexamic Acid for Trauma Patients: A Critical Review of the Literature

    DTIC Science & Technology

    2011-07-01

    REVIEW ARTICLE Tranexamic Acid for Trauma Patients: A Critical Review of the Literature Andrew P. Cap, MD, PhD, David G. Baer, PhD, Jean A. Orman...MPH, ScD, James Aden, PhD, Kathy Ryan, PhD, and Lorne H. Blackbourne, MD Background: Tranexamic acid (TXA) is an antifibrinolytic that inhibits both...prospective clinical evidence to support this application. Key Words: Tranexamic acid , Antifibrinolytic agents, Hemorrhage/drug therapy, Wounds and injuries

  6. Prehospital Air Medical Plasma (PAMPer) Trial

    DTIC Science & Technology

    2015-07-01

    Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204...Clifford Calloway MD, PhD, Associate Professor of Emergency Medicine, University of Pittsburgh Mark Yazer, MD, Medical Director Centralized...Transfusion Service; University of Pittsburgh Barbara Early, RN, BSN, CCRC, MACRO CRC Director , University of Pittsburgh C. Investigators at other

  7. Studies of Tissue Perfusion Failure at LAC+USCMC and the Incorporation of the Results into a National Trauma Database

    DTIC Science & Technology

    2005-04-01

    Context Link] 29. Gibson JG, Seligman AM, Peacock WC, et al: The circulating red cell and plasma volume and the distribution of blood in large and...BS; Gandhi, Ashutosh BS; Chien, Li-Chien MD; Lu, Kevin MD; Martin, Matthew J. MD; Chan, Linda S. PhD; Demetriades, Demetrios MD, PhD; Ahmadpour...Physicians Outcome Prediction of Emergency Patients by Noninvasive Hemodynamic Monitoring* William C. Shoemaker, MD; Charles C. J. Wo, BS; Linda

  8. Organtropic Metastatic Secretomes and Exosomes in Breast Cancer

    DTIC Science & Technology

    2016-10-01

    MD, PhD CONTRACTING ORGANIZATION: Joan & Sanford I Weill Medical College of Cornell University New York, NY 10065 REPORT DATE: October 2016 TYPE...STATEMENT: Approved for Public Release; Distribution Unlimited The views, opinions and/or findings contained in this report are those of the author( s ) and...Cancer 5b. GRANT NUMBER N/A 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR( S ) 5d. PROJECT NUMBER David Lyden, MD, PhD, Ayuko Hoshino, PhD, Irina Matei, PhD

  9. Physician Payment Reform—An Idea Whose Time Has Come

    PubMed Central

    Lee, Philip R.

    1990-01-01

    These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from transcriptions, they are prepared by Homer A. Boushey, MD, Professor of Medicine, and Nathan M. Bass, MD, PhD, Associate Professor of Medicine, under the direction of Lloyd H. Smith, Jr, MD, Professor of Medicine and Associate Dean in the School of Medicine. Requests for reprints should be sent to the Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA 94143. PMID:2185598

  10. 76 FR 62423 - National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-10-07

    ...., Rockville, MD 20852, (Telephone Conference Call). Contact Person: Melissa Stick, PhD, MPH, Chief, Scientific...., Rockville, MD 20852, (Telephone Conference Call). Contact Person: Melissa Stick, PhD, MPH, Chief, Scientific...

  11. 75 FR 994 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-01-07

    ..., 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: Lynn Rust, PhD, Scientific Review Officer... of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817. Contact Person: Lynn Rust, PhD...

  12. Imperforate hymen

    MedlinePlus

    ... 149. Sucato GS, Murray PJ. Pediatric and adolescent gynecology. In: Zitelli, BJ, McIntire SC, Norwalk AJ, eds. ... by: Irina Burd, MD, PhD, Associate Professor of Gynecology and Obstetrics at Johns Hopkins University School of ...

  13. Preterm labor

    MedlinePlus

    ... SG, Niebyl JR, Simpson JL, et al, eds. Obstetrics: Normal and Problem Pregnancies . 7th ed. Philadelphia, PA: ... Burd, MD, PhD, Associate Professor of Gynecology and Obstetrics at Johns Hopkins University School of Medicine, Baltimore, ...

  14. 77 FR 16248 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-03-20

    ... (Virtual Meeting). Contact Person: Kenneth A Roebuck, Ph.D., Scientific Review Officer, Center for... Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Robert Freund, Ph.D., Scientific.... Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting...

  15. The NIH Undiagnosed Diseases Program | NIH MedlinePlus the Magazine

    MedlinePlus

    ... to discover and understand rare diseases,” says Eric D. Green, M.D., Ph.D., director of the National Human Genome Research Institute ( ... interdisciplinary approach,” says NIH Director Francis S. Collins, M.D., Ph.D. “The disorder had long-evaded conventional ...

  16. 76 FR 59707 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-09-27

    ..., (Virtual Meeting). Contact Person: Rebecca Henry, PhD, Scientific Review Officer, Center for Scientific... Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: George M Barnas, PhD, Scientific... Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: George M...

  17. Wenyi Wang, Statistical Bioinformatics Expert, Visits DCEG

    Cancer.gov

    In March 2018, Wenyi Wang, Ph.D., Associate Professor in the Department of Bioinformatics and Computational Biology at the University of Texas MD Anderson Cancer Center, visited DCEG to give a seminar and meet with staff.

  18. 32 CFR 199.7 - Claims submission, review, and payment.

    Code of Federal Regulations, 2011 CFR

    2011-07-01

    ....g., M.D., Ph.D., R.N., etc.) and provider number, if the individual signing the claim is not the... rendering the care, along with the individual's professional status (e.g., M.D., Ph.D., R.N., etc.). (xi... the beneficiary's signature. (1) Claims for laboratory and diagnostic tests and test interpretations...

  19. 32 CFR 199.7 - Claims submission, review, and payment.

    Code of Federal Regulations, 2013 CFR

    2013-07-01

    ....g., M.D., Ph.D., R.N., etc.) and provider number, if the individual signing the claim is not the... rendering the care, along with the individual's professional status (e.g., M.D., Ph.D., R.N., etc.). (xi... the beneficiary's signature. (1) Claims for laboratory and diagnostic tests and test interpretations...

  20. 32 CFR 199.7 - Claims submission, review, and payment.

    Code of Federal Regulations, 2012 CFR

    2012-07-01

    ....g., M.D., Ph.D., R.N., etc.) and provider number, if the individual signing the claim is not the... rendering the care, along with the individual's professional status (e.g., M.D., Ph.D., R.N., etc.). (xi... the beneficiary's signature. (1) Claims for laboratory and diagnostic tests and test interpretations...

  1. 77 FR 64812 - National Institute of General Medical Sciences; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-10-23

    ... Hilton Bethesda, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Saraswathy Seetharam, Ph.D... Drive, Room 3An18K, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Brian R. Pike, Ph.D... Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research...

  2. The study of possible influences of licit and illicit drugs on driver behavior

    DOT National Transportation Integrated Search

    1971-12-01

    Study authors were S. William Berg, M.D., John T. Fryback, A.B.; Donald M. Goldenbaum, Ph.D.; Ralph K. Jones, B.S.; Kent B. Joscelyn, J.D.; Roger P. Maickel, Ph.D.; William Z. Potter, M.D.; and Joseph Zabik, M.S. The study investigated the relationsh...

  3. Management of Suicide-Related Events during Deployment

    DTIC Science & Technology

    2015-02-01

    the supervision of the site PI, Dr. Barbara Stanley. Ms. Emily Biggs , a Master’s level Research assistant, left her position to attend graduate...study progress. The members of the Expert Panel are Lanny Berman, Ph.D., ABPP; Stephen V. Bowles, Ph.D., ABPP; John Bradley, M.D.; Russell B. Carr, M.D

  4. Asad Umar, DVM, PhD | Division of Cancer Prevention

    Cancer.gov

    Dr. Asad Umar received his PhD in Biochemistry and Immunology at the Johns Hopkins University in Baltimore, MD, in 1993. He conducted his postdoctoral training in the laboratories of Patricia Gearhart in Baltimore, MD and Thomas Kunkel at the National Institutes of Environmental Health Sciences in Research Triangle Park, NC. Dr. |

  5. Lasker Awards Honor Three Researchers.

    PubMed

    2017-10-01

    Three top cancer researchers were among recipients of the prestigious Albert and Mary Lasker Foundation awards. Douglas R. Lowy, MD, and John T. Schiller, PhD, were honored for research leading to the development of the first human papillomavirus vaccine. The prize for basic medical research went to Michael N. Hall, PhD, who discovered the TOR signaling pathway and its role in regulating cell growth and metabolism. ©2017 American Association for Cancer Research.

  6. Preparing MD-PhD students for clinical rotations: navigating the interface between PhD and MD training.

    PubMed

    Goldberg, Charles; Insel, Paul A

    2013-06-01

    Many aspects of MD-PhD training are not optimally designed to prepare students for their future roles as translational clinician-scientists. The transition between PhD research efforts and clinical rotations is one hurdle that must be overcome. MD-PhD students have deficits in clinical skills compared with those of their MD-only colleagues at the time of this transition. Reimmersion programs (RPs) targeted to MD-PhD students have the potential to help them navigate this transition.The authors draw on their experience creating and implementing an RP that incorporates multiple types of activities (clinical exam review, objective structured clinical examination, and supervised practice in patient care settings) designed to enhance the participants' skills and readiness for clinical efforts. On the basis of this experience, they note that MD-PhD students' time away from the clinical environment negatively affects their clinical skills, causing them to feel underprepared for clinical rotations. The authors argue that participation in an RP can help students feel more comfortable speaking with and examining patients and decrease their anxiety regarding clinical encounters. The authors propose that RPs can have positive outcomes for improving the transition from PhD to clinical MD training in dual-degree programs. Identifying and addressing this and other transitions need to be considered to improve the educational experience of MD-PhD students.

  7. A Comparison of HAART Outcomes between the US Military HIV Natural History Study (NHS) and HIV Atlanta Veterans Affairs Cohort Study (HAVACS)

    DTIC Science & Technology

    2013-05-01

    Acknowledgments The IDCRP HIV Working Group includes: Susan Banks, RN, CAPT Mary Bavaro, MD, Ionut Bebu, PhD, Helen Chun, MD, Nancy Crum- Cianflone, MD, MPH...Cathy Decker, MD, Conner Eggleston, LTC Tomas Ferguson, MD, COL Susan Fraser, MD, MAJ Joshua Hartzell, MD, MAJ Joshua Hawley, MD, LTC Gunther Hsue, MD

  8. Special Spotlight: Levi A. Garraway, M.D., Ph.D.

    Cancer.gov

    Dr. Levi A. Garraway, a former CRCHD CURE trainee, received the prestigious Jane Cooke Wright Lectureship Award at the 2014 meeting of the American Association for Cancer Research and presented "The Cancer Genome in Biology, Therapy, and Drug Resistance.”

  9. 77 FR 72872 - National Institute of Neurological Disorders and Stroke; Notice of Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-12-06

    ... set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications... Associate Director for Extramural Research; and Administrative and Program Developments. Place: National..., Bethesda, MD 20892. Contact Person: Robert Finkelstein, Ph.D., Associate Director for Extramural Research...

  10. Coffee to Go: Woman "Thinks" First Cup in 15 Years | NIH MedlinePlus the Magazine

    MedlinePlus

    ... Bioengineering (NIBIB) www.nibib.nih.gov/ NIBIB Rehabilitation Engineering Program Area www.nibib.nih.gov/Research/ProgramAreas/ ... M.D., Ph.D., an associate professor of engineering at Brown University in Providence, R.I. and ...

  11. Aflatoxin: An Old Carcinogen Teaches Us New Tricks | Division of Cancer Prevention

    Cancer.gov

    Speaker John D. Groopman, PhD Anna M. Baetjer Professor of Environmental Health Sciences Johns Hopkins Bloomberg School of Public Health Associate Director for Population Sciences Sidney Kimmel Comprehensive Cancer Center Johns Hopkins School of Medicine Baltimore, MD |

  12. 77 FR 22320 - Findings of Research Misconduct

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-04-13

    ... DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Research Misconduct... Research Integrity (ORI) has taken final action in the following case: Peter J. Francis, M.D., Ph.D... Dr. Peter J. Francis, Associate Professor, Casey Eye Institute, OHSU, engaged in research misconduct...

  13. Developing a HER3 Vaccine to Prevent Resistance to Endocrine Therapy

    DTIC Science & Technology

    2014-10-01

    Medicine , Duke University Amy Hobeika, PhD, Assistant Research Professor, Department of Surgery, Duke University H. Kim Lyerly, MD, Professor...Department of Surgery, Duke University William Gwin, MD, Fellow, Department of Medicine , Duke University Bruce Burnett, PhD, Director of Regulatory Affairs... herbal products, over- the-counter (OTC) drugs, vitamins, natural remedies, and alcohol that you are taking before you start the study and before

  14. Modeling Aggressive Medulloblastoma Using Human-Induced Pluripotent Stem Cells

    DTIC Science & Technology

    2015-07-01

    Mingyao Ying, Ph.D. CONTRACTING ORGANIZATION: Hugo W. Moser Research Institute at Kennedy Krieger , Inc., Baltimore, MD 21205 REPORT DATE...Cells W81XWH-14-1-0176 Mingyao Ying, Ph.D. Ying@kennedykrieger.org Hugo W. Moser Research Institute at Kennedy Krieger , Inc. Baltimore, MD 21205...medulloblastoma model derived from human induced pluripotent stem cells. Jonathan Sagal1, Charles G. Eberhart2, Mingyao Ying1. 1Kennedy Krieger

  15. Cognition in the Brain: Investigations Using Positron Emission Tomography

    DTIC Science & Technology

    1992-07-16

    0029 DDIRESS (City. State and ZIP Code) 10. SOURCE Of FUNDING NOS. _____________ .dg. 410 PROGRAM PROJECT TASKC WORK .,%r illing Air Force Base, DC...Bethesda, MD 20892 20. Daniel Bubb, M.D. Department of Neurolinguistics Montreal Neurological Institute 15. Sung-cheng tHuang, Ph.D. 3801 University...Chief of Pediatric Neu- rology Service Director, Center for Morphomet- 24. Terry Allard, Ph.D. ric Analysis Cognitive Science Programs Kennedy 9 Office

  16. IMPACT: Imaging and Molecular Markers for Patients with Lung Cancer: Approaches with Molecular Targets, Complementary/Innovative Treatments, and Therapeutic Modalities

    DTIC Science & Technology

    2014-02-01

    DRP-1: Treatment of Malignant Pleural Effusion with ZD6474, a Novel VEGFR and EGFR TK Inhibitor (PI and co-PI: Roy Herbst, M.D., Ph.D., Carlos...Jimenez, M.D.) Recurrent malignant pleural effusion is a debilitating clinical problem that requires palliation with repeated therapeutic...thoracentesis or pleurodesis (Putnam, J Surg Clin North Am 2002). Malignant pleural effusions have been associated with high levels of VEGF. Treatment with a

  17. High Surplus Energy Status Blocks Protective Breast Cancer Gene | Center for Cancer Research

    Cancer.gov

    High caloric intake, weight gain, and obesity are associated with increased risk of postmenopausal breast cancer, but little is known about the molecular processes through which these metabolic factors contribute to cancer. Li-Jun Di, Ph.D., and Alfonso Fernandez, Ph.D., postdoctoral fellows working with Kevin Gardner, M.D., Ph.D., in CCR's Laboratory of Receptor Biology and Gene Expression, were part of a research team that recently discovered a link between cellular metabolism and BRCA1, a protein involved in DNA repair as well as the regulation of cell cycle and the expression of many genes. Their findings were published in a recent issue of Nature Structural and Molecular Biology.

  18. 77 FR 8266 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-02-14

    ..., (Telephone Conference Call). Contact Person: Michael M. Sveda, Ph.D., Scientific Review Officer, Center for..., MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health...). Contact Person: Richard Panniers, Ph.D., Scientific Review Officer, Center for Scientific Review, National...

  19. 75 FR 38111 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-07-01

    ..., (Virtual Meeting). Contact Person: Arnold Revzin, PhD, Scientific Review Officer, Center for Scientific..., (Virtual Meeting). Contact Person: Jerry L. Taylor, PhD, Scientific Review Officer, Center for Scientific... Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Richard Ingraham, PhD, Scientific...

  20. 77 FR 74675 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-12-17

    ... Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Rajiv Kumar, Ph.D., Chief... Chaudhari, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health... Conference Call). Contact Person: Syed M Quadri, Ph.D., Scientific Review Officer, Center for Scientific...

  1. Cloth Ballistic Vest Alters Response to Blast

    DTIC Science & Technology

    1988-01-01

    Detrick, Frederick, MD 21701-501 ELEMENT NO. NO. NO. jACCESSION NO. 11. TITLE (include Security Classification) CLOTH BALLSISTIC VEST ALTERS RESPONSE...Suppl. ’rintd in USA Cloth Ballistic Vest Alters Response to Blast YANCY Y. PHILLIPS, M.D., THOMAS G. MUNDIE, PH.D., JOHN T. YELVERTON, M.S., AND DONALD R...RICHMOND, PH.D. Ballistic wounds have been and will remain the principal cause of casualties in combat. Cloth ballistic vests (CBV) play an

  2. Investigating the Role of Radiation Therapy Breast Cancer Clinical and Translational Research

    DTIC Science & Technology

    2006-05-01

    radiosensitizing and anticancer properties of green tea and curcumin and found a complex response cascade in cell lines. For example, the anticancer ...this fall. 5. Arber Kodra: Effect of Green Tea and Curcumin on Breast Cancer Cell Lines Mentor: Gary Kao, MD PhD Arber examined the...Breast Cancer Elizabeth Gurney Mentor: Gary Kao, MD, PhD Effect of Green Tea and Curcumin on Breast Cancer Cell Lines Arber Kodra Mentor

  3. The conformation of the histone H3 tail inhibits association of the BPTF PHD finger with the nucleosome

    PubMed Central

    Morrison, Emma A; Bowerman, Samuel; Sylvers, Kelli L

    2018-01-01

    Histone tails harbor a plethora of post-translational modifications that direct the function of chromatin regulators, which recognize them through effector domains. Effector domain/histone interactions have been broadly studied, but largely using peptide fragments of histone tails. Here, we extend these studies into the nucleosome context and find that the conformation adopted by the histone H3 tails is inhibitory to BPTF PHD finger binding. Using NMR spectroscopy and MD simulations, we show that the H3 tails interact robustly but dynamically with nucleosomal DNA, substantially reducing PHD finger association. Altering the electrostatics of the H3 tail via modification or mutation increases accessibility to the PHD finger, indicating that PTM crosstalk can regulate effector domain binding by altering nucleosome conformation. Together, our results demonstrate that the nucleosome context has a dramatic impact on signaling events at the histone tails, and highlights the importance of studying histone binding in the context of the nucleosome. PMID:29648537

  4. 76 FR 77544 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-12-13

    ... 20892 (Virtual Meeting). Contact Person: John Firrell, Ph.D., Scientific Review Officer, Center for..., Bethesda, MD 20892 (Virtual Meeting). Contact Person: Aruna K Behera, Ph.D., Scientific Review Officer... Wharf, 2620 Jones Street, San Francisco, CA 94133. Contact Person: Joseph D Mosca, Ph.D., Scientific...

  5. 76 FR 25701 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-05-05

    ... Person: David L Williams, PhD, Scientific Review Officer, Center for Scientific Review, National... Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Christine L. Melchior, PhD, Scientific...

  6. Characterization of Bc1-2, Bc1-xL, and Bax Pore Formation and Their Role in Apoptosis Regulation

    DTIC Science & Technology

    2002-01-01

    Bcl-2, Bcl-xL, and Bax Pore Formation and Their Role in Apoptosis Regulation PRINCIPAL INVESTIGATOR: Frank Stenner -Liewen, Ph.D. Sharon Schendel, Ph.D...AUTHOR(S) Frank Stenner -Liewen, Ph.D. Sharon Schendel, Ph.D. John C. Reed, M.D., Ph.D. 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING

  7. The Risk and Clinical/Molecular Characteristics of Breast Cancer in Women with Neurofibromatosis Type 1

    DTIC Science & Technology

    2014-10-01

    Neurofibromatosis Type 1 PRINCIPAL INVESTIGATOR: Xia Wang, M.D., Ph.D. CONTRACTING ORGANIZATION: Henry Ford Health System Detroit... Neurofibromatosis Type 1” 5b. GRANT NUMBER 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) Betty Diamond 5d. PROJECT NUMBER Xia Wang, MD, PhD; Renee... Neurofibromatosis type 1 (NF1) in a multi-institutional setting. Aim 1 assessed the incidence of breast cancer in this cohort and the clinical

  8. HBCU Summer Undergraduate Training Program in Prostate Cancer: A Partnership Between USU-CPDR and UDC

    DTIC Science & Technology

    2017-10-01

    Bethesda, MD 20817 REPORT DATE: October 2017 TYPE OF REPORT: Annual PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort...AUTHOR(S) Shiv Srivastava, PhD; Taduru Sreenath, PhD; Center for Prostate Disease Research , Dept of Surgery, Uniformed Services University of the...Army Medical Research Materiel Command Fort Detrick, MD 21702-5012 10. SPONSOR/MONITOR’S ACRONYM(S) 11. SPONSOR/MONITOR’S REPORT NUMBER(S) 12

  9. Defining a clinically meaningful effect for the design and interpretation of randomized controlled trials.

    PubMed

    Keefe, Richard S E; Kraemer, Helena C; Epstein, Robert S; Frank, Ellen; Haynes, Ginger; Laughren, Thomas P; McNulty, James; Reed, Shelby D; Sanchez, Juan; Leon, Andrew C

    2013-05-01

    This article captures the proceedings of a meeting aimed at defining clinically meaningful effects for use in randomized controlled trials for psychopharmacological agents. Experts from a variety of disciplines defined clinically meaningful effects from their perspectives along with viewpoints about how to design and interpret randomized controlled trials. The article offers relevant, practical, and sometimes anecdotal information about clinically meaningful effects and how to interpret them. The concept for this session was the work of co-chairs Richard Keefe and the late Andy Leon. Faculty included Richard Keefe, PhD; James McNulty, AbScB; Robert S. Epstein, MD, MS; Shelby D. Reed, PhD; Juan Sanchez, MD; Ginger Haynes, PhD; Andrew C. Leon, PhD; Helena Chmura Kraemer, PhD; Ellen Frank, PhD, and Kenneth L. Davis, MD. The term clinically meaningful effect is an important aspect of designing and interpreting randomized controlled trials but can be particularly difficult in the setting of psychopharmacology where effect size may be modest, particularly over the short term, because of a strong response to placebo. Payers, regulators, patients, and clinicians have different concerns about clinically meaningful effects and may describe these terms differently. The use of moderators in success rate differences may help better delineate clinically meaningful effects. There is no clear consensus on a single definition for clinically meaningful differences in randomized controlled trials, and investigators must be sensitive to specific concerns of stakeholders in psychopharmacology in order to design and execute appropriate clinical trials.

  10. 76 FR 54240 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-08-31

    ...: Robert G. Keefe, PhD, Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, Room 3256... Conference Call). Contact Person: Robert G. Keefe, PhD, Scientific Review Officer, Scientific Review Program... Drive, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Robert G. Keefe, PhD, Scientific...

  11. Nasal Physiology

    MedlinePlus

    ... Anatomy Virtual Anatomy Disclosure Statement Printer Friendly Nasal Physiology Jeremiah A. Alt, MD, PhD Noam Cohen, MD, ... control the inflammation. CONCLUSION An understanding of the physiology of the nose is critical to understand nasal ...

  12. 78 FR 11896 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-02-20

    ... Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Nancy Sheard, SCD, Scientific Review...: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person..., Bethesda, MD 20892, (Virtual Meeting). Contact Person: Heidi B Friedman, Ph.D., Scientific Review Officer...

  13. Coagulopathy and Shock on Admission is Associated with Mortality for Children with Traumatic Injuries at Combat Support Hospitals

    DTIC Science & Technology

    2012-01-01

    Charles E . Wade, PhD; Lorne H. Blackbourne, MD; Philip C. Spinella, MD Trauma remains one of the most common causes of death in all age groups...the U.S. Government. The authors have not disclosed any potential conflicts of interest. For information regarding this article, E -mail: Jpatregnani...ELEMENT NUMBER 6. AUTHOR(S) Patregnani J. T., Borgman M. A., Maegele M., Wade C. E ., Blackbourne L. H., Spinella P. C., 5d. PROJECT NUMBER 5e. TASK

  14. Association of Posttraumatic Stress Disorder with Somatic Symptoms, Health Care Visits, and Absenteeism among Iraq War Veterans

    DTIC Science & Technology

    2007-01-01

    Health Care Visits, and Absenteeism Among Iraq War Veterans Charles W. Hoge, M.D. Artin Terhakopian, M.D. Carl A. Castro, Ph.D. Stephen C. Messer, Ph.D...Disorder With Somatic Symptoms, Health Care Visits, and Absenteeism Among Iraq War Veterans 5a. CONTRACT NUMBER 5b. GRANT NUMBER 5c. PROGRAM ELEMENT...NUMBER 6. AUTHOR(S) 5d. PROJECT NUMBER 5e. TASK NUMBER 5f. WORK UNIT NUMBER 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) Walter Reed Army

  15. 75 FR 25277 - National Institute on Drug Abuse; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-05-07

    ... applications. Place: National Institutes of Health, 6101 Executive Boulevard, Rockville, MD 20852 (Virtual..., Rockville, MD 20852 (Virtual Meeting). Contact Person: Gerald L. McLaughlin, PhD, Scientific Review...

  16. Defining a Clinically Meaningful Effect for the Design and Interpretation of Randomized Controlled Trials

    PubMed Central

    Kraemer, Helena C.; Epstein, Robert S.; Frank, Ellen; Haynes, Ginger; Laughren, Thomas P.; Mcnulty, James; Reed, Shelby D.; Sanchez, Juan; Leon, Andrew C.

    2013-01-01

    Objective: This article captures the proceedings of a meeting aimed at defining clinically meaningful effects for use in randomized controlled trials for psychopharmacological agents. Design: Experts from a variety of disciplines defined clinically meaningful effects from their perspectives along with viewpoints about how to design and interpret randomized controlled trials. Setting: The article offers relevant, practical, and sometimes anecdotal information about clinically meaningful effects and how to interpret them. Participants: The concept for this session was the work of co-chairs Richard Keefe and the late Andy Leon. Faculty included Richard Keefe, PhD; James McNulty, AbScB; Robert S. Epstein, MD, MS; Shelby D. Reed, PhD; Juan Sanchez, MD; Ginger Haynes, PhD; Andrew C. Leon, PhD; Helena Chmura Kraemer, PhD; Ellen Frank, PhD, and Kenneth L. Davis, MD. Results: The term clinically meaningful effect is an important aspect of designing and interpreting randomized controlled trials but can be particularly difficult in the setting of psychopharmacology where effect size may be modest, particularly over the short term, because of a strong response to placebo. Payers, regulators, patients, and clinicians have different concerns about clinically meaningful effects and may describe these terms differently. The use of moderators in success rate differences may help better delineate clinically meaningful effects. Conclusion: There is no clear consensus on a single definition for clinically meaningful differences in randomized controlled trials, and investigators must be sensitive to specific concerns of stakeholders in psychopharmacology in order to design and execute appropriate clinical trials. PMID:23882433

  17. 76 FR 12125 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-03-04

    ..., Bethesda, MD 20892. (Telephone Conference Call). Contact Person: Carol J. Goter-Robinson, PhD, Scientific...: Carol J. Goter-Robinson, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes...

  18. Conjunctivitis

    MedlinePlus

    ... 22. Review Date 8/20/2016 Updated by: Franklin W. Lusby, MD, ophthalmologist, Lusby Vision Institute, La Jolla, CA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Pinkeye Read more NIH ...

  19. 75 FR 54159 - Center for Scientific Review; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-09-03

    ..., MD 20892 (Telephone Conference Call). Contact Person: Daniel F McDonald, PhD, Scientific Review... 7814, Bethesda, MD 20892, (301) 435-1215, mcdonald@csr.nih.gov . This notice is being published less...

  20. HEALTH EFFECTS OF CHRONIC EXPOSURE TO ARSENIC VIA DRINKING WATER IN INNER MONGOLIA: II. VIBROTACTILE AND VISUAL MEASURES FINAL DOCUMENT TITLE.

    EPA Science Inventory

    HEALTH EFFECTS OF CHRONIC EXPOSURE TO ARSENIC IN DRINKING WATER IN INNER MONGOLIA: II. VIBROTACTILE AND VISUAL MEASURES.

    David Otto, Ph.D., Judy Mumford, Ph.D., Richard Kwok, M.S.P.H., Ken Hudnell, Ph.D.,
    U.S. Environmental Protection Agency; Yanhong Li, M.D., Yajuan ...

  1. Swiss national MD-PhD-program: an outcome analysis.

    PubMed

    Kuehnle, Katrin; Winkler, David T; Meier-Abt, Peter J

    2009-09-19

    This study aims at a first evaluation of the outcome of the Swiss national MD-PhD program during the last 16 years. One hundred and twenty six former and current students in the Swiss national MD-PhD program were surveyed via a Web-based questionnaire in September 2007. Twenty-four questions assessed information regarding participant demographics, information on the PhD thesis and publication activity, current positions and research activity, as well as participant's opinions, attitudes and career goals. Eighty questionnaires were received from 126 MD-PhD students and graduates (63.5% response rate). The responders consisted of present students (36%), former graduates (56%), and dropouts (8%). The percentage of women in the program was 23%, and the average duration of the program was 4.2 +/- 1.4 years. Research interests were predominantly in the fields of neuroscience, immunology, molecular biology and cancer research. A considerable portion of the MD-PhD graduates had an excellent publication record stemming from their PhD research work, and 89% were planning to continue a research-orientated career. Over 50% of those MD-PhD graduates completing their thesis before 2002 had already reached an assistant or full professor position at the time of the survey. Nearly all participants considered the MD-PhD training helpful to their career and high quality standards were assigned to the acquired practical and intellectual skills. However, criticism was expressed concerning the general mentoring and the career related mentoring. Moreover, general mentoring and career related mentoring were significantly less well perceived in research groups employing more than seven PhD students at the same time. The MD-PhD students and graduates surveyed were satisfied with their education and most of them continued a research-orientated career. Regarding the overall positive evaluation, this study supports the view that MD-PhD graduates are well qualified for a successful career in academic medicine.

  2. Ability to Consent to Parkinson Disease Research

    MedlinePlus

    ... Steven Karceski, MD The ability to consent to Parkinson disease research Eran Klein, MD, PhD WHAT IS THIS ... 1 on giving consent to be part of Parkinson disease (PD) research. People with PD often want to ...

  3. Eyelid bump

    MedlinePlus

    ... 423. Review Date 8/20/2016 Updated by: Franklin W. Lusby, MD, ophthalmologist, Lusby Vision Institute, La Jolla, CA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Eyelid Disorders Read more ...

  4. 76 FR 11798 - National Center for Research Resources; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-03-03

    ... Blvd., 1064, Bethesda, MD 20892-4874 (Telephone Conference Call). Contact Person: Guo Zhang, PhD... Health, 6701 Democracy Blvd., Dem. 1, Room 1064, MSC 4874, Bethesda, MD 20892-4874, 301-435-0812, zhanggu...

  5. "Academic racism" and the neglected scholarship of the anatomist M. Wharton Young, MD, PhD (1904-1986).

    PubMed

    Heywood, Peter

    2018-02-01

    Moses Wharton Young, MD, PhD (1904-1986), was an African American Professor of Neuroanatomy at Howard University College of Medicine from 1934 to 1973, during which time he authored about 100 publications on topics that included baldness, asthma, glaucoma, and, most importantly, the structure and function of the inner ear and the pathophysiology of blast injuries. Much of Young's research was ignored during his lifetime, raising the question whether this professional neglect was an instance of "academic racism."

  6. 78 FR 17937 - National Institute of Biomedical Imaging and Bioengineering; Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-03-25

    ... F. Bolger Center, 9600 Newbridge Drive, Potomac, MD 20854. Closed: 12:30 p.m. to 3:30 p.m. Agenda... Newbridge Drive, Potomac, MD 20854. Contact Person: Anthony Demsey, Ph.D., Director, National Institute of...

  7. 78 FR 69430 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-11-19

    ... on Imaging and Biomarkers for Early Cancer, Detection (R01). Date: December 10, 2013. Time: 11:45 a.m... Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review...

  8. 75 FR 43993 - National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-07-27

    ... Level), Bethesda, MD 20817. Contact Person: Anthony Demsey, PhD, Director, National Institute of... Level), Bethesda, MD 20817. Closed: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications...

  9. 75 FR 18216 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-04-09

    ..., Democracy II, 6707 Democracy Blvd, Suite 900, Bethesda, MD 20892. Contact Person: John K. Hayes, PhD, Scientific Review Officer, 6707 Democracy Boulevard, Suite 959, Democracy Two, Bethesda, MD 20892, 301-451...

  10. 76 FR 81951 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-12-29

    ..., Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review Officer... Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 93.337, 93.393-93.396...

  11. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.

    PubMed

    Grunberger, George; Handelsman, Yehuda; Bloomgarden, Zachary T; Fonseca, Vivian A; Garber, Alan J; Haas, Richard A; Roberts, Victor L; Umpierrez, Guillermo E

    2018-03-01

    This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there are no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician. AACE/ACE Task Force on Integration of Insulin Pumps and Continuous Glucose Monitoring in the Management of Patients With Diabetes Mellitus Chair George Grunberger, MD, FACP, FACE Task Force Members Yehuda Handelsman, MD, FACP, FNLA, MACE Zachary T. Bloomgarden, MD, MACE Vivian A. Fonseca, MD, FACE Alan J. Garber, MD, PhD, FACE Richard A. Haas, MD, FACE Victor L. Roberts, MD, MBA, FACP, FACE Guillermo E. Umpierrez, MD, CDE, FACP, FACE Abbreviations: AACE = American Association of Clinical Endocrinologists ACE = American College of Endocrinology A1C = glycated hemoglobin BGM = blood glucose monitoring CGM = continuous glucose monitoring CSII = continuous subcutaneous insulin infusion DM = diabetes mellitus FDA = Food & Drug Administration MDI = multiple daily injections T1DM = type 1 diabetes mellitus T2DM = type 2 diabetes mellitus SAP = sensor-augmented pump SMBG = self-monitoring of blood glucose STAR 3 = Sensor-Augmented Pump Therapy for A1C Reduction phase 3 trial.

  12. Stability of Tranexamic Acid after 12-Week Storage at Temperatures from -20 deg C to 50 deg C

    DTIC Science & Technology

    2013-07-01

    PRELIMINARY REPORTS STABILITY OF TRANEXAMIC ACID AFTER 12-WEEK STORAGE AT TEMPERATURES FROM –20◦C TO 50◦C Rodolfo de Guzman, Jr., MT, I. Amy...Polykratis, BS, Jill L. Sondeen, PhD, Daniel N. Darlington, PhD, Andrew P. Cap, MD, PhD, Michael A. Dubick, PhD ABSTRACT Background. Tranexamic acid (TXA) is... tranexamic acid ; temperature stability; HPLC; thromboelastography; storage PREHOSPITAL EMERGENCY CARE 2013;17:394–400 BACKGROUND Hemorrhage is the leading

  13. Ohio Army National Guard Mental Health Initiative: Risk and Resilience Factors for Combat-Related Posttraumatic Psychopathology and Post Combat Adjustment

    DTIC Science & Technology

    2011-10-01

    Goldmann, M.P.H., Edwin Shirley, Ph.D., Thomas Fine, M.A., Toyomi Goto, M.A., Kimberly Wilson, MSW, Stephen Ganocy, Ph.D., Philip Chan, M.S., Alphonse ...Kimberly Wilson, MSW, Stephen Ganocy, Ph.D., Philip Chan, M.S., Alphonse Derus, B.S., Mary Beth Serrano, M.A., Sandro Galea, M.D. Literature

  14. Leonard F. Peltier, MD, PhD, 1920-2003.

    PubMed

    Reckling, Frederick W; Lo Vecchio, Janolyn G; Reckling, JoAnn B

    2004-05-01

    Leonard F. Peltier, MD, PhD, was an orthopaedic surgeon, academician, administrator, laboratory investigator, historian, and mentor. His career spanned nearly six decades, beginning with graduate education at the University of Minnesota (UM) under the auspices of Owen H. Wangensteen, MD, PhD. In addition to obtaining a PhD in physiology in the UM Graduate School, he completed general and orthopaedic surgery residencies and attained board certification in each specialty. He served in the US Army Occupation Force Medical Corps in Germany just after World War II. In 1957, at 37 years old, he assumed the chairmanship of the orthopaedic training program at the University of Kansas. In 1971, he couldn't resist the opportunity to become one of the founding members of the "start-up" University of Arizona College of Medicine, accepting an appointment as chair of the new orthopaedic training program, where he remained until his retirement in 1990. He took clinical problems to the laboratory, and made important scientific contributions, particularly in the area of fat embolism and in using calcium sulfate (plaster of Paris) to fill bone defects. He served on governing boards of national professional organizations and presided over the American Association for the Surgery of Trauma from 1980-1981. Throughout his career, he was fascinated by, and published extensively in, the history of medicine arena. Known fondly as "the professor" to many of his residents and colleagues, he had a pragmatic, honest, upbeat, and often humorous approach to life's challenges, valuing personal integrity above other virtues. He explored various eclectic interests far beyond his professional contributions while maintaining his family as a central priority. With his exemplary productivity and interests in the surgical and laboratory sciences, history of medicine, appreciation of fine arts, and perceptive and effective interactions with family, friends, patients, and colleagues, the memory of Leonard Peltier evokes the image of a modern-day Renaissance man.

  15. 78 FR 55750 - National Cancer Institute; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-09-11

    ..., Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of.... Contact Person: Caterina Bianco, MD, Ph.D., Scientific Review Officer, Research Programs Review Branch...: David G. Ransom, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of...

  16. 77 FR 45644 - National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-08-01

    ... Drive, Conference Room 1, Potomac, MD 20854. Closed: 1:00 p.m. to 3:00 p.m. Agenda: To review and... Newbridge Drive, Conference Room 1, Potomac, MD 20854. Contact Person: Anthony Demsey, Ph.D., Director...

  17. Trigger finger

    MedlinePlus

    ... by: C. Benjamin Ma, MD, Assistant Professor, Chief, Sports Medicine and Shoulder Service, UCSF Department of Orthopaedic Surgery. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Related MedlinePlus Health Topics Finger Injuries and Disorders ...

  18. 78 FR 10186 - Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-02-13

    ..., MD 20814. Contact Person: Peter Zelazowski, Ph.D., Scientific Review Officer, Division of Scientific... Executive Blvd., Room 5B01, Bethesda, MD 20892, 301-435-6902, peter[email protected] . (Catalogue of...

  19. 76 FR 61720 - Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-10-05

    ..., MD 20814. Contact Person: Peter Zelazowski, PhD, Scientific Review Officer, Division of Scientific... Executive Blvd., Room 5B01, Bethesda, MD 20892, 301-435-6902, peter[email protected] . (Catalogue of...

  20. 77 FR 6570 - Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-02-08

    ..., MD 20852. Contact Person: Peter Zelazowski, Ph.D., Scientific Review Officer, Division of Scientific... Executive Blvd., Room 5B01, Bethesda, MD 20892, (301) 435-6902, peter[email protected] . (Catalogue of...

  1. A Prospective, Randomized Trial of Intravenous Prochlorperazine Versus Subcutaneous Sumatriptan in Acute Migraine Therapy in the Emergency Department(Preprint)

    DTIC Science & Technology

    2009-01-01

    Acute Migraine Therapy in the Emergency Department Mark A. Kostic, MD Francisco J. Gutierrez, MD Thomas S. Rieg, PhD Tammy S. Moore, MD Richard T...1995;25:154-155. 17. Goldstein J, Camargo CA Jr, Pelletier J, et al. Headache in United States emergency departments: demography, work up and

  2. 78 FR 28600 - National Institute of General Medical Sciences; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-05-15

    .... Trempe, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General..., 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Lee Warren Slice, Ph.D., Scientific Review..., Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry...

  3. 76 FR 54238 - National Institute on Aging; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-08-31

    ... personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel, Work Levels..., Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Rebecca J. Ferrell, PhD, Scientific Review... Person: Rebecca J. Ferrell, PhD, Scientific Review Officer, National Institute on Aging, Gateway Building...

  4. Synovial biopsy

    MedlinePlus

    ... Updated by: C. Benjamin Ma, MD, Professor, Chief, Sports Medicine and Shoulder Service, UCSF Department of Orthopaedic Surgery, San Francisco, CA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Autoimmune Diseases Read more Biopsy Read more Fungal ...

  5. Carpal tunnel biopsy

    MedlinePlus

    ... Updated by: C. Benjamin Ma, MD, Professor, Chief, Sports Medicine and Shoulder Service, UCSF Department of Orthopaedic Surgery, San Francisco, CA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Amyloidosis Read more Biopsy Read more Carpal Tunnel ...

  6. Metatarsus adductus

    MedlinePlus

    ... 2016 Updated by: C. Benjamin Ma, MD, Chief, Sports Medicine and Shoulder Service, UCSF Department of Orthopaedic Surgery, San Francisco, CA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Foot Injuries and Disorders Read more NIH MedlinePlus ...

  7. Tendon repair

    MedlinePlus

    ... Updated by: C. Benjamin Ma, MD, Professor, Chief, Sports Medicine and Shoulder Service, UCSF Department of Orthopaedic Surgery, San Francisco, CA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Sprains and Strains Read more NIH MedlinePlus Magazine ...

  8. Compartment syndrome

    MedlinePlus

    ... Updated by: C. Benjamin Ma, MD, Professor, Chief, Sports Medicine and Shoulder Service, UCSF Department of Orthopaedic Surgery, San Francisco, CA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Muscle Disorders Read more NIH MedlinePlus Magazine Read ...

  9. Kyphosis

    MedlinePlus

    ... Updated by: C. Benjamin Ma, MD, Professor, Chief, Sports Medicine and Shoulder Service, UCSF Department of Orthopaedic Surgery, San Francisco, CA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Spine Injuries and Disorders Read more NIH MedlinePlus ...

  10. Tenosynovitis

    MedlinePlus

    ... Updated by: C. Benjamin Ma, MD, Professor, Chief, Sports Medicine and Shoulder Service, UCSF Department of Orthopaedic Surgery, San Francisco, CA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Tendinitis Read more NIH MedlinePlus Magazine Read more ...

  11. Bunion removal

    MedlinePlus

    ... Updated by: C. Benjamin Ma, MD, Professor, Chief, Sports Medicine and Shoulder Service, UCSF Department of Orthopaedic Surgery, San Francisco, CA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Toe Injuries and Disorders Read more NIH MedlinePlus ...

  12. Hammer toe

    MedlinePlus

    ... by: C. Benjamin Ma, MD, Assistant Professor, Chief, Sports Medicine and Shoulder Service, UCSF Department of Orthopaedic Surgery, San Francisco, CA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Toe Injuries and Disorders Read more NIH MedlinePlus ...

  13. Replantation of digits

    MedlinePlus

    ... Updated by: C. Benjamin Ma, MD, Professor, Chief, Sports Medicine and Shoulder Service, UCSF Department of Orthopaedic Surgery, San Francisco, CA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Finger Injuries and Disorders Read more Toe Injuries ...

  14. 76 FR 62081 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-10-06

    ... Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ai-Ping Zou, M.D., PhD, Scientific..., Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846...

  15. 76 FR 51379 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-08-18

    ... Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: John Bleasdale, PhD, Scientific Review.... Contact Person: Reed A Graves, PhD, Scientific Review Officer, Center for Scientific Review, National... Group Biochemistry and Biophysics of Membranes Study Section. Date: September 26-27, 2011. Time: 8 a.m...

  16. 75 FR 32956 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-06-10

    ... Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Joanna M. Pyper, PhD, Scientific Review...: Yi-Hsin Liu, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of... . Name of Committee: Center for Scientific Review Special Emphasis Panel, RFA-DA-10-017: Seek, Test, and...

  17. 78 FR 31951 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-05-28

    ..., Bethesda, MD 20892, (Virtual Meeting). Contact Person: Nuria E Assa-Munt, Ph.D., Scientific Review Officer...; Small Business: Education, Psychology, and Biology in Health Behavior. Date: June 24-25, 2013. Time: 8..., (Virtual Meeting). Contact Person: David R Filpula, Ph.D., Scientific Review Officer, Center for Scientific...

  18. 78 FR 63231 - National Institute of General Medical Sciences; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-10-23

    ... Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Nina Sidorova, Ph.D., Scientific Review Officer..., Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical... Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to...

  19. 78 FR 51735 - Center For Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-08-21

    ...: Biological Chemistry and Macromolecular Biophysics. Date: August 26, 2013. Time: 11:00 a.m. to 12:00 p.m... Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Nitsa Rosenzweig, Ph.D... Conference Call). Contact Person: Aftab A Ansari, Ph.D., Scientific Review Officer, Center for Scientific...

  20. 76 FR 81953 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-12-29

    ... Person: John Firrell, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes...: Biological Chemistry and Macromolecular Biophysics. Date: January 19-20, 2012. Time: 11 a.m. to 10 p.m... Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Donald L. Schneider, Ph.D., Scientific...

  1. 77 FR 62245 - National Institute of General Medical Sciences Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-10-12

    ... Slice, Ph.D., Scientific Review Officer, David Geffen School of Medicine, University of California, Los... North, 6130 Executive Boulevard, Room H, Rockville, MD 20892. Contact Person: Arthur L. Zachary, Ph.D..., Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry...

  2. 78 FR 50065 - National Cancer Institute; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-08-16

    ... Methodological Research for Cancer Epidemiology Cohorts. Date: October 25, 2013. Time: 10:30 a.m. to 2:30 p.m... Lopaczynski, MD, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural.... Contact Person: Shakeel Ahmad, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division...

  3. 75 FR 20852 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-04-21

    ...: Biological Chemistry and Macromolecular Biophysics. Date: May 26-27, 2010. Time: 11 a.m. to 10 p.m. Agenda..., Bethesda, MD 20892 (Virtual Meeting). Contact Person: Donald L. Schneider, PhD, Scientific Review Officer..., Bethesda, MD 20892 (Telephone Conference Call). [[Page 20853

  4. Bursitis of the heel

    MedlinePlus

    ... by: C. Benjamin Ma, MD, Assistant Professor, Chief, Sports Medicine and Shoulder Service, UCSF Department of Orthopaedic Surgery, San Francisco, CA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Bursitis Read more Heel Injuries and Disorders Read ...

  5. Limited range of motion

    MedlinePlus

    ... Updated by: C. Benjamin Ma, MD, Professor, Chief, Sports Medicine and Shoulder Service, UCSF Department of Orthopaedic Surgery, San Francisco, CA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Joint Disorders Read more NIH MedlinePlus Magazine Read ...

  6. 78 FR 38999 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-06-28

    ..., (Virtual Meeting). Contact Person: Elena Smirnova, Ph.D., Scientific Review Officer, Center for Scientific... of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Kenneth A... Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Krish...

  7. Greene/Feizi - U of Penn; Imperial College | Division of Cancer Prevention

    Cancer.gov

    Principal Investigator: Mark Greene, MD, PhDInstitution: University of Pennsylvania, Philadelphia, PA Subcontract Principal Investigator: Ten Feizi, MD, FmedSciInstitution: Imperial College London Former Principal Investigator: Minoru Fukuda, PhD (retired)Institution: Sanford Burnham Medical Research Institute, La Jolla, CA |

  8. Female condoms

    MedlinePlus

    ... of Gynecology and Obstetrics at Johns Hopkins University School of Medicine, Baltimore, MD. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Birth Control Read more NIH MedlinePlus Magazine Read more Health ...

  9. Examination of publications from academic anesthesiology faculty in the United States.

    PubMed

    Hurley, Robert W; Zhao, Kevin; Tighe, Patrick J; Ko, Phebe S; Pronovost, Peter J; Wu, Christopher L

    2014-01-01

    Leaders in academic anesthesiology in the United States have called for an examination of the state of scholarship within anesthesiology departments. National Institutes of Health funding and publication quality of subsets of U.S anesthesiologists have been examined; however, the publication output of and the demographic characteristics that are associated with academic anesthesiologists, defined as faculty associated with a medical college, are unknown. A database from the American Association of Medical Colleges containing demographic information of all academic anesthesiologists in the United States was used to examine the publication output and demographic characteristics of anesthesiology faculty during a 2-year period from 2006 to 2008. All the publications found in the PubMed database for each faculty member were retrieved and included in a database containing their demographics including institution, gender, academic degree, academic rank, nature of appointment (part versus full-time), status of appointment (joint versus primary), departmental division, subspecialty certification status, and additional graduate medical education training. Six thousand one hundred forty-three faculty who held positions at the 108 U.S. academic anesthesiology programs published 8521 manuscripts between 2006 and 2008. Thirty-seven percent of faculty published a manuscript, and the overall median publication rate was 0. The proportion of faculty with at least 1 publication was larger among faculty with higher rank (Odds Ratio [OR] for professors versus instructors = 6.4; confidence interval [CI], 4.57-8.49; P < 0.0001), male gender (OR 1.3; CI, 0.14-1.47; P < 0.0001), possessing a courtesy appointment status (OR 2.1; CI, 1.25-3.52; P = 0.0048) and lacking postgraduate training and subspecialty certification (OR for MD versus MD w/training + certification 1.3; CI, 1.11-1.60; P = 0.0020). Those faculty with an MD had lower probablility of publishing when compared with MD/PhD or PhD faculty (OR 0.45; CI, 0.32-0.65; P < 0.0001; OR 0.27; CI, 0.20-0.37; P < 0.0001, respectively). Within the group of faculty who published at least 1 paper, full professor faculty had 3.8 times more publications than instructors (CI, 2.99-4.88; P < 0.0001), and those who lacked postgraduate training had 1.4 times more publications than those who were trained and certified (CI, 1.16-1.78; P = 0.0009). PhD degree (P = 0.006), male gender (P = 0.013), and courtesy anesthesia appointment (P = 0.037) also were associated with higher publication rates. The overall publication rate of anesthesiologists associated with medical schools was low in this time period. These data establish the pre-"call to action" baseline of scholarly activity by U.S. academic anesthesiologists for future comparisons. Increased use of structured resident and fellow research education programs as well as recruiting more MD/PhD and PhD scientists to the field may help to improve the publication productivity of academic anesthesiology departments.

  10. Repair of webbed fingers or toes

    MedlinePlus

    ... Updated by: C. Benjamin Ma, MD, Professor, Chief, Sports Medicine and Shoulder Service, UCSF Department of Orthopaedic Surgery, San Francisco, CA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Finger Injuries and Disorders Read more Toe Injuries ...

  11. Birth control pills - overview

    MedlinePlus

    ... of Gynecology and Obstetrics at Johns Hopkins University School of Medicine, Baltimore, MD. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Birth Control Read more NIH MedlinePlus Magazine Read more Health ...

  12. Prospective Study of Respiratory Infections at the U.S. Naval Academy

    DTIC Science & Technology

    2001-09-01

    conducting the .findings were significant in demonstrating infection cause and study at the U.S. Naval Academy: Tomoko Hooper, MD MPH; Richard Jhe large...leven M, Ursi D, Van Bever H, Quint W, Niesters HG, Goossens H: Detection of disease. J Infect Dis 1992; 166: 365-73. Mycoplasmapneumoniaeby two...6. AUTHORS 5d. Project Number: Gregory C. Gray, MD, MPH; Robert G. Schultz, MD; Gary D. Gackstetter, DVM, 5e. Task Number: PhD; Richard Thomas, MD

  13. Outcomes of Bacteremia in Burn Patients Involved in Combat Operations Overseas

    DTIC Science & Technology

    2008-03-01

    MD, Mark S Rasnake, MD, Duane R Hospenthal, MD, PhD, FACP, Steven E Wolf, MD, FACS BACKGROUND: Burn patients constitute approximately 5% of...GRANT NUMBER 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR( S ) Ressner R. A., Murray C. K., Griffith M. E., Rasnake M. S ., Hospenthal D. R., Wolf S . E...5d. PROJECT NUMBER 5e. TASK NUMBER 5f. WORK UNIT NUMBER 7. PERFORMING ORGANIZATION NAME( S ) AND ADDRESS(ES) United States Army Institute of Surgical

  14. Medicare Advantage: Issues, Insights, and Implications for the Future

    PubMed Central

    Cotton, Paul; Newhouse, Joseph P.; Volpp, Kevin G.; Fendrick, A. Mark; Oesterle, Susan Lynne; Oungpasuk, Pat; Aggarwal, Ruchi; Wilensky, Gail; Sebelius, Kathleen

    2016-01-01

    Medicare Advantage: Issues, Insights, and Implications for the Future Paul Cotton, Joseph P. Newhouse, PhD, Kevin G. Volpp, MD, PhD, A. Mark Fendrick, MD, Susan Lynne Oesterle, Pat Oungpasuk, Ruchi Aggarwal, Gail Wilensky, PhD, and Kathleen Sebelius Editorial   S-2 D.B. Nash, and A.Y. Schwartz The History, Impact, and Future of the Medicare Advantage Star Ratings System   S-3 P. Cotton Medicare Advantage and Traditional Fee-For-Service Medicare   S-4 J.P. Newhouse Behavioral Economics: Key to Effective Care Management Programs for Patients, Payers, and Providers   S-5 K.G. Volpp Value-Based Insurance Design: A Promising Strategy for Medicare Advantage   S-6 A.M. Fendrick, S.L. Oesterle, P. Oungpasuk, and R. Aggarwal Two Perspectives on the Future of Medicare Advantage   S-7 G. Wilensky and K. Sebelius PMID:27834576

  15. 78 FR 52206 - Center For Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-08-22

    ...: Biophysics, Biochemistry and Chemistry. Date: September 18-19, 2013. Time: 8:00 a.m. to 3:00 p.m. Agenda: To..., Bethesda, MD 20892 (Virtual Meeting). Contact Person: John L Bowers, Ph.D., Scientific Review Officer..., Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701...

  16. Effects of diesel exhaust on influenza-induced nasal inflammation

    EPA Science Inventory

    Title: Effects of Diesel Exhaust on Influenza-Induced Nasal Inflammation T L Noah, MD1,2, K Horvath, BS3, C Robinette, RN2, 0 Diaz Sanchez, PhD4 and I Jaspers, PhD1,2. 1UNC Dept. of Pediatrics, United States; 2UNC Center for Environmental Medicine, Asthma and Lung Biology, ...

  17. 78 FR 24223 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-04-24

    ... Imaging and Bioengineering Special Emphasis Panel; Center for Multiscale Simulations in the Human..., Bethesda, MD 20892, (Virtual Meeting). Contact Person: John K. Hayes, Ph.D., Scientific Review Officer... Boulevard, Room 959, Bethesda, MD 20892, 301-451-3398, [email protected] . Dated: April 18, 2013. David...

  18. 78 FR 38065 - Office of the Director, National Institutes of Health; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-06-25

    ... Rockville Pike, Rockville, MD 20852. Contact Person: Barbara J. Nelson, Ph.D., Scientific Review Officer, Office of Grants Management and Scientific Review, National Center for Advancing Translational Sciences..., National Center for Advancing Translational Sciences, 6701 Democracy Blvd., Room 1078, Bethesda, MD 20892...

  19. 76 FR 75888 - National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-12-05

    ... assistance, such as sign language interpretation or other reasonable accommodations, should notify the... Level, Bethesda, MD 20817. Closed: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications... Level, Bethesda, MD 20817. Contact Person: Anthony Demsey, Ph.D., Director, National Institute of...

  20. 77 FR 35988 - National Institute of Dental and Craniofacial Research; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-06-15

    ... review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Victor Henriquez, PhD., Scientific Review Officer, DEA/SRB/NIDCR, 6701 Democracy Blvd., Room 668, Bethesda, MD 20892-4878, 301-451...

  1. 76 FR 28055 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-05-13

    ... review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892. Contact Person: Ruixia Zhou, PhD, Scientific Review Officer, 6707 Democracy Boulevard, Democracy Two Building, Suite 957, Bethesda, MD 20892, 301-496-4773, [email protected

  2. 77 FR 71605 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-12-03

    ... Institutes of Health, Two Democracy Plaza, 951, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Ruixia Zhou, Ph.D., Scientific Review Officer, 6707 Democracy Boulevard, Democracy Two Building, Suite 957, Bethesda, MD 20892, 301-496-4773, [email protected] . Name of Committee...

  3. 78 FR 6126 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting.

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-01-29

    ... Institutes of Health, Two Democracy Plaza, Suite 920, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Ruixia Zhou, Ph.D., Scientific Review Officer, 6707 Democracy Boulevard, Democracy Two Building, Suite 957, Bethesda, MD 20892, 301-496-4773, [email protected] . Dated...

  4. ROLE OF INSTITUTIONAL CLIMATE IN FOSTERING DIVERSITY IN BIOMEDICAL RESEARCH WORKFORCE: A CASE STUDY

    PubMed Central

    Butts, Gary C.; Hurd, Yasmin; Palermo, Ann-Gel S.; Delbrune, Denise; Saran, Suman; Zony, Chati; Krulwich, Terry A.

    2012-01-01

    This article reviews the barriers to diversity in biomedical research, describes the evolution and efforts to address climate issues to enhance the ability to attract, retain and develop underrepresented minorities (URM) - underrepresented minorities whose underrepresentation is found both in science and medicine, in the graduate school biomedical research doctoral programs (PhD and MD/PhD) at Mount Sinai School of Medicine (MSSM). We also describe the potential beneficial impact of having a climate that supports diversity and inclusion in the biomedical research workforce. MSSM diversity climate efforts are discussed as part of a comprehensive plan to increase diversity in all institutional programs PhD, MD/PhD, MD, and at the residency, post doctoral fellow, and faculty levels. Lessons learned from four decades of targeted programs and activities at MSSM may be of value to other institutions interested in improving diversity in the biomedical science and academic medicine workforce. PMID:22786740

  5. The Role of AKT2 in Human Breast Cancer

    DTIC Science & Technology

    2002-06-01

    factors, Aktl becomes phosphorylated at these two serous cystadenocarcinomas , four mucinous cystadeno- residues. It has been shown that AKT2 is activated...AD Award Number: DAMD17-01-1-0397 TITLE: The Role of AKT2 in Human Breast Cancer PRINCIPAL INVESTIGATOR: Zeng Qiang Yuan, Ph.D. Jin Q. Cheng, M.D...in Human Breast Cancer DAMD17-01-1-0397 6. AUTHOR(S) Zeng Qiang Yuan, Ph.D. Jin Q. Cheng, M.D., Ph.D. 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES

  6. Understanding Gulf War Illness: An Integrative Modeling Approach

    DTIC Science & Technology

    2015-10-01

    ELEMENT NUMBER 6. AUTHOR(S) Mariana Morris, PhD, Nancy Klimas, MD, Gordon Broderick , PhD, James O’Callaghan, 5d. PROJECT NUMBER PhD and James...12, 2015, Dr. Broderick submitted 1st detailed report in follow up of Fort Detrick EAB meeting (September 2014). (Task 1; Subtask 2)  On March 4, 2015...Dr, Broderick submitted a 2nd interim report to address additional questions asked by Dr. Reifman on March 2, 2015. (Task 1; Subtask 2)  Dr

  7. THE CONTEXTUAL EFFECT OF THE PREVALENCE OF LIQOUR STORES AND BARS ON INTAKE OF HARD LIQOUR

    EPA Science Inventory

    The Contextual Effect of the Prevalence of Liquor Stores and Bars on Intake of Hard Liquor

    Kimberly B. Morland PhD?, Steve Wing PhD?, Ana Diez Roux MD PhD?

    ?Department of Epidemiology, University of North Carolina, Chapel Hill, NC; ?The Department of Epidemiology an...

  8. ASBESTOS-INDUCED ACTIVATION OF SIGNALING PATHWAYS IN HUMAN BRONCHIAL EPITHELIAL CELLS

    EPA Science Inventory

    Title: Asbestos-Induced Activation of Signaling Pathways in Human
    Bronchial Epithelial Cells

    X. Wang, MD 1, J. M. Samet, PhD 2 and A. J. Ghio, MD 2. 1 Center for
    Environmental Medicine, Asthma and Lung Biology, University of North
    Carolina, Chapel Hill, NC, Uni...

  9. 76 FR 40923 - National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-07-12

    ... assistance, such as sign language interpretation or other reasonable accommodations, should notify the..., Independence Room (2nd Level), Bethesda, MD 20817. Closed: 1 p.m. to 4 p.m. Agenda: To review and evaluate..., Independence Room (2nd Level), Bethesda, MD 20817 Contact Person: Anthony Demsey, PhD, Director, National...

  10. 75 FR 14175 - National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-03-24

    ... assistance, such as sign language interpretation or other reasonable accommodations, should notify the... Level), Bethesda, MD 20817. Closed: 1:30 p.m. to 3 p.m. Agenda: To review and evaluate grant... (2nd Level), Bethesda, MD 20817. Contact Person: Anthony Demsey, PhD, Director, National Institute of...

  11. 77 FR 31624 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-05-29

    ... Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Rm. 951, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Ruixia Zhou, Ph.D., Scientific Review Officer, 6707 Democracy Boulevard, Democracy Two Building, Suite 957, Bethesda, MD 20892, 301-496-4773, [email protected] . Dated: May 21...

  12. Feasibility Study of a Novel Diet-Based Intervention for Prostate Cancer

    DTIC Science & Technology

    2011-09-01

    Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance.” Peter Van Veldhuizen , Jr., MD will be joining the...Administrator Nathan Eriksen SWOG Prevention Committee Chairs Powel H. Brown, MD, PhD Gary E. Goodman, MD New SWOG Co-Chair Peter Van Veldhuizen , Jr...above. The Cancer and Leukemia Group B (CALGB) will be responsible for circulating all revisions of the protocol to Dr. Peter Van Veldhuizen , Jr

  13. Microenvironment -Programmed Metastatic Prostate Cancer Stem Cells (mPCSCs)

    DTIC Science & Technology

    2016-10-01

    accomplished all goals in Aims 1 and 2. Our lab recently relocated from the MD Anderson Cancer Center to Roswell Park Cancer Institute in Buffalo. We ...G. Tang, M.D., Ph.D. CONTRACTING ORGANIZATION: University of Texas MD Anderson Cancer Center Houston, TX 77030 REPORT DATE: October 2016 TYPE OF... Anderson Cancer Center Houston, TX 77030 9. SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR’S ACRONYM(S) U.S. Army Medical

  14. Rein and Zheng Elected to American Academy of Microbiology | Poster

    Cancer.gov

    By Nancy Parrish, Staff Writer Earlier this year, Alan Rein, Ph.D., and Zhi-Ming (Thomas) Zheng, M.D., Ph.D., were elected to fellowship in the American Academy of Microbiology, the honorific leadership group within the American Society for Microbiology (ASM). They were among 88 microbiologists who were elected to the academy “through a highly selective, peer-review process,

  15. A Clinician-Centered Evaluation of the Usability of AHLTA and Automated Clinical Practice Guidelines at TAMC

    DTIC Science & Technology

    2009-10-01

    gathering has been rescheduled to November 14, 2009, in San Francisco, at the AMIA Conference location. August 14, 2009, SOADEX provided a draft system...Bethesda. MD, USA d Core Unit for Medical Statistics and Informatics, Medical University of Vienna, Austria • Department of Nursing . lnha University...scheduled. Insook Cho, PhD, RN Associate Professor, Maternity Nursing & Nursing Informat- ics, lnha University, Younghyun-dong, Nam-gu, Jncheon, South

  16. Experimental Proteus mirabilis Burn Surface Infection

    DTIC Science & Technology

    1982-02-01

    Reprinted from the Achie of Surgery ECTE February 1982, Volume 117 Copyright 19 2. American Medical Association MAY 2 8 1982 V0A Experimental Proteus ... mirabilis Burn Surface Infection Albert T. McManus, PhD; Charles G. McLeod, Jr, DVM; Arthur D. Mason, Jr, MD * We established a human burn Isolate of... Proteus mirabills as have examined human burn isolates from the genera an experimental pathogen. Infliction of a nonfatal scald injury Enterobacter

  17. Scientometric Analysis of Scientific Validity of Medical Archives Regarding Other Medical Journals in Bosnia and Herzegovina.

    PubMed

    Masic, Izet; Begic, Edin; Zunic, Lejla

    2016-02-01

    Medical Archives is the oldest medical journal in Bosnia and Herzegovina (B&H) (founded in 1947.). A total of 104 articles were published in Medical Archives during 2015. Analyzing the type of articles, original articles are present in majority during 2015-80.7% (in last seven years, 561 (76%) were original out of 738). In last seven years, 651 (88.2%) articles were from the field of clinical medicine (preclinical disciplines, in the last three years are more represented than in previous years). Collaboration rate in 2015 was 0,92. Articles written in collaboration of five authors (21.1 %) are found to be predominant. From year to year, most often required time for a decision on acceptance or on the revision prior acceptance is between 50 and 60 days (30% of cases in 2015). During 2015, 47.1% of articles were originally from B&H (eleven countries were represented). H index of Medical Archive for 2014 was 12, and does not vary during the last decade. In 2015 in B&H about twenty-five journals are issued in the field of biomedical and life sciences in general (six are indexed on Medline/PubMed, one is indexed in the Science Citation Index Expanded (SCIE)/Web of Science base). According to GoogleScholar the biggest h5 index has Bosnian Journal of Basic Medical Sciences (BJBMS) and Medical Archives, while the biggest h5 median has BJBMS i Acta Informatica Medica. The highest H-index (13) in B&H has Izet Masic MD, PhD, Enver Zerem MD, PhD and Semir Vranic MD, PhD, while highest g-index (22) has Enver Zerem MD, PhD (analyzed by software package "Publish or Perish"). By comparing the state of medical publishing in B&H with neighboring countries (Croatia, Serbia, Montenegro), we have concluded that B&H is behind Croatia and Serbia by following parameters: Total Documents, Total Cites and H index but in front of Montenegro.

  18. 78 FR 15024 - National Institute of Neurological Disorders and Stroke, Interagency Pain Research Coordinating...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-03-08

    ..., 31 Center Drive, Room 8A03, Bethesda, MD 20892, or by email to [email protected] . Nominations... CONTACT: Contact Linda Porter, Ph.D., NINDS/ NIH, 31 Center Drive, Room 8A03, Bethesda, MD 20892, porterl... made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation...

  19. 76 FR 60509 - National Institute of Allergy and Infectious Diseases Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-09-29

    ... Strategies for Sexual and Reproductive Health''. Date: October 18, 2011. Time: 12:30 p.m. to 5 p.m. Agenda... Drive, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Jane K. Battles, PhD, Scientific... Health/NIAID, 6700B Rockledge Drive, Room 3147, Bethesda, MD 20892-7616, 301-451-2744, [email protected

  20. Genomic Data Commons and Genomic Cloud Pilots - Google Hangout

    Cancer.gov

    Join us for a live, moderated discussion about two NCI efforts to expand access to cancer genomics data: the Genomic Data Commons and Genomic Cloud Pilots. NCI subject matters experts will include Louis M. Staudt, M.D., Ph.D., Director Center for Cancer Genomics, Warren Kibbe, Ph.D., Director, NCI Center for Biomedical Informatics and Information Technology, and moderated by Anthony Kerlavage, Ph.D., Chief, Cancer Informatics Branch, Center for Biomedical Informatics and Information Technology. We welcome your questions before and during the Hangout on Twitter using the hashtag #AskNCI.

  1. Development of km23-Based Diagnostics and Therapeutics

    DTIC Science & Technology

    2004-05-01

    Publishers, Cancer Treatment and Research Book Series. Chap . 15, 315-327, 2004. Abstracts: Jin Q, MD, Ding W, MD, PhD, Staub CM, Gao G, MD, Mulder KM, PhD...Kluwer Academic Publishers, Cancer Treatment and Research Book Series. Chap . 15, 315-327, 2004. Ilangovan U, Ding W, Zuniga J, Wilson, CL, Hinck AP...Academic Publishers, Cancer Treatment and Research Book Series. Chap . 15, 315-327, 2004. 2. Manuscript Submitted: Jin Q. Ding W, Staub CM, Gao G, Tang Q

  2. Traumatic Brain Injury Screening: Preliminary Findings in a US Army Brigade Combat Team

    DTIC Science & Technology

    2009-01-01

    Screening: Preliminary Findings in a US Army Brigade Combat Team Heidi Terrio, MD, MPH; Lisa A. Brenner, PhD; Brian J. Ivins, MS; John M. Cho, MD; Katherine...Sheila Saliman and Lisa Betthauser is greatly appreciated. Corresponding author: Heidi Terrio, MD, MPH, 1853 O’Connell Blvd, Bldg 1042, Room 107, Fort...more mild TBI symptoms among injured soldiers with and without TBI (n = 1208)∗,† Parameter Adjusted 95% CI adjusted Variable estimate (β) SE β Wald P

  3. Spinal cord abscess

    MedlinePlus

    ... Philadelphia, PA: Elsevier; 2017:chap 42. Kusuma S, Klineberg EO. Spinal infections: diagnosis and treatment of discitis, ... by: Jatin M. Vyas, MD, PhD, Assistant Professor in Medicine, Harvard ...

  4. Role of institutional climate in fostering diversity in biomedical research workforce: a case study.

    PubMed

    Butts, Gary C; Hurd, Yasmin; Palermo, Ann-Gel S; Delbrune, Denise; Saran, Suman; Zony, Chati; Krulwich, Terry A

    2012-01-01

    This article reviews the barriers to diversity in biomedical research and describes the evolution of efforts to address climate issues to enhance the ability to attract, retain, and develop underrepresented minorities, whose underrepresentation is found both in science and medicine, in the graduate-school biomedical research doctoral programs (PhD and MD/PhD) at Mount Sinai School of Medicine. We also describe the potential beneficial impact of having a climate that supports diversity and inclusion in the biomedical research workforce. The Mount Sinai School of Medicine diversity-climate efforts are discussed as part of a comprehensive plan to increase diversity in all institutional programs: PhD, MD/PhD, and MD, and at the residency, postdoctoral fellow, and faculty levels. Lessons learned from 4 decades of targeted programs and activities at the Mount Sinai School of Medicine may be of value to other institutions interested in improving diversity in the biomedical science and academic medicine workforce. © 2012 Mount Sinai School of Medicine.

  5. Vectors for Treatment of Metastatic Breast Cancer

    DTIC Science & Technology

    2006-08-01

    Breast Cancer 5b. GRANT NUMBER DAMD17-03-1-0554 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) Albert B. Deisseroth, M.D., Ph.D. 5d. PROJECT NUMBER...14. ABSTRACT: The objective is to design, build and study vectors which would be able to break tolerance to breast cancer associated TAA and to be...used to suppress the recurrence of metastatic breast cancer following surgical resection. The hypothesis is that by fusing the CD40 ligand stripped of

  6. OSTP FY 2014 Budget Briefing

    NASA Image and Video Library

    2013-04-10

    Director of the National Institutes of Health (NIH) Francis S. Collins, M.D., Ph.D., delivers remarks during a White House Office of Science and Technology Policy (OSTP) Fiscal Year 2014 budget briefing held with with Dr. John P. Holdren, Director of OSTP, Patricia Falcone of OSTP, Charlie Bolden from NASA, Cora Marrett from NSF, and Kathryn Sullivan from NOAA, at the American Association for the Advancement of Science (AAAS) on Wednesday, April 10, 2013 in Washington. Photo Credit: (NASA/Bill Ingalls)

  7. 78 FR 15373 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-03-11

    ..., MD 20892 (Virtual Meeting). Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review Officer, Center... Special Emphasis Panel; Member Conflict: AIDS and AIDS Related Research. Date: April 1, 2013. Time: 12:00..., Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893...

  8. 78 FR 15729 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-03-12

    ..., MD 20892, (Virtual Meeting). Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review Officer... Special Emphasis Panel Member Conflict: AIDS and AIDS Related Research. Date: April 1, 2013. Time: 12:00 p... Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National...

  9. EFFECT OF INHALED ENDOTOXIN ON AIRWAY AND CIRCULATING INFLAMMATORY CELL PHAGOCYTOSIS AND CD11B EXPRESSION IN ATOPIC ASTHMATIC SUBJECTS

    EPA Science Inventory

    Effect of inhaled endotoxin on airway and circulating inflammatory cell phagocytosis and CD11b expression in atopic asthmatic subjects

    Neil E. Alexis, PhD, Marlowe W. Eldridge, MD, David B. Peden, MD, MS

    Chapel Hill and Research Triangle Park, NC

    Backgrou...

  10. Reinnervation of Paralyzed Muscle by Nerve Muscle Endplate Band Grafting

    DTIC Science & Technology

    2016-10-01

    PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 DISTRIBUTION STATEMENT: Approved for Public Release... Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 11. SPONSOR/MONITOR’S REPORT NUMBER(S) 12. DISTRIBUTION / AVAILABILITY STATEMENT...Nyirenda, PhD1 Liancai Mu, MD, PhD1 1Department of Research , Hackensack University Medical Center, Upper Airway Research Laboratory, Hackensack, New

  11. Top1 May Do More Than Relax DNA | Center for Cancer Research

    Cancer.gov

    Topoisomerase 1 (Top1) is an enzyme with a well known role in relaxing DNA supercoils by making reversible nicks in DNA. The ribonuclease (RNase) H class of enzymes is equally well known for removing ribonucleotides from hybrid duplex DNA when they are misincorporated during DNA replication. Recently, Shar-yin Huang, Ph.D., and Yves Pommier, M.D., Ph.D., in CCR’s Laboratory of

  12. Chancroid

    MedlinePlus

    ... one half of infected men have only a single ulcer. Women often have 4 or more ulcers. ... MD, PhD, Assistant Professor in Medicine, Harvard Medical School; Assistant in Medicine, Division of Infectious Disease, Department ...

  13. Hymenolepiasis

    MedlinePlus

    ... also called hymenolepiasis. Causes Hymenolepis live in warm climates and are common in the southern United States. ... MD, PhD, Assistant Professor in Medicine, Harvard Medical School; Assistant in Medicine, Division of Infectious Disease, Department ...

  14. NIAAA Spectrum

    MedlinePlus

    ... evidence that a hormone produced in the stomach influences alcohol consumption in humans. Steep Increase in Rate ... visits. 5 Questions With... Lorenzo Leggio, M.D., Ph.D. Chief of the NIAAA/NIDA Section on ...

  15. Myeloma

    MedlinePlus

    ... II diabetes). Source: Myeloma . Reviewed by Larry D. Anderson, Jr, MD, PhD Related Links Click here to ... More Please consider a donation to LLS so we can continue to provide patient support and education ...

  16. Leprosy

    MedlinePlus

    ... countries worldwide, and in temperate, tropical, and subtropical climates. About 100 cases per year are diagnosed in ... MD, PhD, Assistant Professor in Medicine, Harvard Medical School; Assistant in Medicine, Division of Infectious Disease, Department ...

  17. Aspergillosis

    MedlinePlus

    ... airway blockage Respiratory failure When to Contact a Medical Professional Call your provider if you develop symptoms ... Vyas, MD, PhD, Assistant Professor in Medicine, Harvard Medical School; Assistant in Medicine, Division of Infectious Disease, ...

  18. The Role of Cardiovascular Muscle Cell Na+-K+ Pump Activity in the Development and Maintenance of Reduced Renal Mass Hypertension in Rats

    DTIC Science & Technology

    1981-09-28

    hypertension (Finch and Leach, 1970; Haeusler et al. 1972) depending on whether the peripheral or the central sympathetic nevous system was destroyed...Dissertation directed by: Motllal B. Pamnanl, M.D., Ph.D. Associate Professor, Department of Physiology The mechanism of the elevated systemic arterial...vascular Na"*"-K̂ pump activity and development of hypertension; and 4) investigate the role of the sympathetic nervous system and the AV3V region

  19. Methods of Academic Course Planning for Cancer Biology PhD Students to Enhance Knowledge of Clinical Oncology.

    PubMed

    Mattes, Malcolm D; Swart, Elizabeth; Markwell, Steven M; Wen, Sijin; Vona-Davis, Linda C

    2017-09-15

    Little is known about how clinical oncology concepts are taught to PhD students or the most effective methods of doing so. In this study, electronic surveys were sent to faculty and students at PhD training programs, assessing their institution's methods of clinical oncology education and their perspective on optimal approaches to clinical oncology education. Only 40.0% of students reported any clinical oncology component to their institution's training, and only 26.5% had a clinician on their graduate advisory committee. Forty-three percent of students believed that they had a good understanding for translating basic science research into clinical practice, and 77.2% of all participants believed dual degree MD/PhD students were superior to PhD students in this regard. Lectures on clinical oncology research topics were the most valuable type of experience for all participants and were also the most common type of experience utilized. Working with a clinician to develop a clinical trial with correlative endpoints was also highly valued, but was only utilized by approximately 10% of programs. Faculty rated the value of nearly all types of clinical oncology exposure significantly lower than did students. Inclusion of the approaches identified in this study is likely to enhance PhD training in oncology-related disciplines. Cancer Res; 77(18); 4741-4. ©2017 AACR . ©2017 American Association for Cancer Research.

  20. 77 FR 42735 - Appointments to the Medicare Payment Advisory Commission

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-07-20

    ..., South Shore Hospital; Jack Hoadley, Ph.D., Research Professor, Health Policy Institute, Georgetown... Ford Health System; Rita Redberg, MD, Professor, Clinical Medicine, University of California at San...

  1. Creeping eruption

    MedlinePlus

    ... eruption is more common in countries with warm climates. In the United States, the Southeast has the ... MD, PhD, Assistant Professor in Medicine, Harvard Medical School; Assistant in Medicine, Division of Infectious Disease, Department ...

  2. Whipworm infection

    MedlinePlus

    ... the world, especially in countries with warm, humid climates. Some outbreaks have been traced to contaminated vegetables ( ... MD, PhD, Assistant Professor in Medicine, Harvard Medical School; Assistant in Medicine, Division of Infectious Disease, Department ...

  3. [The Chilean Association of Biomedical Journal Editors].

    PubMed

    Reyes, H

    2001-01-01

    On September 29th, 2000, The Chilean Association of Biomedical Journal Editors was founded, sponsored by the "Comisión Nacional de Investigación Científica y Tecnológica (CONICYT)" (the Governmental Agency promoting and funding scientific research and technological development in Chile) and the "Sociedad Médica de Santiago" (Chilean Society of Internal Medicine). The Association adopted the goals of the World Association of Medical Editors (WAME) and therefore it will foster "cooperation and communication among Editors of Chilean biomedical journals; to improve editorial standards, to promote professionalism in medical editing through education, self-criticism and self-regulation; and to encourage research on the principles and practice of medical editing". Twenty nine journals covering a closely similar number of different biomedical sciences, medical specialties, veterinary, dentistry and nursing, became Founding Members of the Association. A Governing Board was elected: President: Humberto Reyes, M.D. (Editor, Revista Médica de Chile); Vice-President: Mariano del Sol, M.D. (Editor, Revista Chilena de Anatomía); Secretary: Anna María Prat (CONICYT); Councilors: Manuel Krauskopff, Ph.D. (Editor, Biological Research) and Maritza Rahal, M.D. (Editor, Revista de Otorrinolaringología y Cirugía de Cabeza y Cuello). The Association will organize a Symposium on Biomedical Journal Editing and will spread information stimulating Chilean biomedical journals to become indexed in international databases and in SciELO-Chile, the main Chilean scientific website (www.scielo.cl).

  4. 78 FR 66754 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-11-06

    ... Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Lynn E Luethke, Ph.D., Scientific Review... Scientific Review Special Emphasis Panel, Social Psychology, Personality and Interpersonal Processes Overflow...

  5. Venogram

    MedlinePlus

    ... PhD, Department of Surgery, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A. ...

  6. Aortopulmonary window

    MedlinePlus

    ... del Nido PJ, Swanson SJ, eds. Sabiston and Spencer Surgery of the Chest . 9th ed. Philadelphia, PA: ... MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Congenital Heart Defects Read ...

  7. Scientometric Analysis of Scientific Validity of Medical Archives Regarding Other Medical Journals in Bosnia and Herzegovina

    PubMed Central

    Masic, Izet; Begic, Edin; Zunic, Lejla

    2016-01-01

    Introduction: Medical Archives is the oldest medical journal in Bosnia and Herzegovina (B&H) (founded in 1947.). A total of 104 articles were published in Medical Archives during 2015. Analyzing the type of articles, original articles are present in majority during 2015–80.7% (in last seven years, 561 (76%) were original out of 738). In last seven years, 651 (88.2%) articles were from the field of clinical medicine (preclinical disciplines, in the last three years are more represented than in previous years). Collaboration rate in 2015 was 0,92. Articles written in collaboration of five authors (21.1 %) are found to be predominant. From year to year, most often required time for a decision on acceptance or on the revision prior acceptance is between 50 and 60 days (30% of cases in 2015). During 2015, 47.1% of articles were originally from B&H (eleven countries were represented). H index of Medical Archive for 2014 was 12, and does not vary during the last decade. Findings: In 2015 in B&H about twenty-five journals are issued in the field of biomedical and life sciences in general (six are indexed on Medline/PubMed, one is indexed in the Science Citation Index Expanded (SCIE)/Web of Science base). According to GoogleScholar the biggest h5 index has Bosnian Journal of Basic Medical Sciences (BJBMS) and Medical Archives, while the biggest h5 median has BJBMS i Acta Informatica Medica. The highest H-index (13) in B&H has Izet Masic MD, PhD, Enver Zerem MD, PhD and Semir Vranic MD, PhD, while highest g-index (22) has Enver Zerem MD, PhD (analyzed by software package “Publish or Perish”). Conclusion: By comparing the state of medical publishing in B&H with neighboring countries (Croatia, Serbia, Montenegro), we have concluded that B&H is behind Croatia and Serbia by following parameters: Total Documents, Total Cites and H index but in front of Montenegro. PMID:26980926

  8. The Human Dimension of Networks

    DTIC Science & Technology

    2008-06-01

    Networking Organizational Issues Authors: Bruce J. West Ph.D. Army Research Office Elizabeth K. Bowman Ph.D. Army Research Laboratory – Human...Contact: Elizabeth K.Bowman AMSRD-ARL-HR Bulding 459, Aberdeen Proving Ground, MD 21005 410-278-5924 EBowman@arl.army.mil 1 Report Documentation Page...L.E. Brus , Nature 383, 802 (1996); M. Kuno, D.P. Fromim, s.R. Hohmson, A. Gallagher and D.J. Nesbitt, Phys. Rev. B 67, 125304 (2003); K.R. Shimizu

  9. Novel Influenza A (H1N1) Outbreak at the U.S. Air Force Academy: Epidemiology and Viral Shedding Duration (American Journal of Preventive Medicine, Volume 20, Number 10, 2009)

    DTIC Science & Technology

    2009-01-01

    and Viral Shedding Duration atherine Takacs Witkop, MD, MPH, Mark R. Duffy, DVM, MPH, Elizabeth A. Macias, PhD, homas F. Gibbons, PhD, James D. Escobar...oseltami- ir two times daily for 5 days if the patients indicated onset of ymptoms no more than 72 hours prior to presentation. pper-class cadets

  10. 78 FR 7438 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-02-01

    ..., 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Lisa Steele, Ph..., CA 90405. Contact Person: Valerie Durrant, Ph.D., Scientific Review Officer, Center for Scientific...

  11. 75 FR 1793 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-01-13

    ...; Social Psychology, Personality and Interpersonal Processes Study Section. Date: February 4-5, 2010. Time..., MD 20892 (Virtual Meeting). Contact: Bob Weller, PhD, Scientific Review Officer, Center for...

  12. As You Get Older

    MedlinePlus

    ... to the Second Edition: Kathleen Kapp-Simon, PhD, Psychology David J. Reisberg, DDS, Prosthodontics James Sidman, MD, ... Speech ...........................................................................................................................8 Your Ears, Nose and Throat .......................................................................................10 Social Relationships ..........................................................................................................11 Looking Toward the Future ........................................................................................13 Stories ...

  13. Viral Evolution Core | FNLCR Staging

    Cancer.gov

    Brandon F. Keele, Ph.D. PI/Senior Principal Investigator, Retroviral Evolution Section Head, Viral Evolution Core Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research Frederick, MD 21702-1201 Tel: 301-846-173

  14. Gastroschisis repair

    MedlinePlus

    ... PhD, Department of Surgery, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A. ...

  15. Omphalocele repair

    MedlinePlus

    ... PhD, Department of Surgery, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A. ...

  16. Extremity angiography

    MedlinePlus

    ... PhD, Department of Surgery, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A. ...

  17. Plasma Cytokines Following Thermal Injury and Their Relationship with Patient Mortality, Burn Size, and Time Postburn,

    DTIC Science & Technology

    1993-09-01

    AND TIME POSTBURN Adriana C. Drost, MS, David G. Burleson, PhD, William G. Cioffi, Jr., MD, Bryan S. Jordan, RN, MS, Arthur D. Mason, Jr., MD, and...trauma. J 2, IL-6). Science 239-502,1i988 Surg Res 48:622, 1990 7. Garmnan RD, Jacobs KA , Clark SC, et al: B-cell-stimulatory factor 23. Hack CE, De Groot

  18. Investigating Genetic Alterations in Bladder Cancer | Center for Cancer Research

    Cancer.gov

    Bladder cancer (BC) is the fifth most common cancer worldwide and the sixth most common cancer in the U.S. Mutations in a number of oncogenes and tumor suppressor genes were previously associated with invasive or noninvasive forms of the disease. More recently, next generation sequencing (NGS) of bladder tumors from over 100 Chinese patients revealed alterations in additional genes, including those encoding chromatin remodeling enzymes, like lysine specific histone demethylase 6A (KDM6A) and ARID1A, and spindle checkpoint proteins. Because the NGS studies analyzed tumors from patients of a single ethnicity, the results may not be representative of alterations in other patients. To expand on these findings, Michael Nickerson, Ph.D., and Michael Dean, Ph.D., of CCR’s Cancer and Inflammation Program and their colleagues, including Dan Theodorescu, M.D., Ph.D., Director of the University of Colorado NCI-Designated Comprehensive Cancer Center, performed exome sequencing of 14 tumors and targeted sequencing of another 40 tumors all from non-Asian patients diagnosed with BC in the U.S.

  19. 78 FR 23572 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-04-19

    ..., Rockville, MD 20852. Contact Person: Priti Mehrotra, Ph.D., Chief, Immunology Review Branch, Scientific... Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856...

  20. 77 FR 53205 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-08-31

    ..., Bethesda, MD 20892, (Virtual Meeting). Contact Person: Fouad A El-Zaatari, Ph.D., Scientific Review Officer... Committee: Risk, Prevention and Health Behavior Integrated Review Group, Social Psychology, Personality and...

  1. Open pleural biopsy

    MedlinePlus

    ... PhD, Department of Surgery, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A. ...

  2. 77 FR 25487 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-04-30

    ... (Virtual Meeting). Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review Officer, Center for Scientific... Scientific Review Special Emphasis Panel; Cancer Therapeutics AREA Grant Applications. Date: May 24, 2012...

  3. 78 FR 21615 - National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-04-11

    ... grant applications. Place: National Institutes of Health, 5635 Fishers Lane, Terrace Level Conference Rooms, Rockville, MD 20852. Contact Person: Katrina L Foster, Ph.D., Scientific Review Administrator...

  4. 77 FR 38845 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-06-29

    ... Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Ruixia Zhou, Ph.D., Scientific Review Officer, 6707 Democracy Boulevard, Democracy Two Building...

  5. D and C - slideshow

    MedlinePlus

    ... this page: //medlineplus.gov/ency/presentations/100013.htm D and C - series—Normal anatomy To use the ... MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Related MedlinePlus Health Topics ...

  6. Aspm, a Key Element in Medulloblastoma Pathogenesis and a Novel Target for Treatment

    DTIC Science & Technology

    2013-10-01

    pathogenesis ( Wechsler -Reya and Scott, 1999; Kenney and Rowitch, 2000; Zurawel et al., 2000; Ellison et al., 2011; Hatten and Roussel, 2011; Roussel...Laboratories, Bar Harbor, ME, USA) to generate Aspm floxed (Aspmf/+) mice. Math-1 cre mice were generously shared by David Rowitch, MD, PhD, UCSF and...Robert Wechsler -Reya, PhD, 10 Sanford-Burnham Medical Research Institute, La Jolla, CA and have been previously described (Matei et al., 2005

  7. Scientific Growth and Identity Development during a Postbaccalaureate Program: Results from a Multisite Qualitative Study

    PubMed Central

    Remich, Robin; Naffziger-Hirsch, Michelle E.; Gazley, J. Lynn; McGee, Richard

    2016-01-01

    This report builds upon our previous study, which described five patterns of why college graduates join National Institutes of Health (NIH)-funded diversity-focused Postbaccalaureate Research Education Programs (PREP). A 2015 report from the NIH showed that a high fraction of PREP participants matriculate into PhD and MD/PhD programs. This current study reveals how participants change during PREP, the program elements that facilitate change, and how identity as a graduate student and future scientist develops. Data come from in-depth interviews done at the beginning and end of PREP with 48 individuals from seven PREP programs. Results reveal three domains of development: academics, research, and presentation of oneself; each domain contains a developmental continuum. Key attributes of PREP enabling development include opportunities to attend graduate-level classes and seminars; time to practice reading literature; extended lab time with one’s own project; high and explicit expectations from mentors; and multiple opportunities to talk about science and improve communication skills. PREP enabled participants to develop their identities as graduate students and to anticipate being seen by others as highly prepared for PhD training. After PREP, 85% (n = 41) started the PhD or MD/PhD, making PREP an intervention approach with great potential to broaden participation in biomedical PhD programs. PMID:27496357

  8. Training Patterns and Lifetime Career Achievements of US Academic Cardiothoracic Surgeons.

    PubMed

    Rosati, Carlo Maria; Valsangkar, Nakul P; Gaudino, Mario; Blitzer, David; Vardas, Panos N; Girardi, Leonard N; Turrentine, Mark W; Brown, John W; Koniaris, Leonidas G

    2017-03-01

    We aimed to investigate the impact of taking dedicated time for research (DTR) during training and/or getting a PhD on subsequent career achievements of US academic cardiothoracic surgeons. Online resources (institutional Web sites, CTSNet, Scopus, NIH RePORTER) were queried to collect training information (timing of medical school/residency/fellowship graduation, DTR, PhD) and academic metrics (publications, citations, research funding) for 694 academic cardiothoracic surgeons practicing at 56 premiere US institutions. Excluding missing data, 464 (75 %) surgeons took DTR and 156 (25 %) did not; 629 (91 %) were MD only and 65 (9 %) also had a PhD. DTR was associated with higher number of ongoing publications (~5.6/year vs. ~3.8/year), with no difference for accrued number of total citations. History of DTR was more prevalent among surgeons with versus without NIH funding (87 vs. 71 %; p < 0.001), but no difference was seen across academic ranks and among those who were division/department chiefs. No overall increase in publications/citations, academic rank advancement, NIH funding, or leadership roles was found for those with a PhD. Among cardiothoracic surgeons, devoting time during the training years exclusively to research might be associated with higher career-long academic productivity in terms of annual number new publications and ability to get NIH funding, but without significant impact in terms of academic rank or institutional role advancement. No significant difference was found between those with versus without a PhD in terms of career-long number of publications/citations, academic rank, NIH funding, or leadership role, even though sample size might have been insufficient to identify any such potential difference.

  9. U.S. Army Culture: An Introduction for Behavioral Health Researchers

    DTIC Science & Technology

    2017-10-01

    U.S. ARMY CULTURE An Introduction for Behavioral Health Researchers Center for the Study of Traumatic Stress Department of Psychiatry Uniformed...Services University 30 U.S. ARMY CULTURE — An Introduction for Behavioral Health Researchers U.S. ARMY CULTURE An Introduction for Behavioral... Health Researchers EDITORS Eric G. Meyer, MD James E. McCarroll, PhD Robert J. Ursano, MD Center for the Study of Traumatic Stress Department of Psychiatry

  10. Center for the Study of Traumatic Stress

    DTIC Science & Technology

    2008-01-01

    Gruber, M., Jones R.T., King D.W., King L.A., McNally, R.J., Ursano R.J., Petukhova M., Kessler R. Exposure to Hurricane Related Stressors and...Assistance Medicine F. Edward Hebert School of Medicine Uniformed Services University of the Health Sciences 4301 Jones Bridge Road Bethesda, MD 20814-4799...Uniformed Services University of the Health Sciences 4301 Jones Bridge Road Bethesda, MD 20814-4799 cfullert@erols.com David S. Krantz, Ph.D. Chair

  11. What Is a Bone Marrow Transplant?

    MedlinePlus

    ... Print this page My Cart What is a bone marrow transplant? A bone marrow transplant is a ... blood.” – Edmund Waller, MD, PHD What is a bone marrow transplant? A bone marrow transplant is a ...

  12. 77 FR 57097 - Office of the Director, National Institutes of Health Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-09-17

    ... Pike, Rockville, MD 20852. Contact Person: Barbara J. Nelson, Ph.D., Scientific Review Officer, Office of Grants Management & Scientific Review, National Center for Advancing Translational, Sciences NCATS...

  13. 76 FR 35453 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-06-17

    ... Laboratory, 9700 S. Cass Avenue, Argonne, IL 60439. Contact Person: James W. Mack, PhD, Scientific Review...: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person...

  14. Grantee Spotlight: Bill Nelson, M.D., Ph.D.

    Cancer.gov

    Dr. William (Bill) Nelson is playing an integral role in advancing our understanding of cancer health disparities and helping to foster the interests of young students from underrepresented backgrounds in cancer/cancer health disparities research.

  15. Abdominoplasty - slideshow

    MedlinePlus

    ... in the belly. In abdominoplasty, some of the fat is removed. Review Date 1/31/2017 Updated by: Mary C. Mancini, MD, PhD, Department of Surgery, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA. Review provided by VeriMed ...

  16. 78 FR 737 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-01-04

    ... evaluate grant applications. Place: Sheraton Silver Spring Hotel, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: B. Duane Price, Ph.D., Scientific Review Officer, Scientific Review Program, DHHS...

  17. 77 FR 1939 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-01-12

    ...: To review and evaluate grant applications. Place: Crowne Plaza Washington DC-Silver Spring, Silver Spring, MD 20910. Contact Person: B. Duane Price, Ph.D., Scientific Review Officer, Scientific Review...

  18. 78 FR 11660 - Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-02-19

    ... Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Peter Zelazowski, Ph.D..., peter[email protected] . (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population...

  19. Tracheitis

    MedlinePlus

    ... Otolaryngology – Head and Neck Surgery, The University of Texas Medical School at Houston, Houston, TX. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. team. Staphylococcal Infections Read more Tracheal ...

  20. STS-78 Flight Day 4

    NASA Technical Reports Server (NTRS)

    1996-01-01

    On this fourth day of the STS-78 mission, the flight crew, Cmdr. Terence T. Henricks, Pilot Kevin R. Kregel, Payload Cmdr. Susan J. Helms, Mission Specialists Richard M. Linnehan, Charles E. Brady, Jr., and Payload Specialists Jean-Jacques Favier, Ph.D. and Robert B. Thirsk, M.D., discuss the flight during an interview with the Cable News Network (CNN). The crew then continues research concentrated on the Torque Velocity Dynamometer measurements of leg and arm muscle power, the Astronaut Lung Function Experiment, and effects of microgravity exercise with the bicycle ergometer and its associated instruments.

  1. Rein and Zheng Elected to American Academy of Microbiology | Poster

    Cancer.gov

    By Nancy Parrish, Staff Writer Earlier this year, Alan Rein, Ph.D., and Zhi-Ming (Thomas) Zheng, M.D., Ph.D., were elected to fellowship in the American Academy of Microbiology, the honorific leadership group within the American Society for Microbiology (ASM). They were among 88 microbiologists who were elected to the academy “through a highly selective, peer-review process, based on their records of scientific achievement and original contributions that have advanced microbiology,” according to the society’s website.

  2. Great Help for Older Americans | NIH MedlinePlus the Magazine

    MedlinePlus

    ... that may prevent or delay disability. Claude D. Pepper Older American Independence Centers (OAICs) University of California ... Wake Forest University P.I. Stephen Kritchevsky, PhD Pepper Coordinating Center Kevin High, MD University of Florida ...

  3. 76 FR 65205 - Office of the Director, National Institutes of Health; Notice of Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-10-20

    ... available. Individuals who plan to attend and need special assistance, such as sign language interpretation..., 5635 Fishers Lane, Terrace Level, Rockville, MD 20852. Contact Person: Robert Eisinger, PhD, Executive...

  4. 78 FR 17419 - Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-03-21

    ... Person: Peter Zelazowski, Ph.D., Scientific Review Officer, Division of Scientific Review, Eunice Kennedy..., Bethesda, MD 20892, 301-435-6902, peter[email protected] . (Catalogue of Federal Domestic Assistance...

  5. 76 FR 22716 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-04-22

    ..., Bethesda, MD 20892, 301-402- 5671, [email protected] . Name of Committee: Brain Disorders and Clinical... Hotel, 2033 M Street, NW., Washington, DC 20036. Contact Person: Samuel C Edwards, PhD, Chief, Brain...

  6. Upper airway biopsy

    MedlinePlus

    ... Otolaryngology – Head and Neck Surgery, The University of Texas Medical School at Houston, Houston, TX. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Biopsy Read more Cancer Read more ...

  7. 77 FR 13134 - Center for Scientific Review ; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-03-05

    ..., (Virtual Meeting) Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review Officer, Center for Scientific... Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93...

  8. 77 FR 51032 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-08-23

    ... Washington DC Hotel, 2660 Woodley Road NW., Washington, DC 20008. Contact Person: Ai-Ping Zou, MD, Ph.D... Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333...

  9. Combination Immunotherapy for the Treatment of High-Risk HER2-Positive Breast Cancer

    DTIC Science & Technology

    2017-10-01

    AWARD NUMBER: W81XWH-14-1-0109 TITLE: Combination Immunotherapy for the Treatment of High-Risk HER2-Positive Breast Cancer PRINCIPAL INVESTIGATOR...Elizabeth A. Mittendorf, MD, PhD CONTRACTING ORGANIZATION: University of Texas MD Anderson Cancer Center Houston, TX 77030 REPORT DATE: October...CONTRACT NUMBER Combination Immunotherapy for the Treatment of High-Risk HER2-Positive Breast Cancer 5b. GRANT NUMBER W81XWH-14-1-0109 5c. PROGRAM

  10. Stereotypic movement disorder

    MedlinePlus

    ... Clinical Assistant Professor of Pediatrics, University of Washington School of Medicine, Seattle, WA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Child Mental Health Read more NIH MedlinePlus Magazine Read more Health ...

  11. 76 FR 71580 - National Heart, Lung, and Blood Institute; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-11-18

    ... Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be... Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Charles Joyce, Ph.D., Scientific...

  12. 77 FR 65567 - Center for Scientific Review; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-10-29

    ...: Risk, Prevention and Health Behavior Date: November 2, 2012. Time: 10:00 p.m. to 12:00 p.m. Agenda: To..., Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Lee S Mann, Ph.D., Scientific Review...

  13. Grantee Spotlight: Marcia Cruz-Correa, M.D., Ph.D.

    Cancer.gov

    Dr. Marcia Cruz-Correa, a CRCHD grantee, and her team of researchers from the University of Puerto Rico discovered a link between human papillomavirus and colorectal cancer in tissue samples from a large cohort of colorectal cancer patients.

  14. 77 FR 58854 - Office of the Director, National Institutes of Health; Notice of Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-09-24

    ... current understanding of the basic biology of the genital tract for HIV prevention. An update will be... Level, Suite T-500, Rockville, MD 20852. Contact Person: Robert Eisinger, Ph.D., Executive Secretary...

  15. 76 FR 58522 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-09-21

    ...: Ai-Ping Zou, MD, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of... Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396...

  16. 77 FR 47653 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-08-09

    ... (Telephone Conference Call). Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review Officer, Center for... Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396...

  17. Associations Between NIH Funding and Advanced Bibliometric Indices Among Radiological Investigators.

    PubMed

    Rosenkrantz, Andrew B; Jiang, Anthony

    2016-06-01

    Whereas data support the h index (reflecting both publications and citations) as an indicator of academic productivity, other advanced bibliometric indices aiming to address shortcomings of the h index remain poorly studied. Our objective was to compare the associations between bibliometric indices and total National Institutes of Health (NIH) grant funding among investigators within U.S. academic radiology departments. NIH grant funding amounts for 400 NIH-funded investigators within radiology departments were obtained from Blue Ridge Institute for Medical Research. Investigators' publications and associated citations were identified using Scopus. Indices computed for each investigator included: publication count, citation count, h index, i-10 index, hc index (h index adjusted for recency of publications), m quotient (h index adjusted for career duration), and e index and g index (both account for highly cited articles). Spearman correlations were performed between indices and funding. Multivariable linear regression was performed to identify significant independent predictors of funding. For MD investigators: the indices exhibited no-to-weak correlations with funding (r = 0.173-0.387); m quotient exhibited the largest correlation and was the only significant (albeit weak) independent predictor of funding (P = 0.011). For PhD investigators: correlation with funding was weak for m quotient (r = 0.323), although moderate for other indices (r = 0.518-0.568); publication count exhibited highest correlation; publication count (P < 0.001) and hc index (P = 0.024) were significant independent predictors of funding. Bibliometric indices were more strongly associated with grant funding for PhD than for MD radiology investigators, with publication count exhibiting the strongest association in the latter group. Time-weighted adjustments, as reflected by the m quotient and hc index, may improve efforts to predict funding using bibliometrics. Copyright © 2016 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

  18. The human pain genetics database: an interview with Luda Diatchenko.

    PubMed

    Diatchenko, Luda

    2018-06-05

    Luda Diatchenko, MD, PhD is a Canada Excellence Research Chair in Human Pain Genetics, Professor, Faculty of Medicine, Department of Anesthesia and Faculty of Dentistry at McGill University, Alan Edwards Centre for Research on Pain. She earned her MD and PhD in the field of molecular biology from the Russian State Medical University. She started her career in industry, she was a Leader of the RNA Expression Group at Clontech, Inc., and subsequently, Director of Gene Discovery at Attagene, Inc. During this time, she was actively involved in the development of several widely used and widely cited molecular tools for the analysis of gene expression and regulation. Her academic career started at 2000 in the Center for Neurosensory Disorders at University of North Carolina. Her research since then is focused on determining the cellular and molecular biological mechanisms by which functional genetic variations impact human pain perception and risk of development of chronic pain conditions, enabling new approaches to identify new drug targets, treatment responses to analgesics and diagnostic. Multiple collaborative activities allow the Diatchenko group to take basic genetic findings all the way from human association studies, through molecular and cellular mechanisms to animal models and ultimately to human clinical trials. In total, she has authored or co-authored over 120 peer-reviewed research papers in journals, ten book chapters and edited a book in human pain genetics. She is a member and an active officer of several national and international scientific societies, including the International Association for the Study of Pain and the American Pain Society.

  19. EF5 PET of Tumor Hypoxia: A Predictive Imaging Biomarker of Response to Stereotactic Ablative Radiotherapy (SABR) for Early Lung Cancer

    DTIC Science & Technology

    2017-11-01

    SABR) for Early Lung Cancer PRINCIPAL INVESTIGATOR: Billy W Loo Jr, MD PhD CONTRACTING ORGANIZATION: The Leland Stanford Junior University...Response to Stereotactic Ablative Radiotherapy (SABR) for Early Lung Cancer 5b. GRANT NUMBER 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) Billy W Loo Jr, MD...for early stage lung cancer in patients who are not candidates for surgery because of excessive surgical risk, and will be an important treatment option

  20. A Randomized Clinical Trial of Allopregnanolone for the Treatment of Severe Traumatic Brain Injury

    DTIC Science & Technology

    2010-10-01

    by four outside reviewers: Kia Shahlaie, M.D., Ph.D. (University of California, San Francisco ), Anne-Marie Guerguerian, M.D. (University of Toronto...of the Pre-IND Package described below and the UC Davis IRB filing. Pre-IND Meeting Information Package and IND. Medkura Pharmaceutical and Camargo ... Camargo a Pre-IND meeting information document was developed which will serve as the basis for the IND filing that will be made after the Pre-IND meeting

  1. State of the Art of Fluid Resuscitation 2010: Prehospital and Immediate Transition to the Hospital

    DTIC Science & Technology

    2011-05-01

    Medical Center), Raul Coimbra, MD, PhD (University of California San Diego Medical Center), Eileen Bulger, MD (University of Washington), and Steven...terrorism: 2001–2004. Ann Surg. 2007;245:986–991. 19. Potenza BM, Hoyt DB, Coimbra R, et al. The epidemiology of serious and fatal injury in San Diego ... Mosby , Inc.; 2010. 30. McSwain NE Jr, Salomone J, Pons P, Giebner S (eds). PHTLS: Basic and Advanced Prehospital Trauma Life Support. 6th ed. St. Louis

  2. Using Forensics to Untangle Batch Effects in TCGA Data - TCGA

    Cancer.gov

    Rehan Akbani, Ph.D., and colleagues at the University of Texas MD Anderson Cancer Center developed a tool called MBatch to detect, diagnose, and correct batch effects in TCGA data. Read more about batch effects in this Case Study.

  3. 76 FR 29254 - National Heart, Lung, and Blood Institute; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-05-20

    ... Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be...., Linthicum Heights, MD 21090. Contact Person: Charles Joyce, PhD, Scientific Review Officer, Office of...

  4. A Broader View of Immunotherapies | Center for Cancer Research

    Cancer.gov

    Fresh out of graduate school at Wayne State University in Michigan in 1985, Bernard Fox, Ph.D., landed a coveted fellowship with Steven Rosenberg, M.D., just as the first patients were being treated with cell-based immunotherapies at NCI.

  5. 75 FR 4828 - Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-01-29

    ..., (Telephone Conference Call). Contact Person: Peter Zelazowski, PhD, Scientific Review Officer, Division of... Executive Boulevard, Rm. 5B01, Bethesda, MD 20892-7510, 301-435- 6902, peter[email protected] . (Catalogue...

  6. 75 FR 39698 - Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-07-12

    ..., (Telephone Conference Call). Contact Person: Peter Zelazowski, PhD, Scientific Review Officer, Division of... Executive Boulevard, Room 5B01, Bethesda, MD 20892-7510, 301-435- 6902, peter[email protected] . This...

  7. 76 FR 17928 - Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-03-31

    ... Conference). Contact Person: Peter Zelazowski, PhD, Scientific Review Officer, Division of Scientific Review...., Room 5B01, Bethesda, MD 20892, 301-435-6902, peter[email protected] . (Catalogue of Federal Domestic...

  8. 76 FR 32979 - Eunice Kennedy Shriver National Institute of Child Health and Human Development; Notice of Closed...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-06-07

    ... 20814. Contact Person: Peter Zelazowski, PhD, Scientific Review Officer, Division of Scientific Review...., Room 5B01, Bethesda, MD 20892, 301-435-6902, peter[email protected] . (Catalogue of Federal Domestic...

  9. 75 FR 65496 - Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-10-25

    ... Person: Peter Zelazowski, PhD, Scientific Review Officer, Division of Scientific Review, Eunice Kennedy... 5B01, Bethesda, MD 20892-7510, 301-435- 6902, peter[email protected] . (Catalogue of Federal Domestic...

  10. 76 FR 5593 - Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-02-01

    ... Conference Call). Contact Person: Peter Zelazowski, PhD, Scientific Review Officer, Division Of Scientific... Executive Blvd., Room 5B01, Rockville, MD, 301-435-6902, peter[email protected] . (Catalogue of Federal...

  11. 76 FR 34720 - National Institute on Aging; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-06-14

    ... Indicators, Health and Aging. Date: July 7, 2011. Time: 11 a.m. to 3 p.m. Agenda: To review and evaluate... 2C212, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: Rebecca J. Ferrell, PhD...

  12. STS-89 M.S. Bonnie Dunbar, Ph.D., participates in TCDT

    NASA Technical Reports Server (NTRS)

    1998-01-01

    STS-89 Mission Specialist Bonnie Dunbar, Ph.D., prepares to drive an M-113 armored personnel carrier as part of Terminal Countdown Demonstration Test (TCDT) activities. The TCDT is held at KSC prior to each Space Shuttle flight to provide crews with an opportunity to participate in simulated countdown activities. The STS-89 mission will be the eighth docking of the Space Shuttle with the Russian Space Station Mir. After docking, Mission Specialist Andrew Thomas, Ph.D., will transfer to the space station, succeeding David Wolf, M.D., who will return to Earth aboard Endeavour. Dr. Thomas will live and work on Mir until June. STS-89 is scheduled for a Jan. 22 liftoff at 9:48 p.m.

  13. Children and grief

    MedlinePlus

    ... Clinical Assistant Professor of Pediatrics, University of Washington School of Medicine, Seattle, WA. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team. Related MedlinePlus Health Topics Bereavement Child Mental Health Browse the Encyclopedia A.D.A.M., ...

  14. The Opioid Crisis | NIH MedlinePlus the Magazine

    MedlinePlus

    ... disorder. Millions more suffer from chronic pain. Earlier this year, NIH Director Francis S. Collins, M.D., Ph.D., ... to manage pain. Stay tuned for updates on this important initiative from ... within the past year. More than 1.2 million emergency department visits ...

  15. 76 FR 46308 - Center for Scientific Review; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-08-02

    ... Person: Ai-Ping Zou, MD, PHD, Scientific Review Officer,Center for Scientific Review, National Institutes..., Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893...

  16. 78 FR 22893 - Center for Scientific Review; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-04-17

    ...). Contact Person: Ai-Ping Zou, M.D., Ph.D., Scientific Review Officer, Center for Scientific Review...; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93...

  17. The bright thread: the Bulletin's 75th anniversary.

    PubMed Central

    Beatty, W K

    1986-01-01

    This chronological review of the Bulletin of the Medical Library Association deals with the years 1911 through 1985. The Bulletin has had nineteen editors, from Marcia C. Noyes and John Ruhräh, M.D. (1911-26), through Susan Crawford, Ph.D. (1983-1986). This paper describes the Bulletin's gradual expansion in size and contents, the initiation of various departments and sections, and some of the pioneering articles. Major steps in expenses, income, and subscription price are given. Important changes in the format and the growth of the administrative and advisory structures are covered. Images PMID:3527309

  18. The bright thread: the Bulletin's 75th anniversary.

    PubMed Central

    Beatty, W K

    1998-01-01

    This chronological review of the Bulletin of the Medical Library Association deals with the years 1911 through 1985. The Bulletin has had nineteen editors, from Marcia C. Noyes and John Ruhräh, M.D. (1911-26), through Susan Crawford, Ph.D. (1983-1986). This paper describes the Bulletin's gradual expansion in size and contents, the initiation of various departments and sections, and some of the pioneering articles. Major steps in expenses, income, and subscription price are given. Important changes in the format and the growth of the administrative and advisory structures are covered. Images PMID:9578946

  19. Perspective: PhD scientists completing medical school in two years: looking at the Miami PhD-to-MD program alumni twenty years later.

    PubMed

    Koniaris, Leonidas G; Cheung, Michael C; Garrison, Gwen; Awad, William M; Zimmers, Teresa A

    2010-04-01

    Producing and retaining physician-scientists remains a major challenge in advancing innovation, knowledge, and patient care across all medical disciplines. Various programs during medical school, including MD-PhD programs, have been instituted to address the need for continued production of physician-scientists. From 1971 through 1989, 508 students with a prior PhD in the sciences, mathematics, or engineering graduated in two years from an accelerated MD program at the University of Miami School of Medicine. The program, designed to address potential clinical physician shortages rather than physician-scientist shortages, quickly attracted many top-notch scientists to medicine. Many program graduates went to top-tier residencies, pursued research careers in academic medicine, and became academic leaders in their respective fields. A retrospective examination of graduates conducted in 2008-2009 demonstrated that approximately 59% took positions in academic university medical departments, 3% worked for governmental agencies, 5% entered industry as researchers or executives, and 33% opted for private practice. Graduates' positions included 85 full professors, 11 university directors or division heads, 14 academic chairs, 2 medical school deans, and 1 astronaut. Overall, 30% of graduates had obtained National Institutes of Health funding after completing the program. These results suggest that accelerated medical training for accomplished scientists can produce a large number of successful physician-scientists and other leaders in medicine. Furthermore, these results suggest that shortening the medical portion of combined MD-PhD programs might also be considered.

  20. 78 FR 79460 - Findings of Research Misconduct

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-12-30

    ... DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Research Misconduct... Research Integrity (ORI) has taken final action in the following case: Baoyan Xu, M.D., Ph.D., National... University, Chonqing, China, engaged in research misconduct in research supported by intramural research at...

  1. 78 FR 67363 - Findings of Research Misconduct

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-11-12

    ... DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Research Misconduct... Research Integrity (ORI) has taken final action in the following case: Hao Wang, M.D., Ph.D., Western..., WU, engaged in research misconduct in research supported by National Institute of Allergy and...

  2. 78 FR 8157 - National Cancer Institute; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-02-05

    ... Person: Donald L Coppock, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division... Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Ellen K Schwartz, EDD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural...

  3. 76 FR 576 - National Cancer Institute; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-01-05

    ..., Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of...: Wlodek Lopaczynski, M.D., PhD, Scientific Review Officer, Research Programs Review Branch, Division of... Institute Special Emphasis Panel; Collaborative Research in Integrative Cancer Biology and the Tumor...

  4. 76 FR 35225 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-06-16

    ... personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Drug Discovery... DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review... Drive, Bethesda, MD 20892. (Telephone Conference Call) Contact Person: Guangyong Ji, PhD, Scientific...

  5. 78 FR 28234 - National Cancer Institute; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-05-14

    ...: Caterina Bianco, MD, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of... Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute....396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399...

  6. Dynamics of the Extended String-Like Interaction of TFIIE with the p62 Subunit of TFIIH.

    PubMed

    Okuda, Masahiko; Higo, Junichi; Komatsu, Tadashi; Konuma, Tsuyoshi; Sugase, Kenji; Nishimura, Yoshifumi

    2016-09-06

    General transcription factor II E (TFIIE) contains an acid-rich region (residues 378-393) in its α-subunit, comprising 13 acidic and two hydrophobic (Phe387 and Val390) residues. Upon binding to the p62 subunit of TFIIH, the acidic region adopts an extended string-like structure on the basic groove of the pleckstrin homology domain (PHD) of p62, and inserts Phe387 and Val390 into two shallow pockets in the groove. Here, we have examined the dynamics of this interaction by NMR and molecular dynamics (MD) simulations. Although alanine substitution of Phe387 and/or Val390 greatly reduced binding to PHD, the binding mode of the mutants was similar to that of the wild-type, as judged by the chemical-shift changes of the PHD. NMR relaxation dispersion profiles of the interaction exhibited large amplitudes for residues in the C-terminal half-string in the acidic region (Phe387, Glu388, Val390, Ala391, and Asp392), indicating a two-site binding mode: one corresponding to the final complex structure, and one to an off-pathway minor complex. To probe the off-pathway complex structure, an atomically detailed free-energy landscape of the binding mode was computed by all-atom multicanonical MD. The most thermodynamically stable cluster corresponded to the final complex structure. One of the next stable clusters was the off-pathway structure cluster, showing the reversed orientation of the C-terminal half-string on the PHD groove, as compared with the final structure. MD calculations elucidated that the C-terminal half-acidic-string forms encounter complexes mainly around the positive groove region with nearly two different orientations of the string, parallel and antiparallel to the final structure. Interestingly, the most encountered complexes exhibit a parallel-like orientation, suggesting that the string has a tendency to bind around the groove in the proper orientation with the aid of Phe387 and/or Val390 to proceed smoothly to the final complex structure. Copyright © 2016 Biophysical Society. Published by Elsevier Inc. All rights reserved.

  7. Vision for Control: Optimality and Usability

    DTIC Science & Technology

    2003-01-15

    units etc. The laboratory currently houses 12 full-time members: 2 postdocs (D. Cremers , A. Duci), one M.D. pursuing his Ph.D. (G. Scarlatis), 8 Ph.D...having performed research under my direction, both students have demonstrated leadership abilities by supervising younger students, such as summer interns

  8. New trial engineers immune cells to treat solid tumors | Center for Cancer Research

    Cancer.gov

    No existing systemic treatments can currently eradicate the great majority of metastatic solid cancers. To meet that need, Steve Rosenberg, M.D., Ph.D., is testing a new immunotherapy that targets each tumor’s unique genetic mutations in a clinical trial.

  9. Innovations in the En Route Care of Combat Casualties

    DTIC Science & Technology

    2014-01-01

    Beekley, A. C., Martin , M. J., Nelson, T., Grathwohl, K. W., Griffi th, M., Beilman, G., & Holcomb, J. B. (2010). Continuous noninvasive tissue...Medicine Occupational Health Program University of Maryland School of Medicine Baltimore, MD Petra Goodman, PhD, WHNP-BC COL (Ret), U.S. Army

  10. 78 FR 21616 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-04-11

    ..., 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Samuel C Edwards, Ph.D., IRG CHIEF, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive...: Center for Scientific Review Special Emphasis Panel; PAR Panel: Pregnancy in Women with Disabilities...

  11. 75 FR 76019 - National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-12-07

    ... strategic plan. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Independence Room (2nd Level... proposals. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Independence Room (2nd Level), Bethesda, MD 20817. Contact Person: Anthony Demsey, PhD, Director, National Institute of Biomedical Imaging...

  12. IFESS 2005 Special Session 5 Artifical Vision. Final progress report

    DOE Office of Scientific and Technical Information (OSTI.GOV)

    Weiland, James D.

    A special session on visual prostheses was held during the Annual Meeting of the International Functional Electrical Stimulation Society (IFESS), in Montreal, Canada, July 5-9, 2005. IFESS is a meeting that typically attracts researchers in implantable nerve stimulators, functional electrical stimulation, and rehabilitation. All of these areas have significant overlap with the retinal prosthesis, but these areas have decades of research behind them. The special session provided a forum for researchers with vast experience in nerve stimulation to interact with leading research in retinal and cortical visual prostheses. The grant paid for the travel and conference costs of the presentersmore » in the session. The session was chaired by James Weiland (the PI on this grant). The session co-chair was Phil Troyk, Ph.D., from the Illinois Institute of Technology. The Department of Energy was acknowledged at the start of the session as the sponsor. The following talks were delivered: Clinical Trial of a Prototype Retinal Prosthesis James Weiland, Ph.D. Doheny Eye Institute, Los Angeles, California The U.S. Department of Energy's Artificial Sight Program Elias Greenbaum, Ph.D. Oak Ridge National Laboratory, Oak Ridge, Tennessee A 16-Channel stimulator ASIC for use in an intracortical visual prosthesis Phillip R. Troyk, Ph.D. Illinois Institute of Technology, Chicago, Illinois Two approaches to the Optic Nerve Visual Prosthesis Jean Delbeke, M.D. University Cath de Louvain, Louvain, Belgium Design and Implementation of High Power Efficiency Modules for a Cortical Visual Stimulator Mohammad Sawan, Ph.D. Ecole Polytechnique de Montreal, Montreal, Canada Remaining funds from the grant were used to support Dr. Weiland's travel to the Association for Research in Vision and Ophthalmology in May 2006, with DOE approval, where several projects, supported by the DOE artificial retina program, were presented.« less

  13. 2013 Awards Gala Event | NIH MedlinePlus the Magazine

    MedlinePlus

    ... Dr. Roger I. Glass , M.D., Ph.D. (right), was Jack Andraka , 16 (middle), who recently won the 2012 Gordon E. Moore Award, grand prize of the Intel International Science and Engineering Fair. Andraka developed a quick and inexpensive method to identify pancreatic, ovarian, and lung cancer during ...

  14. 77 FR 67827 - National Heart, Lung, and Blood Institute; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-11-14

    ... Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: William J. Johnson, Ph.D., Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701... Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Research Centers at Minority...

  15. 77 FR 22580 - National Cancer Institute; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-04-16

    ... and Methodological Research for Cancer Epidemiology Cohorts. Date: May 15, 2012. Time: 12:30 p.m. to 5..., Rockville, MD 20852. Contact Person: Shakeel Ahmad, Ph.D., Scientific Review Officer, Research Programs... Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93...

  16. 77 FR 50140 - National Human Genome Research Institute; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-08-20

    ... DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Human Genome..., Human Genome Research, National Institutes of Health, HHS) Dated: August 13, 2012. Anna Snouffer, Deputy..., Bethesda, MD 20892. Contact Person: Camilla E. Day, Ph.D., Scientific Review Officer, CIDR, National Human...

  17. 75 FR 7489 - National Cancer Institute; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-02-19

    ... review and evaluate grant applications. Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Lalita D. Palekar, PhD, Scientific Review Officer, Special Review and... Institute Special Emphasis Panel; NCI Cancer Nanotechnology Training (R25) and Career Development Award (K99...

  18. 76 FR 76981 - National Cancer Institute; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-12-09

    ...: February 15-16, 2012. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place... Marinelli Road, North Bethesda, MD 20852. Contact Person: Caron A Lyman, PhD, Scientific Review Officer, National Cancer Institute, NIH, Division of Extramural Activities, Research Programs Review Branch, 6116...

  19. Grantee Spotlight: Manuel L. Penichet, M.D., Ph.D. - Reprogramming the Immune System to Kill Cancer

    Cancer.gov

    Dr. Manuel L. Penichet, former CURE K01 trainee and NCI R01 grantee, aims to genetically engineer antibodies that can be used to directly target and eliminate cancer cells and also stimulate the body’s immune system to fight and destroy cancer.

  20. One Burn, One Standard

    DTIC Science & Technology

    2014-09-01

    Johannes Kepler University Linz Software GmbH Research Department Medical Informatics Hagenberg, Austria Herbert L. Haller, MD Trauma Hospital Linz of...0000000000000004 Address correspondence to M. Giretzlehner, PhD, Johannes Kepler University Linz, RISC Software GmbH, Research Department Medical Informatics, Softwarepark 35, 4232 Hagenberg, Austria. One Burn, One Standard LETTER TO THE EDITOR

  1. 76 FR 35900 - Center For Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-06-20

    ...: Child Psychopathology and Developmental Disabilities. Date: July 5, 2011. Time: 1 p.m. to 3:30 p.m... Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Melissa Gerald, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room...

  2. Allied health education in Oklahoma.

    PubMed

    Holder, L; Nelson, S; Curcio, B

    1990-11-01

    This article is the first of several dealing with medical education and recruitment in Oklahoma and generated at the request of the OSMA-OUHSC Liaison Committee. The articles were sought out and submitted with the assistance of Edward N. Brandt, Jr., MD, PhD, executive dean at the University of Oklahoma College of Medicine.

  3. 75 FR 8373 - National Human Genome Research Institute; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-02-24

    ... Research Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee... unwarranted invasion of personal privacy. Name of Committee: National Human Genome Research Institute Special..., NHGRI Twinbrook Library, 5635 Fishers Lane, Bethesda, MD 20892-9306. Contact Person: Keith McKenney, PhD...

  4. Scientific Growth and Identity Development during a Postbaccalaureate Program: Results from a Multisite Qualitative Study.

    PubMed

    Remich, Robin; Naffziger-Hirsch, Michelle E; Gazley, J Lynn; McGee, Richard

    2016-01-01

    This report builds upon our previous study, which described five patterns of why college graduates join National Institutes of Health (NIH)-funded diversity-focused Postbaccalaureate Research Education Programs (PREP). A 2015 report from the NIH showed that a high fraction of PREP participants matriculate into PhD and MD/PhD programs. This current study reveals how participants change during PREP, the program elements that facilitate change, and how identity as a graduate student and future scientist develops. Data come from in-depth interviews done at the beginning and end of PREP with 48 individuals from seven PREP programs. Results reveal three domains of development: academics, research, and presentation of oneself; each domain contains a developmental continuum. Key attributes of PREP enabling development include opportunities to attend graduate-level classes and seminars; time to practice reading literature; extended lab time with one's own project; high and explicit expectations from mentors; and multiple opportunities to talk about science and improve communication skills. PREP enabled participants to develop their identities as graduate students and to anticipate being seen by others as highly prepared for PhD training. After PREP, 85% (n = 41) started the PhD or MD/PhD, making PREP an intervention approach with great potential to broaden participation in biomedical PhD programs. © 2016 R. Remich et al. CBE—Life Sciences Education © 2016 The American Society for Cell Biology. This article is distributed by The American Society for Cell Biology under license from the author(s). It is available to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).

  5. NASA astronaut and Mir 24 crew member David Wolf after landing

    NASA Technical Reports Server (NTRS)

    1998-01-01

    NASA astronaut and Mir 24 crew member David Wolf, M.D., who was on the Russian Space Station Mir since late September 1997, greets his friend, Tammy Kruse, shortly after his return to Earth on Jan. 31. Dr. Wolf returned aboard the orbiter Endeavour with the rest of the STS-89 crew, including Commander Terrence Wilcutt; Pilot Joe Edwards Jr.; and Mission Specialists James Reilly, Ph.D.; Michael Anderson; Bonnie Dunbar, Ph.D.; and Salizhan Sharipov with the Russian Space Agency. STS-89 Mission Specialist Andrew Thomas, Ph.D., succeeded Dr. Wolf on Mir and is scheduled to remain on the Russian space station until the STS-91 Shuttle mission returns in June 1998. In addition to the docking and crew exchange, STS-89 included the transfer of science, logistical equipment and supplies between the two orbiting spacecrafts.

  6. KSC-98pc407

    NASA Image and Video Library

    1998-03-23

    KENNEDY SPACE CENTER, FLA. -- The Space Shuttle Columbia arrives at the top of Launch Pad 39B after its morning rollout prior to STS-90. The Neurolab experiments are the primary payload on this nearly 17-day space flight. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, includes Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  7. 77 FR 32651 - National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-06-01

    ... meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections...). Contact Person: Charles H Washabaugh, Ph.D., Scientific Review Officer, Scientific Review Branch, National... applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Charles N...

  8. 76 FR 30951 - Advisory Committee on Training in Primary Care Medicine and Dentistry; Notice of Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-05-27

    ... Committee on Training in Primary Care Medicine and Dentistry; Notice of Meeting In accordance with section... following meeting: Name: Advisory Committee on Training in Primary Care Medicine and Dentistry (ACTPCMD.... Glass, M.D., Ph.D., Advisory Committee Executive Secretary, Division of Medicine and Dentistry, Bureau...

  9. Calibrating Crash Modification Factors for Wyoming-Specific Conditions : Application of the Highway Safety Manual - Part D

    DOT National Transportation Integrated Search

    2017-04-01

    Mohamed Ahmed, Ph.D., P.E.- orcid.org/0000-0002-1921-0724; Sherif Gaweesh, M.S. - orcid.org/0000-0001-7977-6378; Md Julfiker Hossain -orcid.org/0000-0001-7173-7040; Sadia Sharmin orcid.org/0000-0003-0947-8345; Thomas Peel orcid.org/ 0000-0002...

  10. Always Tired? You May Have Sleep Apnea

    MedlinePlus

    ... Medicine, an oral appliance is worn only during sleep and fits like a sports mouth guard or an orthodontic retainer. It supports the jaw in a forward position to help maintain an open upper airway. There are no drugs that are approved by the FDA to treat sleep apnea. Ronald Farkas, M.D., Ph.D., at ...

  11. 77 FR 26301 - National Cancer Institute; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-05-03

    ....396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399..., MD 20892 (Telephone Conference Call). Contact Person: Virginia P. Wray, Ph.D., Deputy Chief, Research... Special Emphasis Panel; Cell-Based Imaging. Date: June 19, 2012. Time: 1:00 p.m. to 4:00 p.m. Agenda: To...

  12. 77 FR 26771 - Office of the Director, National Institutes of Health Notice of Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-05-07

    ... Institutes of Health, Office of the Director, NIH, Office of Science Policy, 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Lyric Jorgenson, Ph.D., Office of Science Policy, Office of the Director, NIH, National Institutes of Health, 6705 Rockledge Drive, Suite 750...

  13. AIDS Researcher Gives Retrospective

    ERIC Educational Resources Information Center

    Hawkins, B. Denise

    2011-01-01

    Nearly 30 years ago, renowned immunologist James E.K. Hildreth, M.D., Ph.D., was compelled to start researching the virus that causes AIDS. He marveled at its enigma and was pressed into action by its ability to cut lives short and devastate communities. The disease set him on a course of medical inquiry that has included biomedical breakthroughs…

  14. 77 FR 72868 - The Centers for Disease Control (CDC)/Health Resources and Services Administration (HRSA...

    Federal Register 2010, 2011, 2012, 2013, 2014

    2012-12-06

    ... Hepatitis and STD Prevention and Treatment Notice of Charter Renewal This gives notice under the Federal..., Viral Hepatitis and STD Prevention and Treatment, Department of Health and Human Services, has been..., M.D., Ph.D., Designated Federal Officer, CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD...

  15. Postdoctoral Fellow | Center for Cancer Research

    Cancer.gov

    A post-doctoral fellowship is currently available for productive, highly-motivated, and energetic individuals in the Inflammation and Tumorigenesis Section of Dr. Yinling Hu at the NCI-Frederick campus.  A dynamic research environment and outstanding resources are available for enthusiastic individuals.  Requirements include a Ph.D., M.D., or equivalent degree and experience

  16. 75 FR 11895 - National Institute of General Medical Sciences; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-03-12

    ... confidential trade secrets or commercial property such as patentable material, and personal information... Sciences Special Emphasis Panel, Modeling the Scientific Workforce. Date: April 5, 2010. Time: 1 p.m. to 3..., Natcher Building, 45 Center Drive, Room 3AN.34, Bethesda, MD 20892. Contact Person: Brian R. Pike, PhD...

  17. Retraction Statement: "Overexpression of miR-708 and its targets in the childhood common precursor B-cell ALL" by Xue Li, MMed, Dong Li, PhD, Yong Zhuang, MMed, Qing Shi, BSc, Wei Wei, MMed, and Xiuli Ju, MD, PhD.

    PubMed

    2017-05-01

    The above article, published online 23 August 2013 in Pediatric Blood and Cancer, Volume 60, Issue 12, December 2013, Pages 2060-2067, has been retracted by agreement among the authors, the journal's Editor-in-Chief, Peter E. Newburger, M.D., and Wiley Periodicals, Inc. The decision to retract was agreed upon following notification that the paper substantially duplicates a prior study already published in Chinese https://www.ncbi.nlm.nih.gov/pubmed/23611221. The authors were not aware that publication in another language would constitute a duplicate publication and, upon being informed of this fact, have agreed to withdraw the paper from Pediatric Blood and Cancer. Reference Li X, Li D, Zhuang Y, Shi Q, Wei W and Ju X. Overexpression of miR-708 and its targets in the childhood common precursor B-cell ALL. Pediatr Blood Cancer. 2013; 60: 2060-2067. doi:10.1002/pbc.24583. © 2017 Wiley Periodicals, Inc.

  18. Advancing the understanding of progression in multiple sclerosis: an interview with Shibeshih Belachew.

    PubMed

    Belachew, Shibeshih

    2018-02-01

    Shibeshih Belachew speaks to Laura Dormer, Commissioning Editor: Dr Shibeshih Belachew, MD, PhD, is a Senior Medical Director for Multiple Sclerosis (MS) Disease Area in Global Product Development Medical Affairs at Roche (Basel, Switzerland). Prior to joining Roche in January 2016, he was Director of MS Franchise and Head of Medical Director's office for Biogen Region Europe and Canada. Previously at Biogen he also served as a Director in Global Neurology for the natalizumab program in Cambridge (MA, USA). Prior to joining industry, he was a Clinical Professor of Neurology at the University of Liège in Belgium. Shibeshih completed neurology postgraduate training at the University of Liège and has a PhD in Biomedical Science in the field of Developmental Neurobiology. Shibeshih has been a post-doctoral fellow in the Laboratory of Cellular and Synaptic Neurophysiology at the National Institutes of Health (Bethesda, MD, USA) and later at the Center for Neuroscience Research of Children's National Medical Center in Washington DC. He is a member of the Belgian Neurological Society.

  19. The SPACEHAB double module is moved into the payload changeout room at Launch Pad 39B

    NASA Technical Reports Server (NTRS)

    1999-01-01

    This fish-eye view shows the SPACEHAB Double module being moved into the payload changeout room at Launch Pad 39B before being transferred to Space Shuttle Discovery's payload bay for mission STS-96. The second flight supporting construction of the International Space Station, STS-96 is a logistics and resupply mission, carrying more than 5,000 pounds of supplies, a Russian- built crane and a U.S.-built crane, plus experiments such as STARSHINE, which was developed by and for students. Comprising the crew are Commander Kent V. Rominger, Pilot Rick Douglas Husband, and Mission Specialists Ellen Ochoa (Ph.D.), Tamara E. Jernigan (Ph.D.), Daniel Barry (M.D., Ph.D.), Julie Payette, with the Canadian Space Agency, and Valery Ivanovich Tokarev, with the Russian Space Agency. Liftoff is scheduled for May 20 at 9:32 a.m. EDT.

  20. STS-96 M.S. Tokarev tries gas mask as part of a TCDT

    NASA Technical Reports Server (NTRS)

    1999-01-01

    STS-96 Mission Specialist Valery Ivanovich Tokarev, with the Russian Space Agency, tries on an oxygen gas mask during Terminal Countdown Demonstration Test (TCDT) activities at Launch Pad 39B. The TCDT provides the crew with simulated countdown exercises, emergency egress training and opportunities to inspect the mission payloads in the orbiter's payload bay. Other crew members taking part in the TCDT are Commander Kent V. Rominger, Pilot Rick Douglas Husband, and Mission Specialists Tamara E. Jernigan (Ph.D.), Daniel Barry (M.D., Ph.D.), Ellen Ochoa (Ph.D.) and Julie Payette, with the Canadian Space Agency. Scheduled for liftoff on May 20 at 9:32 a.m., STS-96 is a logistics and resupply mission for the International Space Station, carrying such payloads as a Russian crane, the Strela; a U.S.-built crane; the Spacehab Oceaneering Space System Box (SHOSS), a logistics items carrier; and STARSHINE, a student-led experiment.

  1. Laboratory of Viral Diseases Guest Researcher Seminar Series | Center for Cancer Research

    Cancer.gov

    Laboratory of Viral Diseases Guest Researcher Seminar Series New Epigenetic Regulators of HIV Latency Speaker: Melanie Ott, M.D., Ph.D, Senior Investigator & Professor of Medicine Gladstone Institutes & University of California Building 33, Main Conference Room 1N09 Main NIH CAMPUS *BLDG 33 is a secure facility, please allow time to pass through security.

  2. 78 FR 9933 - National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-02-12

    ... meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections... 20892, (Virtual Meeting). Contact Person: Charles N. Rafferty, Ph.D., Chief, Scientific Review Branch..., National Institutes of Health, Bethesda, MD 20817, 301-594-5019, charles[email protected] . (Catalogue of...

  3. 76 FR 24892 - National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-05-03

    ... meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections..., (Telephone Conference Call). Contact Person: Charles N. Rafferty, PhD, Chief, Scientific Review Branch... Democracy Boulevard, Suite 800, Bethesda, MD 20817, 301-594-5019, charles[email protected] . (Catalogue of...

  4. 75 FR 16152 - National Heart, Lung, and Blood Institute; Notice of Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-03-31

    ... sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions..., MD 20892. Contact Person: Stephen C. Mockrin, Ph.D., Director, Division of Extramural Research... show one form of identification (for example, a government-issued photo ID, driver's license, or...

  5. 78 FR 25458 - National Eye Institute; Notice of Meeting

    Federal Register 2010, 2011, 2012, 2013, 2014

    2013-05-01

    ... the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5..., Bethesda, MD 20892. Contact Person: Lore Anne McNicol, Ph.D., Director, Division of Extramural Research... will be asked to show one form of identification (for example, a government-issued photo ID, driver's...

  6. Inaugural Technology Showcase Draws Hundreds | Poster

    Cancer.gov

    Before a crowded auditorium of science and business professionals at the Frederick National Laboratory for Cancer Research’s Advanced Technology Research Facility, Joost Oppenheim, M.D., had just finished his presentation about a compound with the potential to expand the impact of a promising category of cancer therapeutics when he fielded a question from Stephan Stern, Ph.D.

  7. KSC-98pc1023

    NASA Image and Video Library

    1998-09-02

    During a break in the Crew Equipment Interface Test (CEIT), the STS-95 crew gathers with United Space Alliance (USA) personnel and their families. From left are Pilot Steven W. Lindsey; Payload Specialist John H. Glenn Jr., a senator from Ohio; Pedro Duque, with the European Space Agency (ESA); Mission Specialist Stephen K. Robinson, Ph.D.; Chiaki Mukai, with the National Space Development Agency of Japan (NASDA); Mission Commander Curtis L. Brown Jr. (with arm raised); Mission Specialist Scott E. Parazynski, M.D.; Jim Furr, USA National Space Flight Awareness representative; Jack King, USA Public Affairs; Bob Sieck, KSC director of Shuttle Processing; and Ed Adamek, USA vice president and associate program manager for Ground Operations at KSC

  8. KSC-98pc505

    NASA Image and Video Library

    1998-04-17

    KENNEDY SPACE CENTER, FLA. -- The Space Shuttle Columbia soars from Launch Pad 39B at 2:19 p.m. EDT Apr. 17 to begin the nearly 17-day STS-90 Neurolab mission. The launch was delayed 24 hours due to difficulty with a network signal processor, which was replaced Apr. 16, on the orbiter. The crew members are Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system.

  9. KSC-98PC501

    NASA Image and Video Library

    1998-04-17

    Framed by native Floridian foliage, the Space Shuttle Columbia soars from Launch Pad 39B at 2:19 p.m. EDT Apr. 17 to begin the nearly 17-day STS-90 Neurolab mission. The launch was delayed 24 hours due to difficulty with a network signal processor, which was replaced Apr. 16, on the orbiter. The crew members are Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system

  10. KSC-98dc496

    NASA Image and Video Library

    1998-04-17

    The Space Shuttle Columbia soars from Launch Pad 39B at 2:19 p.m. EDT Apr. 17 to begin the nearly 17-day STS-90 Neurolab mission. The launch was delayed 24 hours due to difficulty with a network signal processor, which was replaced Apr. 16, on the orbiter. The crew members are Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system

  11. KSC-98pc506

    NASA Image and Video Library

    1998-04-17

    KENNEDY SPACE CENTER, FLA. -- The Space Shuttle Columbia lifts off from Launch Pad 39B at 2:19 p.m. EDT Apr. 17 to begin the nearly 17-day STS-90 Neurolab mission. The launch was delayed 24 hours due to difficulty with a network signal processor, which was replaced Apr. 16, on the orbiter. The crew members are Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system

  12. KSC-98pc499

    NASA Image and Video Library

    1998-04-17

    KENNEDY SPACE CENTER, FLA. -- The Space Shuttle Columbia soars from Launch Pad 39B at 2:19 p.m. EDT Apr. 17 to begin the STS-90 Neurolab mission. The launch was delayed 24 hours due to difficulty with a network signal processor, which was replaced Apr. 16, on the orbiter. The crew members are Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system

  13. KSC-98pc516

    NASA Image and Video Library

    1998-04-17

    KENNEDY SPACE CENTER, FLA. -- The Space Shuttle Columbia soars from Launch Pad 39B at 2:19 p.m. EDT Apr. 17 to begin the STS-90 Neurolab mission. The launch was delayed 24 hours due to difficulty with a network signal processor, which was replaced Apr. 16, on the orbiter. The crew members are Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system

  14. KSC-98pc502

    NASA Image and Video Library

    1998-04-17

    Framed by native Floridian foliage, the Space Shuttle Columbia soars from Launch Pad 39B at 2:19 p.m. EDT Apr. 17 to begin the nearly 17-day STS-90 Neurolab mission. The launch was delayed 24 hours due to difficulty with a network signal processor, which was replaced Apr. 16, on the orbiter. The crew members are Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system

  15. KSC-98pc498

    NASA Image and Video Library

    1998-04-17

    KENNEDY SPACE CENTER, FLA. -- The Space Shuttle Columbia soars from Launch Pad 39B at 2:19 p.m. EDT Apr. 17 to begin the nearly 17-day STS-90 Neurolab mission. The launch was delayed 24 hours due to difficulty with a network signal processor, which was replaced Apr. 16, on the orbiter. The crew members are Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system

  16. KSC-98dc497

    NASA Image and Video Library

    1998-04-17

    The Space Shuttle Columbia soars from Launch Pad 39B at 2:19 p.m. EDT Apr. 17 to begin the nearly 17-day STS-90 Neurolab mission. The launch was delayed 24 hours due to difficulty with a network signal processor, which was replaced Apr. 16, on the orbiter. The crew members are Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system

  17. STS-89 M.S. Andrew Thomas, Ph.D., participates in TCDT

    NASA Technical Reports Server (NTRS)

    1998-01-01

    STS-89 Mission Specialist Andrew Thomas, Ph.D., participates in a question and answer session for the media as part of Terminal Countdown Demonstration Test (TCDT) activities. The TCDT is held at KSC prior to each Space Shuttle flight to provide crews with an opportunity to participate in simulated countdown activities. The STS-89 mission will be the eighth docking of the Space Shuttle with the Russian Space Station Mir. After docking, Dr. Thomas will transfer to the space station, succeeding David Wolf, M.D., who will return to Earth aboard Endeavour. Dr. Thomas will live and work on Mir until June. STS-89 is scheduled for a Jan. 22 liftoff at 9:48 p.m.

  18. Transforming the diagnosis of tuberculosis: an editorial board member's opinion at the 15th year of Expert Review of Molecular Diagnostics.

    PubMed

    Pai, Madhukar; Raison, Claire

    2015-03-01

    Interview with Professor Madhukar Pai, MD, PhD by Claire Raison (Commissioning Editor). Professor Madhukar Pai did his medical training and community medicine residency in Vellore, India. He completed his PhD in epidemiology at the University of California, Berkeley (CA, USA) and a postdoctoral fellowship at the University of California, San Francisco (CA, USA). He is currently an associate professor of epidemiology at McGill University in Montreal (Canada). He serves as the Director of Global Health Programs, and as an Associate Director of the McGill International Tuberculosis Centre. In addition, he serves as a Consultant for the Bill & Melinda Gates Foundation. He also serves on the Scientific Advisory Committee of the Foundation for Innovative New Diagnostics, Geneva, Switzerland. His research is focused on improving the diagnosis and treatment of tuberculosis, especially in high-burden countries such as India and South Africa. His research is supported by grant funding from the Gates Foundation, Grand Challenges Canada and Canadian Institutes of Health Research. He has more than 200 peer-reviewed publications. He is recipient of the Union Scientific Prize, Chanchlani Global Health Research Award and Stars in Global Health award from Grand Challenges Canada, and is a member of the Royal Society of Canada.

  19. Generation of physician-scientists manpower: a follow-up study of the first 294 graduates of the Harvard-MIT Program of Health Sciences and Technology.

    PubMed

    Abelmann, W H; Nave, B D; Wilkerson, L

    1997-06-01

    The MD program of the Harvard-MIT Division of Health Sciences and Technology was founded in 1970. One of its goals was the application of the academic resources of the two universities to the education of leaders in academic medicine and biomedical sciences. The first MD class was admitted in 1971. Prerequisites for admission are a strong background in quantitative sciences and demonstrated interest in research. Research and a thesis are obligatory. Enrollment in a PhD program is elective. Questionnaires were sent to 293 alumni who graduated from the MD program between 1975 and 1988, followed up by letters and telephone calls. By 1988, 296 students had graduated, 207 with an MD only, 89 with MD-PhD degrees. Follow-up by questionnaires of 293 living graduates (92%), plus indirect data on 11 others, revealed that 212 (75%) held faculty appointments in 64 medical schools. Overall, 73.5% of respondents were engaged in research: 68% of MDs and 86% of MD-PhDs. One hundred and four (38%) respondents spent more than 50% of their time on research: 54 (29%) of MDs and 50 (60%) of MD-PhDs. Seventy-five percent of respondents were active in teaching. Our experience indicates that both an MD-PhD program and a research-oriented MD program are effective in producing physician-scientists and leaders in academic medicine.

  20. Scientific Growth and Identity Development during a Postbaccalaureate Program: Results from a Multisite Qualitative Study

    ERIC Educational Resources Information Center

    Remich, Robin; Naffziger-Hirsch, Michelle E.; Gazley, J. Lynn; McGee, Richard

    2016-01-01

    This report builds upon our previous study, which described five patterns of why college graduates join National Institutes of Health (NIH)-funded diversity-focused Postbaccalaureate Research Education Programs (PREP). A 2015 report from the NIH showed that a high fraction of PREP participants matriculate into PhD and MD/PhD programs. This current…

  1. Vaccines 2.0 | Center for Cancer Research

    Cancer.gov

    In 1974, Jay A. Berzofsky, M.D., Ph.D., now Chief of CCR’s Vaccine Branch, came to NIH to study protein folding. His curious mind and collaborative spirit quickly led him into the intertwined fields of immunology and vaccine development. With close to 500 publications to his name, Berzofsky has pioneered the characterization of B- and T-cell epitopes and their modification to

  2. Military Families In Transition: Stress, Resilience, And Well-Being

    DTIC Science & Technology

    2014-01-01

    Smith College of Engineering and Computer Science Professor, Department of Physics , College of Arts and Sciences Fellow: AIAA, ASME, APS, Institute...of Physics (UK) Syracuse University Richard E. Heyman, PhD Professor Family Translational Research Group Department of Cariology and Comprehensive...Pasquina, MD COL(R), USA Residency Director and Chair, Physical Medicine & Rehabilitation Uniformed Services University Walter Reed National

  3. Pancreatic Cancer Chemoprevention Translational Workshop | Division of Cancer Prevention

    Cancer.gov

    Thursday, September 10th (6:00 to 9:30 PM) Welcome Barnett Kramer, MD, MPH (6:00 to 6:10 PM) Director of the Division of Cancer Prevention, NCI Introduction – Goals of the Workshop: ABCs of Cancer Prevention (Agents, Biomarkers, Cohorts) Mark Miller, PhD (6:10 to 6:25 PM) Program Director Division of Cancer Prevention, NCI |

  4. Biomarkers of Risk for Post-traumatic Stress Disorder (PTSD)

    DTIC Science & Technology

    2009-05-01

    Post - traumatic Stress Disorder ( PTSD ) PRINCIPAL INVESTIGATOR: Audrey R. Tyrka, MD, PhD... Post - traumatic Stress Disorder ( PTSD ) 5a. CONTRACT NUMBER 5b. GRANT NUMBER W81XWH-07-1-0269 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S...1,087,938. 11. United States Department of Defense, “Biomarkers of risk for post - traumatic stress disorder ( PTSD ),” Principal Investigator,

  5. Dana-Farber Cancer Institute | Office of Cancer Genomics

    Cancer.gov

    Functional Annotation of Cancer Genomes Principal Investigator: William C. Hahn, M.D., Ph.D. The comprehensive characterization of cancer genomes has and will continue to provide an increasingly complete catalog of genetic alterations in specific cancers. However, most epithelial cancers harbor hundreds of genetic alterations as a consequence of genomic instability. Therefore, the functional consequences of the majority of mutations remain unclear.

  6. 75 FR 67379 - Center for Scientific Review; Notice of Closed Meetings

    Federal Register 2010, 2011, 2012, 2013, 2014

    2010-11-02

    ...: Weight Loss, Obesity and Physical Activity. Date: November 15, 2010. Time: 10 a.m. to 11:30 a.m. Agenda..., Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Lee S. Mann, PhD, Scientific Review Officer... Research Transition (A-START) in Drug Abuse and HIV/AIDS. Date: November 29, 2010. Time: 11 a.m. to 4 p.m...

  7. NCI Scientists Awarded National Medal of Technology and Innovation by President Obama | Poster

    Cancer.gov

    Two NCI scientists received the National Medal of Technology and Innovation, the nation’s highest honor for technological achievement. The award was announced by President Obama in October. The honorees, John Schiller, Ph.D., Laboratory of Cellular Oncology (LCO), Center for Cancer Research, NCI, and Douglas Lowy, M.D., also from LCO and NCI deputy director, received their

  8. CCR researchers provide insight into pathway that initiates a common type of skin cancer | Center for Cancer Research

    Cancer.gov

    Since studies in mice have elucidated much about tumor biology, Stuart Yuspa, M.D., and Christophe Cataisson, Ph.D., of CCR’s Laboratory of Cancer Biology and Genetics, and their colleagues decided to study mice that overexpress hepatocyte growth factor (HGF) to understand the role the pathway plays in squamous cell cancer (SCC).

  9. Site-Specific Differentiation of Fibroblasts in Normal and Scleroderma Skin

    DTIC Science & Technology

    2010-06-01

    SITE-SPECIFIC DIFFERENTIATION OF FIBROBLASTS IN NORMAL AND SCLERODERMA SKIN PRINCIPAL INVESTIGATOR: Howard Y. Chang, M.D., Ph.D...2010 4. TITLE AND SUBTITLE Site-Specific Differentiation of Fibroblasts in Normal and 5a. CONTRACT NUMBER Scleroderma Skin 5b. GRANT NUMBER...activated fibroblasts from SSc. 15. SUBJECT TERMS Scleroderma , fibroblasts, gene expression 16. SECURITY CLASSIFICATION OF: U 17. LIMITATION OF

  10. NIH Funding within Otolaryngology: 2005-2014.

    PubMed

    Lennon, Christen J; Hunter, Jacob B; Mistry, Akshitkumar M; Espahbodi, Mana; Deasey, Matthew; Niesner, K J; Labadie, Robert F

    2017-11-01

    Objective Analyze grants awarded between 2005 and 2014 to otolaryngology departments that appear in the National Institutes of Health (NIH) RePORTER database, summarize characteristics of grant recipients associated with otolaryngology departments as listed in the RePORTER between 2005 and 2014, and identify trends in otolaryngology NIH funding between 2005 and 2014 by topic. Study Design Case series. Setting NIH database inquiry. Subjects Grant recipients. Methods The RePORTER was queried for all grants awarded to otolaryngology departments between 2005 and 2014. All grants classified as new, renewal, or revision were included while duplicates were excluded. Results In total, 475 grants to 51 institutions were categorized by topic and subtopic. Internet searches were conducted for characteristics of 352 principal investigators. Sixty-seven percent of awardees had a PhD, 22% had an MD, and 11% had an MD/PhD. Sex ratios varied by degrees held. Although 31% of all grant recipients were women, this ratio was not seen when recipients were classified by degree type, with 78% of women holding a PhD compared with 55% of men ( P = .0013). Of the award types, 39% were R01s, 15% were R21s, and 10% were R03s. The top 3 represented topics were otology/neurotology (52%), audiology (25%), and head and neck surgery (14%). The mean annual award amount, after adjusting for inflation to 2014 dollars, was $226,495.76, with 72.8% awarded by the National Institute of Deafness and Communication Disorders. Twenty percent of awardees received multiple grants. Conclusion NIH funding in otolaryngology tends to be awarded to those with PhDs studying the hearing sciences, with 1 in 5 having multiple awards. As in other areas of NIH funding, women are underrepresented overall.

  11. The utility of cadaver-based approaches for the teaching of human anatomy: A survey of British and Irish anatomy teachers.

    PubMed

    Balta, Joy Y; Cronin, Michael; Cryan, John F; O'Mahony, Siobhain M

    2017-03-01

    Utilizing reality anatomy such as dissection and demonstrating using cadavers has been described as a superior way to create meaning. The chemicals used to embalm cadavers differentially alter the tissue of the human body, which has led to the usage of different processes along the hard to soft-fixed spectrum of preserved cadavers. A questionnaire based approach was used to gain a better insight into the opinion of anatomists on the use of preserved cadavers for the teaching of human anatomy. This study focused on anatomy teachers in the United Kingdom and Ireland. From the 125 participating anatomists, 34.4% were medically qualified, 30.4% had a PhD in a non-anatomical science and 22.4% had a PhD in an anatomical science, these figures include ten anatomists who had combinations of MD with the two other PhD qualifications. The main findings from the questionnaire were that 61.6% of participants agreed that hard-fixed formalin cadavers accurately resemble features of a human body whereas 21.6% disagreed. Moreover, anatomists rated the teaching aids on how accurately they resemble features of the human body as follows: plastic models the least accurate followed by plastinated specimens, hard fixed cadavers; soft preserved cadavers were considered to be the most accurate when it comes to resembling features of the human body. Though anatomists considered soft preserved cadavers as the most accurate tool, further research is required in order to investigate which techniques or methods provide better teaching tool for a range of anatomical teaching levels and for surgical training. Anat Sci Educ 10: 137-143. © 2016 American Association of Anatomists. © 2016 American Association of Anatomists.

  12. KSC-98pc270

    NASA Image and Video Library

    1998-02-05

    KENNEDY SPACE CENTER, FLA. -- The STS-90 Neurolab payload is lowered into its payload canister in KSC's Operations and Checkout Building. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch in April, will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  13. KSC-98pc504

    NASA Image and Video Library

    1998-04-17

    KENNEDY SPACE CENTER, FLA. -- Framed by native Floridian foliage, the Space Shuttle Columbia soars from Launch Pad 39B at 2:19 p.m. EDT Apr. 17 to begin the nearly 17-day STS-90 Neurolab mission. The launch was delayed 24 hours due to difficulty with a network signal processor, which was replaced Apr. 16, on the orbiter. The crew members are Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system

  14. KSC-98pc292

    NASA Image and Video Library

    1998-02-12

    The STS-90 Neurolab payload is positioned into the cargo bay of Space Shuttle Columbia today in Orbiter Processing Facility bay 3. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch in April, will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  15. KSC-98pc269

    NASA Image and Video Library

    1998-02-05

    KENNEDY SPACE CENTER, FLA. -- The STS-90 Neurolab payload is lowered into its payload canister in KSC's Operations and Checkout Building. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch in April, will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  16. KSC-98pc503

    NASA Image and Video Library

    1998-04-17

    KENNEDY SPACE CENTER, FLA. -- The Space Shuttle Columbia surges skyward from Launch Pad 39B at 2:19 p.m. EDT Apr. 17 to begin the nearly 17-day STS-90 Neurolab mission. The launch was delayed 24 hours due to difficulty with a network signal processor, which was replaced Apr. 16, on the orbiter. The crew members on-board include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system

  17. KSC-98pc507

    NASA Image and Video Library

    1998-04-17

    KENNEDY SPACE CENTER, FLA. -- The Space Shuttle Columbia lifts off from Launch Pad 39B at 2:19 p.m. EDT Apr. 17 to begin the nearly 17-day STS-90 Neurolab mission. A torrent of water is seen flowing onto the mobile launcher platform as several large quench nozzles, or "rainbirds," mounted on platform's surface operate as a sound suppression system. The crew members are Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system

  18. KSC-99pp0477

    NASA Image and Video Library

    1999-04-29

    The STS-96 crew pose for a group photo after emergency egress training at Launch Pad 39B. From left are Mission Specialist Ellen Ochoa (Ph.D.); Pilot Rick Douglas Husband; Mission Specialists Julie Payette, Daniel Barry (M.D., Ph.D.), and Tamara E. Jernigan (Ph.D.); Commander Kent V. Rominger; and Mission Specialist Valery Ivanovich Tokarev. Payette is with the Canadian Space Agency, and Ivanovich Tokarev with the Russian Space Agency. Behind them is the tip of the external tank, which is 153.8 feet high. The external tank provides fuel to the three space shuttle main engines in the orbiter during liftoff and ascent. It is eventually jettisoned, entering the Earth's atmosphere, breaking up and impacting a remote ocean area. STS-96, scheduled for liftoff on May 20 at 9:32 a.m., is a logistics and resupply mission for the International Space Station, carrying such payloads as a Russian crane, the Strela; a U.S.-built crane; the Spacehab Oceaneering Space System Box (SHOSS), a logistics items carrier; and STARSHINE, a student-led experiment

  19. STS-96 M.S. Payette and Pilot Husband try on gas masks as part of a TCDT

    NASA Technical Reports Server (NTRS)

    1999-01-01

    At Launch Pad 39B, STS-96 Mission Specialist Julie Payette, with the Canadian Space Agency, and Pilot Rick Douglas Husband practice putting on oxygen gas masks as part of Terminal Countdown Demonstration Test (TCDT) activities. The TCDT provides the crew with emergency egress traiing, simulated countdown exercises and opportunities to inspect the mission payloads in the orbiter's payload bay. Other crew members taking part in the TCDT are Commander Kent V. Rominger and Mission Specialists Tamara E. Jernigan (Ph.D.), Daniel Barry (M.D., Ph.D.), Ellen Ochoa (Ph.D.) and Valery Ivanovich Tokarev, with the Russian Space Agency. Scheduled for liftoff on May 20 at 9:32 a.m., STS- 96 is a logistics and resupply mission for the International Space Station, carrying such payloads as a Russian crane, the Strela; a U.S.-built crane; the Spacehab Oceaneering Space System Box (SHOSS), a logistics items carrier; and STARSHINE, a student- led experiment.

  20. Englerin A Delivers One-Two Punch to Kidney Cancer Cells | Center for Cancer Research

    Cancer.gov

    While overall cancer death rates continue to decline in the U.S., mortality rates for certain cancer sites, including the kidney, are on the rise. New treatments are needed to reverse this trend and one potentially rich source is natural products, compounds derived from living organisms. John Beutler, Ph.D., and his colleagues, in CCR’s Molecular Targets Laboratory located at the NCI campus in Frederick, Maryland, identified englerin A from an extract of the African plant Phyllanthus engleri that was particularly toxic to kidney cancer cells. To further investigate the activity of englerin A, the Beutler group teamed up with researchers led by Marston Linehan, M.D., and Len Neckers, Ph.D., in CCR’s Urologic Oncology Branch.

  1. KSC-99pp0641

    NASA Image and Video Library

    1999-06-07

    At the Cape Canaveral Air Station Skid Strip, STS-96 crew members and their families board a plane to return to the Johnson Space Center in Houston, Texas. From left are the son, Ivan, and wife, Irina, of Mission Specialist Valery Ivanovich Tokarev (carrying a duffel bag); and Mission Specialist Ellen Ochoa, holding her son, Wilson Miles-Ochoa. Other crew members also returning are Commander Kent V. Rominger, Pilot Rick D. Husband, and Mission Specialists Tamara E. Jernigan (Ph.D.), Daniel Barry (M.D., Ph.D.) and Julie Payette (with the Canadian Space Agency). After a successful 10-day mission to the International Space Station aboard Space Shuttle Discovery, the crew landed June 6 at 2:02:43 a.m. EDT, in the 11th night landing at KSC

  2. The association between scholarly impact and National Institutes of Health funding in ophthalmology.

    PubMed

    Svider, Peter F; Lopez, Santiago A; Husain, Qasim; Bhagat, Neelakshi; Eloy, Jean Anderson; Langer, Paul D

    2014-01-01

    To examine whether there is an association between scholarly impact, as measured by the h-index, academic rank, and National Institutes of Health (NIH) awards in academic ophthalmology. Retrospective analysis of NIH RePORTER and Scopus databases. Not applicable. Five hundred seventy-three NIH awards to 391 primary investigators (PIs) in ophthalmology departments were examined. Grant recipients were organized by academic rank, obtained from online listings, and h-index, calculated using the Scopus database. Non-NIH-funded faculty from 20 randomly chosen academic ophthalmology departments also were organized by rank and h-index for comparison with their NIH-funded colleagues. Scholarly impact, as measured by the h-index, and NIH funding. The h-index increased with successive academic rank among non-NIH-funded and NIH-funded faculty, as did NIH funding among the latter group. The NIH-funded faculty had higher scholarly impact, as measured by the h-index, than their non-NIH-funded PIs (h = 18.3 vs. 7.8; P <0.0001), even when considering publications only in the prior 5 years; h-index increased with increasing NIH funding ranges. The h-indices of those holding an MD degree (21.4±1.6 standard error of mean) were not statistically higher than those of PhD holders (17.9±0.6) and those with both an MD and PhD degree (18.1±1.7; P = 0.14). The h-index increases with increasing academic rank among NIH-funded and non-NIH-funded faculty in ophthalmology departments. This bibliometric is associated strongly with NIH funding because NIH-funded PIs had higher scholarly impact than their non-NIH-funded colleagues, and increasing impact was noted with higher funding. The h-index is an objective and easily calculable measure that may be valuable as an adjunct in assessing research productivity, a significant factor for academic promotion in academic ophthalmology. Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

  3. 76 FR 23606 - Submission for OMB Review; Comment Request; National Institutes of Health Loan Repayment Programs

    Federal Register 2010, 2011, 2012, 2013, 2014

    2011-04-27

    ... National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request to... financial assistance, in the form of educational loan repayment, to M.D., PhD, Pharm.D., D.D.S., D.M.D..., directly to financial institutions. The information proposed for collection will be used by the Division of...

  4. Integrated Cancer Research in Five Thematic Areas in Interest

    DTIC Science & Technology

    2005-07-01

    Professor of Urology (on-going RSU), Howard Crawford, PhD, Assistant Professor of Pharmacological Sciences (on-going RSU), Marjana Maletic- Savatic ...young scientists. Drs. Adler, Crawford, Maletic- Savatic received base support from this mechanism as they further develop their research programs...Mirjana Maletic- Savatic , MD-PhD, Assistant Professor Neurology: Human Neural Stem Cells - In Vivo Models for Cerebral Carcinoma The study of human

  5. NIH–Lacks Family Partnership Gives Henrietta Lacks’ Descendants a Seat at the Table | Poster

    Cancer.gov

    The NIH Bethesda campus recently welcomed several special guests for a presentation titled Given a Voice: Update on the NIH–Lacks Family Partnership. Henrietta Lacks’ grandchildren Jeri Lacks-Whye (who is also the Lacks family spokesperson) and David Lacks, Jr. came to speak with NIH Director Francis S. Collins, Ph.D., M.D. about the importance of protecting patients and their

  6. Clinical trial tests combinations of immunotherapy drugs for prostate cancer | Center for Cancer Research

    Cancer.gov

    Metastatic castration-resistant prostate cancer (mCRPC) is a disease that has spread beyond the prostate and no longer responds to hormone therapy. James Gulley, M.D., Ph.D., of the Genitourinary Malignancies Branch is leading a study of combination immunotherapy where patients will be treated with two, three or four drugs that affect the immune system in different ways to

  7. Mission-Based Scenario Research: Experimental Design and Analysis

    DTIC Science & Technology

    2011-08-10

    with Army Reserach Lab; DCS Corporation, Alexandria, Va and Warren, Mi 14. ABSTRACT In this paper , we discuss a neuroimaging experiment that...Development and Engineering Center Warren, MI Kelvin S. Oie, PhD Army Research Laboratory Aberdeen Proving Ground, MD ABSTRACT In this paper , we...experiment, this paper will emphasize analyses that employ a pattern classification analysis approach. These classification examples aim to identify

  8. Effect of Dietary Intervention on Prostate Tumor Development in Tramp Mice

    DTIC Science & Technology

    2005-05-01

    successful. Dr. Olga Rogozina who has both an MD. and Ph.D. join our research group May of 2004. She is working 50% effort on this project and will be...3443. 5. Gingrich,J.R., Barrios ,R.J., Morton,R.A., Boyce,B.F., DeMayo,F.J., Finegold,M.J., Angelopoulou,R., Rosen,J.M., and Greenberg,N.M. (1996

  9. Cyber Security: A Crisis of Prioritization

    DTIC Science & Technology

    2005-02-01

    Society (CITRIS) and Professor University of California, Berkeley J. Carter Beese , Jr. President Riggs Capital Partners Pedro Celis, Ph.D. Software...Science University of North Carolina at Chapel Hill William J. Hannigan President AT&T Jonathan C. Javitt, M.D., M.P.H. Senior Fellow Potomac Institute...CHAIR F. Thomson Leighton MEMBERS J. Carter Beese , Jr. Patricia Thomas Evans Luis E. Fiallo Harold Mortazavian David A. Patterson Alice G

  10. Effects of Radiation on the Microbiota and Intestinal Inflammatory Disease

    DTIC Science & Technology

    2016-09-01

    focal (GI tract) irradiation of mice on the bacterial and fungal microbiota. We have identified substantial changes in intestinal microbial...minimal acute symptoms, will develop long-term consequences of irradiation including permanent changes to bowel function and intestinal fibrosis, which...mice exposed to total body irradiation (TBI) or focal radiation to the GI tract. Timeline Status Site 1 (Stephen Shiao, MD, PhD) Site 2

  11. Trends in National Institutes of Health Funding of Principal Investigators in Dermatology Research by Academic Degree and Sex.

    PubMed

    Cheng, Michelle Y; Sukhov, Andrea; Sultani, Hawa; Kim, Kyoungmi; Maverakis, Emanual

    2016-08-01

    National Institutes of Health (NIH) grants are becoming increasingly competitive in the academic research arena. Identifying NIH funding disparities is an important step in improving academic diversity. To examine recent NIH funding trends in dermatology. Retrospective study with linear regression analysis and repeated-measures analysis of variance of all NIH grants awarded to departments of dermatology from fiscal year 2009 to 2014. Funding data were exported from the NIH Research Portfolio Online Reporting Tools Expenditures and Results. Publication data were drawn from Scopus. All NIH-funded principal investigators in dermatology were categorized by their academic degree and sex. The NIH funding trends were compared by investigator degree (MD, PhD, or MD/PhD) and sex. A total of 1292 NIH-funded grants were awarded to dermatology research from fiscal year 2009 through 2014. Adjusted NIH funding for dermatologic research diminished by 4.6% from $67.3 million in 2009 to $64.2 million in 2014, with a nadir of $58.6 million in 2013. Funding for the NIH's Research Project Grant Program (R01) decreased by 21.0% from $43.9 million to $34.7 million during this period. The dollar amount of NIH funding significantly trended down for investigators with an MD degree by $1.35 million per year from $23.6 million in 2009 to $18.4 million in 2014 (P = .02) while there was no significant change in NIH funding for MD/PhD (from $17.6 million in 2009 to $19.8 million in 2014; P = .44) and PhD investigators (from $26.1 million in 2009 to $25.9 million in 2014; P = .74). Similarly, the total dollar amount of R01 grants awarded to principal investigators with only an MD degree trended down by $1.4 million per year from $13.2 million in 2009 to $6.0 million in 2014 (P < .001). The number of female investigators with NIH grants in dermatology trended down significantly compared with the trend of their male counterparts (from 49 women in 2009 to 43 women in 2014 vs from 84 men in 2009 to 97 men in 2014; P = .04). There is a downward trend in NIH funding for female and MD-only dermatology investigators. Departmental support and junior faculty mentorship for women and MD investigators is crucial for maintaining their presence in NIH-funded dermatology research.

  12. PERSPECTIVE: Translational neural engineering: multiple perspectives on bringing benchtop research into the clinical domain

    NASA Astrophysics Data System (ADS)

    Rousche, Patrick; Schneeweis, David M.; Perreault, Eric J.; Jensen, Winnie

    2008-03-01

    A half-day forum to address a wide range of issues related to translational neural engineering was conducted at the annual meeting of the Biomedical Engineering Society. Successful practitioners of translational neural engineering from academics, clinical medicine and industry were invited to share a diversity of perspectives and experiences on the translational process. The forum was targeted towards traditional academic researchers who may be interested in the expanded funding opportunities available for translational research that emphasizes product commercialization and clinical implementation. The seminar was funded by the NIH with support from the Rehabilitation Institute of Chicago. We report here a summary of the speaker viewpoints with particular focus on extracting successful strategies for engaging in or conducting translational neural engineering research. Daryl Kipke, PhD, (Department of Biomedical Engineering at the University of Michigan) and Molly Shoichet, PhD, (Department of Chemical Engineering at the University of Toronto) gave details of their extensive experience with product commercialization while holding primary appointments in academic departments. They both encouraged strong clinical input at very early stages of research. Neurosurgeon Fady Charbel, MD, (Department of Neurosurgery at the University of Illinois at Chicago) discussed his role in product commercialization as a clinician. Todd Kuiken, MD, PhD, (Director of the Neural Engineering for Artificial Limbs at the Rehabilitation Institute of Chicago, affiliated with Northwestern University) also a clinician, described a model of translational engineering that emphasized the development of clinically relevant technology, without a strong commercialization imperative. The clinicians emphasized the importance of communicating effectively with engineers. Representing commercial neural engineering was Doug Sheffield, PhD, (Director of New Technology at Vertis Neuroscience, Inc.) who strongly encouraged open industrial academic partnerships as an efficient path forward in the translational process. Joe Pancrazio, PhD, a Program Director at NIH's National Institute of Neurological Disorders and Stroke, emphasized that NIH funding for translational research was aimed at breaking down scientific barriers to clinic entrance. Vivian Weil, PhD, (Director of Center for the Study of Ethics in the Professions at the Illinois Institute of Technology) a specialist on ethics in science and engineering, spoke of the usefulness of developing a code of ethics for addressing ethical aspects of translation from the bench to clinical implementation and of translation across disciplines in multi-disciplinary projects. Finally, the patient perspective was represented by Mr Jesse Sullivan. A double-arm amputee and patient of Dr Kuiken's, Mr Sullivan demonstrated the critically important role of the patient in successful translational neural engineering research.

  13. Translational neural engineering: multiple perspectives on bringing benchtop research into the clinical domain

    PubMed Central

    Rousche, Patrick; Schneeweis, David M; Perreault, Eric J; Jensen, Winnie

    2009-01-01

    A half-day forum to address a wide range of issues related to translational neural engineering was conducted at the annual meeting of the Biomedical Engineering Society. Successful practitioners of translational neural engineering from academics, clinical medicine and industry were invited to share a diversity of perspectives and experiences on the translational process. The forum was targeted towards traditional academic researchers who may be interested in the expanded funding opportunities available for translational research that emphasizes product commercialization and clinical implementation. The seminar was funded by the NIH with support from the Rehabilitation Institute of Chicago. We report here a summary of the speaker viewpoints with particular focus on extracting successful strategies for engaging in or conducting translational neural engineering research. Daryl Kipke, PhD, (Department of Biomedical Engineering at the University of Michigan) and Molly Shoichet, PhD, (Department of Chemical Engineering at the University of Toronto) gave details of their extensive experience with product commercialization while holding primary appointments in academic departments. They both encouraged strong clinical input at very early stages of research. Neurosurgeon Fady Charbel, MD, (Department of Neurosurgery at the University of Illinois at Chicago) discussed his role in product commercialization as a clinician. Todd Kuiken, MD, PhD, (Director of the Neural Engineering for Artificial Limbs at the Rehabilitation Institute of Chicago, affiliated with Northwestern University) also a clinician, described a model of translational engineering that emphasized the development of clinically relevant technology, without a strong commercialization imperative. The clinicians emphasized the importance of communicating effectively with engineers. Representing commercial neural engineering was Doug Sheffield, PhD, (Director of New Technology at Vertis Neuroscience, Inc.) who strongly encouraged open industrial–academic partnerships as an efficient path forward in the translational process. Joe Pancrazio, PhD, a Program Director at NIH’s National Institute of Neurological Disorders and Stroke, emphasized that NIH funding for translational research was aimed at breaking down scientific barriers to clinic entrance. Vivian Weil, PhD, (Director of Center for the Study of Ethics in the Professions at the Illinois Institute of Technology) a specialist on ethics in science and engineering, spoke of the usefulness of developing a code of ethics for addressing ethical aspects of translation from the bench to clinical implementation and of translation across disciplines in multi-disciplinary projects. Finally, the patient perspective was represented by Mr Jesse Sullivan. A double-arm amputee and patient of Dr Kuiken’s, Mr Sullivan demonstrated the critically important role of the patient in successful translational neural engineering research. PMID:18310805

  14. Translational neural engineering: multiple perspectives on bringing benchtop research into the clinical domain.

    PubMed

    Rousche, Patrick; Schneeweis, David M; Perreault, Eric J; Jensen, Winnie

    2008-03-01

    A half-day forum to address a wide range of issues related to translational neural engineering was conducted at the annual meeting of the Biomedical Engineering Society. Successful practitioners of translational neural engineering from academics, clinical medicine and industry were invited to share a diversity of perspectives and experiences on the translational process. The forum was targeted towards traditional academic researchers who may be interested in the expanded funding opportunities available for translational research that emphasizes product commercialization and clinical implementation. The seminar was funded by the NIH with support from the Rehabilitation Institute of Chicago. We report here a summary of the speaker viewpoints with particular focus on extracting successful strategies for engaging in or conducting translational neural engineering research. Daryl Kipke, PhD, (Department of Biomedical Engineering at the University of Michigan) and Molly Shoichet, PhD, (Department of Chemical Engineering at the University of Toronto) gave details of their extensive experience with product commercialization while holding primary appointments in academic departments. They both encouraged strong clinical input at very early stages of research. Neurosurgeon Fady Charbel, MD, (Department of Neurosurgery at the University of Illinois at Chicago) discussed his role in product commercialization as a clinician. Todd Kuiken, MD, PhD, (Director of the Neural Engineering for Artificial Limbs at the Rehabilitation Institute of Chicago, affiliated with Northwestern University) also a clinician, described a model of translational engineering that emphasized the development of clinically relevant technology, without a strong commercialization imperative. The clinicians emphasized the importance of communicating effectively with engineers. Representing commercial neural engineering was Doug Sheffield, PhD, (Director of New Technology at Vertis Neuroscience, Inc.) who strongly encouraged open industrial-academic partnerships as an efficient path forward in the translational process. Joe Pancrazio, PhD, a Program Director at NIH's National Institute of Neurological Disorders and Stroke, emphasized that NIH funding for translational research was aimed at breaking down scientific barriers to clinic entrance. Vivian Weil, PhD, (Director of Center for the Study of Ethics in the Professions at the Illinois Institute of Technology) a specialist on ethics in science and engineering, spoke of the usefulness of developing a code of ethics for addressing ethical aspects of translation from the bench to clinical implementation and of translation across disciplines in multi-disciplinary projects. Finally, the patient perspective was represented by Mr Jesse Sullivan. A double-arm amputee and patient of Dr Kuiken's, Mr Sullivan demonstrated the critically important role of the patient in successful translational neural engineering research.

  15. 11th Annual NIH Pain Consortium Symposium on Advances in Pain Research | Division of Cancer Prevention

    Cancer.gov

    The NIH Pain Consortium will convene the 11th Annual NIH Pain Consortium Symposium on Advances in Pain Research, featuring keynote speakers and expert panel sessions on Innovative Models and Methods. The first keynote address will be delivered by David J. Clark, MD, PhD, Stanford University entitled “Challenges of Translational Pain Research: What Makes a Good Model?” |

  16. Manual of Hemorrhagic Fever with Renal Syndrome

    DTIC Science & Technology

    1989-04-01

    Reference and Research * ~(Hemorrhagic fever with renal syndrome) Institute for Vral Diseases, Korea University Preface The discovery of Hantaan virus...in 1976 launched a new era in the study of hemorrhagic fever with renal syndrome (HFRS) throughout the world. Accumulated data indicate that there...HFRS that has made all of this possible. April 1989 H. W. Lee M.D. J. M. Dalrymple Ph.D. Foreword Haemorrhagic Fever with Renal Syndrome (HFRS) is

  17. A Population-Based Study of Dietary Acrylamide and Prostate Cancer Risk

    DTIC Science & Technology

    2006-03-01

    159 microgram/day. 3. The four food products that contributed the most to the total intake of acrylamide among controls were crisp bread, coffee ... Acrylamide and Prostate Cancer Risk PRINCIPLE INVESTIGATOR: Hans-Olov Adami, M.D., Ph.D. CONTRACTING ORGANIZATION: Karolinska...NUMBER A Population-Based Study of Dietary Acrylamide and Prostate Cancer Risk 5b. GRANT NUMBER W81XWH-04-1-0288 5c. PROGRAM ELEMENT NUMBER

  18. A Collaborative Translational Autism Research Program for the Military

    DTIC Science & Technology

    2016-02-26

    AFRL-SA-WP-TR-2016-0001 A Collaborative Translational Autism Research Program for the Military Gail E. Herman, MD, PhD; Emily...DATES COVERED (From – To) September 2012 – December 2015 4. TITLE AND SUBTITLE A Collaborative Translational Autism Research Program for the...proposed research is that a collaborative translational autism research program with the military will result in the improved diagnosis and care of those

  19. Biomarkers of Risk for Post-Traumatic Stress Disorder (PTSD)

    DTIC Science & Technology

    2008-05-01

    post - traumatic stress disorder ( PTSD ),” Principal Investigator, 4/07-4/10, $276,422. 12. R01 MH0687670-01 “DEX/CRH Response... Stress Disorder ( PTSD ) PRINCIPAL INVESTIGATOR: Audrey R. Tyrka, M.D., Ph.D. CONTRACTING ORGANIZATION: Butler Hospital... Stress Disorder ( PTSD ) 5a. CONTRACT NUMBER 5b. GRANT NUMBER W81XWH-07-1-0269 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) Audrey R.

  20. Evaluation of Immune Responses Mediated by Listeria-Stimulated Human Dendritic Cells: Implications for Cancer Vaccine Therapy

    DTIC Science & Technology

    2014-07-01

    and J.W. Young, Human dendritic cells : potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol, 2005. 175(3): p...by Listeria-Stimulated Human Dendritic Cells : Implications for Cancer Vaccine Therapy PRINCIPAL INVESTIGATOR: David J. Chung, MD, PhD...5a. CONTRACT NUMBER Evaluation of Immune Responses Mediated by Listeria-Stimulated Human Dendritic Cells : Implications for Cancer Vaccine

  1. Reducing Cancer Health Disparities through Community Engagement: Working with Faith-Based Organizations (Project CHURCH) | Division of Cancer Prevention

    Cancer.gov

    Speaker | "Reducing Cancer Health Disparities through Community Engagement: Working with Faith-Based Organizations (Project CHURCH)" will be presented by Lorna H. McNeill, PhD, MPH, Chair of the Department of Health Disparities at the University of Texas MD Anderson Cancer Center in Houston, TX. Date: 2/20/2018; Time: 11:00am - 12:00pm; Location: NCI Shady Grove Campus,

  2. Journal of Rehabilitation Research and Development, Volume 30, Number 1, 1993

    DTIC Science & Technology

    1993-01-01

    Dynamical Feedback Control of Robotic Ma- Contact: Osa Jackson-Wyatt, PhD, PT, Physical nipulators with Joint Flexibility. Sira- Ramirez H, Therapy Program...Rehabilitation Research and Development Vol. 30 No. 1 1993 Contact: Hebertt Sira- Ramirez , Departamento Contact: Takayoshi Ueta, MD, Dept. of Orthopedic...Rio de Janeiro, Brazil 172 Journal of Rehabilitation Research and Development Vol. 30 No. 1 1993 Contact. Conference Secretariat, Rua do Ouvidor

  3. Prostate Cancer Pathology Resource Network

    DTIC Science & Technology

    2013-07-01

    The PCBN is organized with a Coordinating Center (JHU – led by Bruce Trock, Ph.D.), and Network Sites at NYU (led by Jonathan Melamed, M.D. and Peng...Resource Network Site must contribute biospecimens from a minimum of 50 patients per year, with the expectation that biospecimen contribution will...available to the Pathology Resource Network Site . o Each year both sites have contributed over 500 newly accrued specimens, with specimens obtained as

  4. The Roles of the Bone Marrow Microenvironment in Controlling Tumor Dormancy

    DTIC Science & Technology

    2015-10-01

    Shiozawa, M.D., Ph.D. CONTRACTING ORGANIZATION: Wake Forest School of Medicine Ann Arbor, MI 48109 REPORT DATE: October 2015 TYPE OF REPORT...PERFORMING ORGANIZATION REPORT NUMBER Wake Forest University Health Sciences Medical Center Blvd. Winston-Salem NC 27157 9. SPONSORING... Wake Forest School of Medicine as of 03/01/15. The PI obtained the necessary institutional approvals (IACUC, IRB, IBC) and submitted the grant

  5. CCR’s Douglas Lowy and John Schiller receive the 2017 Lasker~DeBakey Clinical Medical Research Award | Center for Cancer Research

    Cancer.gov

    Douglas Lowy, M.D., and John Schiller, Ph.D., of CCR’s Laboratory of Cellular Oncology have received the 2017 Lasker~DeBakey Clinical Medical Research Award for their groundbreaking research leading to the development of human papillomavirus (HPV) vaccines. The Lasker Awards are widely regarded as the country’s most prestigious biomedical research prizes.

  6. Delta-Tocotrienol: Radiation Protection and Effects on Signal Transduction Pathways

    DTIC Science & Technology

    2011-06-15

    Delta- Tocotrienol : Radiation Protection and Effects on Signal Transduction Pathways Venkataraman Srinivasan, PhD Mang Xiao, MD Principal...2011 2. REPORT TYPE 3. DATES COVERED 00-00-2011 to 00-00-2011 4. TITLE AND SUBTITLE Delta- Tocotrienol : Radiation Protection And Effects On...Mechanisms? 17 Survival of γ-irradiated mouse bone marrow and primary human hematopoietic CD34+ cells was significantly enhanced by Delta- tocotrienol (DT3

  7. Induced Accelerated Aging in Induced Pluripotent Stem Cell Lines from Patients with Parkinson’s Disease

    DTIC Science & Technology

    2014-07-01

    after manipulation of the cells prohibited this approach. 2. Differentiation into oligoprecursor cells ( OPCs ) and oligodendrocytes As we have...Jing Bian, PhD and Birgitt Schuele, MD 18 Development of expandable OPCs from human iPSC derived...Neri et al., 2010) + + + + Human iPSC derived OPCs and Oligos (Wang et al., 2013) + + + + mEpsc derived OPCs and Oligos (Najm et al

  8. Effects of Radiation on the Microbiota and Intestinal Inflammatory Disease

    DTIC Science & Technology

    2016-09-01

    completion of initial experiments investigating the effect of whole body and focal (GI tract) irradiation of mice on the bacterial and fungal microbiota. We...acute symptoms, will develop long-term consequences of irradiation including permanent changes to bowel function and intestinal fibrosis, which can...exposed to total body irradiation (TBI) or focal radiation to the GI tract. Timeline Status Site 1 (Stephen Shiao, MD, PhD) Site 2

  9. KSC-97PC1813

    NASA Image and Video Library

    1997-12-12

    The Neurolab payload for STS-90, scheduled to launch aboard the Shuttle Columbia from Kennedy Space Center (KSC) on April 2, 1998, undergoes further processing in the Operations and Checkout Building at KSC. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90 will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  10. KSC-97PC1815

    NASA Image and Video Library

    1997-12-12

    The Neurolab payload for STS-90, scheduled to launch aboard the Shuttle Columbia from Kennedy Space Center (KSC) on April 2, 1998, undergoes further processing in the Operations and Checkout Building at KSC. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90 will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  11. KSC-98pc290

    NASA Image and Video Library

    1998-02-12

    The STS-90 Neurolab payload is lowered into position into the cargo bay of Space Shuttle Columbia today in Orbiter Processing Facility bay 3. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch in April, will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  12. KSC-97PC1812

    NASA Image and Video Library

    1997-12-12

    The Neurolab payload for STS-90, scheduled to launch aboard the Shuttle Columbia from Kennedy Space Center (KSC) on April 2, 1998, undergoes further processing in the Operations and Checkout Building at KSC. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90 will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  13. KSC-98pc343

    NASA Image and Video Library

    1998-03-09

    KENNEDY SPACE CENTER, FLA. -- The STS-90 Neurolab payload and four Getaway Specials (GAS) await payload bay door closure in the orbiter Columbia today in Orbiter Processing Facility bay 3. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch in April, will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  14. KSC-97PC1714

    NASA Image and Video Library

    1997-11-11

    The Neurolab payload for STS-90, scheduled to launch aboard the Shuttle Columbia from Kennedy Space Center (KSC) on April 2, 1998, is moved to its workstand in the Operations and Checkout Building at KSC. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90 will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  15. KSC-98pc267

    NASA Image and Video Library

    1998-02-05

    KENNEDY SPACE CENTER, FLA. -- A technician looks at the STS-90 Neurolab payload as it is moved from its test stand in KSC's Operations and Checkout Building. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch in April, will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  16. KSC-98pc291

    NASA Image and Video Library

    1998-02-12

    The STS-90 Neurolab payload is lowered into position into the cargo bay of Space Shuttle Columbia today in Orbiter Processing Facility bay 3. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch in April, will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  17. KSC-98pc406

    NASA Image and Video Library

    1998-03-23

    KENNEDY SPACE CENTER, FLA. -- The Space Shuttle Columbia arrives at the top of Launch Pad 39B after its morning rollout prior to STS-90. The white room of the Orbiter Access Arm where astronauts suit up for launch can be seen to the left of the orbiter. The Neurolab experiments are the primary payload on this nearly 17-day space flight. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, includes Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  18. KSC-97PC1814

    NASA Image and Video Library

    1997-12-12

    The Neurolab payload for STS-90, scheduled to launch aboard the Shuttle Columbia from Kennedy Space Center (KSC) on April 2, 1998, undergoes further processing in the Operations and Checkout Building at KSC. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90 will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  19. KSC-98pc289

    NASA Image and Video Library

    1998-02-12

    The STS-90 Neurolab payload is prepared to be positioned into the cargo bay of Space Shuttle Columbia today in Orbiter Processing Facility bay 3. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch in April, will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  20. KSC-98pc268

    NASA Image and Video Library

    1998-02-05

    KENNEDY SPACE CENTER, FLA. -- Technicians gather around the STS-90 Neurolab payload during weight and center-of-gravity measurements in KSC's Operations and Checkout Building. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch in April, will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  1. KSC-97PC1713

    NASA Image and Video Library

    1997-11-11

    The Neurolab payload for STS-90, scheduled to launch aboard the Shuttle Columbia from Kennedy Space Center (KSC) on April 2, 1998, is moved to its workstand in the Operations and Checkout Building at KSC. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90 will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  2. KSC-97PC1715

    NASA Image and Video Library

    1997-11-11

    The Neurolab payload for STS-90, scheduled to launch aboard the Shuttle Columbia from Kennedy Space Center (KSC) on April 2, 1998, is moved to its workstand in the Operations and Checkout Building at KSC. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90 will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  3. Recent advances in the treatment and management of excessive daytime sleepiness.

    PubMed

    Black, Jed; Duntley, Stephen P; Bogan, Richard K; O'Malley, Mary B

    2007-02-01

    Excessive daytime sleepiness (EDS) is a prevalent complaint among patients in psychiatric care. Patients with conditions of EDS have often been misdiagnosed with depression due to their complaints of lack of energy, poor concentration, memory disturbance, and a reduced interest in life. Impaired alertness associated with EDS can be detrimental to a person's quality of life by causing decreased work performance, self-consciousness, low self esteem, and social isolation. Excessive sleepiness is also associated with various health problems, comorbid medical and psychiatric conditions, and fatal accidents occurring after the driver has fallen asleep at the wheel. Contributing factors leading to EDS range from insufficient sleep hours to central nervous system-mediated debilitating hypersomnolence. Circadian rhythm disorders, sleep disorders such as obstructive sleep apnea and narcolepsy, and medications that cause sleepiness may also contribute to symptoms of EDS. Recognition of the symptoms of sleep deprivation is essential, as many such patients do not have a clear awareness of their own sleepiness. Treatment options, depending upon the condition, include light therapy or appropriate airway management techniques such as nasal continuous positive airway pressure (CPAP). Occasionally, wakefulness-promoting medications are necessary, particularly in patients with narcolepsy. In this expert roundtable supplement, Stephen P. Duntley, MD, reviews the definition and prevalence of EDS and discusses the contributing factors and consequences of daytime sleepiness. Next, Richard K. Bogan, MD, FCCP, gives an overview of the differential diagnosis of EDS and the assessment tools available for identifying sleepiness in symptomatic patients. Finally, Mary B. O'Malley, MD, PhD, reviews treatment of EDS, including counseling on sleep hygiene and duration of sleep, mechanical treatments, bright-light therapy, and wake-promoting medications.

  4. The STS-96 crew takes part in a Crew Equipment Interface Test at KSC

    NASA Technical Reports Server (NTRS)

    1999-01-01

    In the Orbiter Processing Facility bay 1, STS-96 Mission Specialists Daniel Barry (M.D., Ph.D.), Valery Ivanovich Tokarev and Tamara E. Jernigan (Ph.D.) look into the payload bay of the orbiter Discovery. The STS-96 crew is at KSC for a Crew Equipment Interface Test. Other crew members participating are Commander Kent V. Rominger, Pilot Rick Douglas Husband, and Mission Specialists Ellen Ochoa (Ph.D.) and Julie Payette, with the Canadian Space Agency. The primary payload of STS-96 is the SPACEHAB Double Module. In addition, the Space Shuttle will carry unpressurized cargo such as the external Russian cargo crane known as STRELA; the Spacehab Oceaneering Space System Box (SHOSS), which is a logistics items carrier; and an ORU Transfer Device (OTD), a U.S.-built crane that will be stowed on the station for use during future ISS assembly missions. These cargo items will be stowed on the International Cargo Carrier, fitted inside the payload bay behind the SPACEHAB module. STS-96 is targeted for launch on May 24 from Launch Pad 39B.

  5. The STS-96 crew takes part in a Crew Equipment Interface Test at KSC

    NASA Technical Reports Server (NTRS)

    1999-01-01

    In the Orbiter Processing Facility bay 1, STS-96 Commander Kent V. Rominger and Mission Specialists Ellen Ochoa (Ph.D.) and Valery Ivanovich Tokarev pose inside the orbiter Discovery. The STS-96 crew is at KSC to take part in a Crew Equipment Interface Test. Other members participating are Pilot Rick Douglas Husband and Mission Specialists Tamara E. Jernigan (Ph.D.), Daniel Barry (M.D., Ph.D.) and Julie Payette, who is with the Canadian Space Agency. Tokarev represents the Russian Space Agency. The primary payload of STS-96 is the SPACEHAB Double Module. In addition, the Space Shuttle will carry unpressurized cargo such as the external Russian cargo crane known as STRELA; the Spacehab Oceaneering Space System Box (SHOSS), which is a logistics items carrier; and an ORU Transfer Device (OTD), a U.S.-built crane that will be stowed on the station for use during future ISS assembly missions. These cargo items will be stowed on the International Cargo Carrier, fitted inside the payload bay behind the SPACEHAB module. STS-96 is targeted for launch on May 24 from Launch Pad 39B.

  6. KSC-99pp0314

    NASA Image and Video Library

    1999-03-24

    In the Orbiter Processing Facility bay 1, STS-96 Mission Specialist Daniel Barry, M.D., Ph.D., looks at one of the foot restraints used for extravehicular activity, or space walks. The STS-96 crew is at KSC to take part in a Crew Equipment Interface Test. The other crew members are Commander Kent V. Rominger, Pilot Rick Douglas Husband, and Mission Specialists Ellen Ochoa (Ph.D.), Tamara E. Jernigan (Ph.D.), Julie Payette and Valery Ivanovich Tokarev. Payette represents the Canadian Space Agency and Tokarev the Russian Space Agency. The primary payload of STS-96 is the SPACEHAB Double Module. In addition, the Space Shuttle will carry unpressurized cargo such as the external Russian cargo crane known as STRELA; the Spacehab Oceaneering Space System Box (SHOSS), which is a logistics items carrier; and an ORU Transfer Device (OTD), a U.S.-built crane that will be stowed on the station for use during future ISS assembly missions. These cargo items will be stowed on the International Cargo Carrier, fitted inside the payload bay behind the SPACEHAB module. STS-96 is targeted for launch on May 24 from Launch Pad 39B

  7. STS-96 Discovery Night Landing with Drag chute

    NASA Technical Reports Server (NTRS)

    1999-01-01

    With its drag chute fully deployed, Space Shuttle Discovery lands on KSC's brightly lighted Shuttle Landing Facility runway 15, completing the 9-day, 19-hour, 13-minute and 1-second long STS-96 mission. Main gear touchdown was at 2:02:43 EDT June 6 , landing on orbit 154 of the mission. Nose gear touchdown was at 2:02:59 a.m. EDT, and the wheels stopped at 2:03:39 a.m. EDT. At the controls were Commander Kent V. Rominger and Pilot Rick D. Husband. Also onboard the orbiter were Mission Specialists Ellen Ochoa (Ph.D.), Tamara E. Jernigan (Ph.D.), Daniel S. Barry (M.D., Ph.D.), Julie Payette and Valery Ivanovich Tokarev. Payette represents the Canadian Space Agency and Tokarev the Russian Space Agency. The crew returned from the second flight to the International Space Station on a logistics and resupply mission. This was the 94th flight in the Space Shuttle program and the 26th for Discovery, also marking the 47th landing at KSC, the 24th in the last 25 missions, 11th at night, and the 18th consecutive landing in Florida.

  8. STS-96 Discovery night landing side view

    NASA Technical Reports Server (NTRS)

    1999-01-01

    Beneath a bright moon, the landing of Space Shuttle Discovery at KSC's Shuttle Landing Facility runway 15 is reflected in the nearby canal. This 47th Shuttle landing at KSC completes the 9- day, 19-hour, 13-minute and 1-second long STS-96 mission. It is the 94th flight in the Space Shuttle program, the 26th for Discovery, the 11th night landing, and the 18th consecutive landing in Florida. Main gear touchdown was at 2:02:43 EDT June 6 , landing on orbit 154 of the mission. Nose gear touchdown was at 2:02:59 a.m. EDT, and the wheels stopped at 2:03:39 a.m. EDT. At the controls were Commander Kent V. Rominger and Pilot Rick D. Husband. Also onboard the orbiter were Mission Specialists Ellen Ochoa (Ph.D.), Tamara E. Jernigan (Ph.D.), Daniel S. Barry (M.D., Ph.D.), Julie Payette and Valery Ivanovich Tokarev. Payette represents the Canadian Space Agency and Tokarev the Russian Space Agency. The crew returned from the second flight to the International Space Station on a logistics and resupply mission.

  9. Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury

    DTIC Science & Technology

    2014-10-01

    Cord Injury PRINCIPAL INVESTIGATOR: Thomas J. Schnitzer, M.D., Ph.D. CONTRACTING ORGANIZATION : Northwestern University, Evanston, IL 60208 REPORT...Bone Architechture in Chronic Spinal Cord Injury Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architechture in Chronic...PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) Northwestern University, 633 Clark St., Evanston,IL 60208-0001 AND ADDRESS(ES) 8. PERFORMING ORGANIZATION

  10. Defeating a rare, aggressive form of skin cancer with avelumab | Center for Cancer Research

    Cancer.gov

    For the one-year anniversary of the FDA’s approval of avelumab, CCR Communications caught up with Richard Mulcahy to share his success story as a clinical trial patient. Mulcahy was diagnosed with Merkel cell carcinoma in September of 2016. It’s been over a year since he received his first treatment of avelumab as part of a clinical trial led by Isaac Brownell, M.D., Ph.D.,

  11. NCI Scientists Awarded National Medal of Technology and Innovation by President Obama | Poster

    Cancer.gov

    Two NCI scientists received the National Medal of Technology and Innovation, the nation’s highest honor for technological achievement. The award was announced by President Obama in October. The honorees, John Schiller, Ph.D., Laboratory of Cellular Oncology (LCO), Center for Cancer Research, NCI, and Douglas Lowy, M.D., also from LCO and NCI deputy director, received their medals at a White House ceremony on Nov. 20.

  12. Assessing the Mechanisms of MDS and its Transformation to Leukemia in a Novel Humanized Mouse

    DTIC Science & Technology

    2014-09-01

    mice is suboptimal (bottom). Stephanie Halene, M.D., Ph.D. 6 agents in MISTRG mice. MISTRG mice tolerated cytarabine (50mg/kg vs 100mg/kg...Chemotherapy treatment in MISTRG mice. Non-engrafted MISTRG mice were treated with vehicle, Doxorubicin, Cytarabine , or a combination of Doxorubicin and... Cytarabine . Approximately 50% of mice survive chemotherapy treatment (A) due to significant cytopenias (B, white blood cell count (top), hemoglobin (middle

  13. Circumvention of Taxol-Resistance in Human Breast Cancers by Improved Water Soluble Taxanes

    DTIC Science & Technology

    2001-10-01

    possible roles of interferon alpha, tumor necrosis factor alpha and transforming growth factor beta in Mn-SOD induction by polysaccharide K. Cancer ...chemoembolization in combination with local hyperthermia. Japanese Journal of Cancer & Chemotherapy. 16:2957-2960 61. Kidd P. (2000) The use of mushroom glucans ...Circumvention of Taxol-Resistance in Human Breast Cancers by Improved Water Soluble Taxanes PRINCIPAL INVESTIGATOR: Li-Xi Yang, M.D., Ph.D. CONTRACTING

  14. SCI with Brain Injury: Bedside to Bench Modeling for Developing Treatment and Rehabilitation Strategies

    DTIC Science & Technology

    2013-10-01

    to Bench Modeling For Developing Treatment and Rehabilitation Strategies PRINCIPAL INVESTIGATOR: Geoffrey Manley, MD, PhD RECIPIENT...to Bench Modeling For Developing Treatment and Rehabilitation Strategies 5b. GRANT NUMBER W81XWH-10-1-0912 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR... treatment of this “dual- diagnosis” are lacking. This project proposed using current clinical-practice evidence to guide development of an animal model to

  15. Trial of Naltrexone and Dextromethorphan for Gulf War Veterans’ Illnesses

    DTIC Science & Technology

    2014-07-01

    09-2-0065 TITLE: Trial of Naltrexone and Dextromethorphan for Gulf War Veterans Illnesses PRINCIPAL INVESTIGATOR: William J. Meggs, MD, PhD... Dextromethorphan and Naltrexone for Gulf War Veterens’ Illness 5a. CONTRACT NUMBER 5b. GRANT NUMBER W81XWH-09-2-0065 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR...neuron-inflammation, which can be down regulated, by Naltrexone and Dextromethorphan . This is untested but potentially ground breaking concept that

  16. Pyruvate-Enhanced Resuscitation for Hemorrhagic Shock and Hindlimb Ischemia

    DTIC Science & Technology

    2015-06-06

    Albert Yurvati Albert H Olivencia-Yurvati 611102 c . THIS PAGE The public reporting burden for this collection of information is estimated to average 1...journals (N/A for none) ( c ) Presentations Received Paper TOTAL: Received Paper TOTAL: Number of Non Peer-Reviewed Conference Proceeding publications (other...Mallet . “Surgical management of the goat.” , Lab Animal (06 2011) Devin C . Flaherty, DO, PhD, Besim Hoxha, MD, Shirley Nelson, RLAT, Jie Sun, BS

  17. Large Oncosomes: A Novel Liquid Biopsy for Genetic Profiling in Patients with Castration-Resistant Prostate Cancer

    DTIC Science & Technology

    2017-09-01

    Resistant Prostate Cancer PRINCIPAL INVESTIGATOR: Dolores Di Vizio, MD, PhD CONTRACTING ORGANIZATION: Cedars-Sinai Medical Center Los Angeles...Castration-Resistant Prostate Cancer 5a. CONTRACT NUMBER 5b. GRANT NUMBER W81XWH-16-1-0397 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) Dolores Di...biopsy” changing the landscape of precision medicine. 15. SUBJECT TERMS Metastatic Castration Resistant Prostate Cancer , Extracellular Vesicles

  18. MIT Laboratory for Computer Science Progress Report, July 1984-June 1985

    DTIC Science & Technology

    1985-06-01

    larger (up to several thousand machines) multiprocessor systems. This facility, funded by the newly formed Strategic Computing Program of the Defense...Szolovits, Group Leader R. Patil Collaborating Investigators M. Criscitiello, M.D., Tufts-New England Medical Center Hospital J. Dzierzanowski, Ph.D., Dept...COMPUTATION STRUCTURES Academic Staff J. B. Dennis, Group Leader Research Staff W. B. Ackerman G. A. Boughton W. Y-P. Lim Graduate Students T-A. Chu S

  19. Genetic and Epigenetic Determinants of Lung Cancer Subtype: Adenocarcinoma to Small Cell Conversion

    DTIC Science & Technology

    2016-10-01

    PRINCIPAL INVESTIGATOR: Charles M. Rudin, MD PhD CONTRACTING ORGANIZATION: Sloan Kettering Institute for Cancer Research New York, NY 10065 REPORT DATE...October 2016 TYPE OF REPORT: Final PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012 DISTRIBUTION...ORGANIZATION REPORT NUMBER Sloan Kettering Institute for Cancer Research 1275 York Avenue New York, NY 10065-6007 9. SPONSORING / MONITORING AGENCY NAME(S

  20. Evaluation of Immune Responses Mediated by Listeria-Stimulated Human Dendritic Cells: Implications for Cancer Vaccine Therapy

    DTIC Science & Technology

    2013-07-01

    by Listeria -Stimulated Human Dendritic Cells: Implications for Cancer Vaccine Therapy PRINCIPAL INVESTIGATOR: David J. Chung, MD, PhD...2013 4. TITLE AND SUBTITLE 5a. CONTRACT NUMBER W81XWH-11-1-0384 Evaluation of Immune Responses Mediated by Listeria -Stimulated Human Dendritic...Unlimited 13. SUPPLEMENTARY NOTES 14. ABSTRACT The purpose of this project is to study the immunomodulatory effect of Listeria on human

  1. Developing Novel Therapeutic Approaches in Small Cell Lung Carcinoma Using Genetically Engineered Mouse Models and Human Circulating Tumor Cells

    DTIC Science & Technology

    2014-10-01

    AD_________________ Award Number: W81XWH-13-1-0325 TITLE: Developing Novel Therapeutic Approaches in Small Cell Lung Carcinoma Using ...Genetically Engineered Mouse Models and Human Circulating Tumor Cells PRINCIPAL INVESTIGATOR: Jeffrey Engelman MD PhD CONTRACTING ORGANIZATION ...Novel Therapeutic Approaches in Small Cell Lung 5a. CONTRACT NUMBER W81XWH-13-1-0325 Carcinoma Using Genetically Engineered Mouse Models and 5b

  2. Development of novel non agoinst PPAR-gamma ligands for lung cancer treatment

    DTIC Science & Technology

    2017-08-01

    Melin Khandekar, M.D., Ph.D. CONTRACTING ORGANIZATION : Massachusetts General Hospital Boston, MA 02114 REPORT DATE: August 2017 TYPE OF REPORT...5f. WORK UNIT NUMBER 7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) Massachusetts General Hospital 55 Fruit St. Boston, MA 02114 55 AND...ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBER 9. SPONSORING / MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSOR/MONITOR’S ACRONYM(S) U.S

  3. CCR research lays foundation for FDA approval of CAR T cell therapy Yescarta | Center for Cancer Research

    Cancer.gov

    Decades ago, the use of chimeric antigen receptor (CAR)-expressing T cells as an effective form of immunotherapy was a speculative idea. In 2010, a breakthrough clinical trial conducted by Steven Rosenberg, M.D., Ph.D., and his clinical team showed that CAR T cells recognizing the CD19 receptor were useful in the treatment of some types of B-cell malignancies. Read more...

  4. Characterizing Treatable Causes of Small Fiber Polyneuropathy in Gulf War Veterans

    DTIC Science & Technology

    2015-10-01

    multisymptom illness CWP Chronic widespread pain DOD Department of Defense ESR Erythrocyte sedimentation rate GTT Glucose tolerance test Hgb Hemoglobin...War Veterans 5b. GRANT NUMBER W81XWH-14-1-0499 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) Anne Louise Oaklander MD, PhD 5d. PROJECT NUMBER Max M...widespread pain, chronic multisymptom illness, small- fiber polyneuropathy, case definition ACCOMPLISHMENTS: What were the major goals of the project

  5. Disease Heterogeneity and Immune Biomarkers in Preclinical Mouse Models of Ovarian Carcinogenesis

    DTIC Science & Technology

    2012-08-01

    heterogeneity and to identify immune biomarkers of natural and vaccine-induced immune responses in mice with either endometriosis , ovarian cancer or... endometriosis progressing to ovarian cancer. We have made significant progress on this aim. We briefly summarize below our work in this aim, with emphasis...2) in mice with endometriosis and ovarian tumors 8 In collaboration with Xin Huang PhD and Robert P Edwards MD, we recently concluded a

  6. KSC-97PC1716

    NASA Image and Video Library

    1997-11-11

    The Neurolab payload for STS-90, scheduled to launch aboard the Shuttle Columbia from Kennedy Space Center (KSC) on April 2, 1998, is ready for processing after being placed in its workstand in the Operations and Checkout Building at KSC. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90 will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  7. KSC-97PC1720

    NASA Image and Video Library

    1997-11-12

    The Neurolab payload for STS-90, scheduled to launch aboard the Shuttle Columbia from Kennedy Space Center (KSC) on April 2, 1998, is installed in the Spacelab module by Boeing technicians in the Operations and Checkout Building at KSC. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90 will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  8. KSC-97PC1717

    NASA Image and Video Library

    1997-11-11

    The Neurolab payload for STS-90, scheduled to launch aboard the Shuttle Columbia from Kennedy Space Center (KSC) on April 2, 1998, is ready for processing after being placed in its workstand in the Operations and Checkout Building at KSC. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90 will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  9. KSC-97PC1719

    NASA Image and Video Library

    1997-11-12

    The Neurolab payload for STS-90, scheduled to launch aboard the Shuttle Columbia from Kennedy Space Center (KSC) on April 2, 1998, is installed in the Spacelab module by Boeing technicians in the Operations and Checkout Building at KSC. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90 will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  10. KSC-98pc280

    NASA Image and Video Library

    1998-02-06

    The STS-90 Neurolab payload is honored with a ceremony after being lowered into its payload canister in KSC's Operations and Checkout Building for the last time. This phase of the Shuttle program is winding down as the second phase of the International Space Station (ISS) program gets under way. Microgravity and life science research that formerly was conducted in Spacelab modules, such as Neurolab, will eventually be conducted inside the completed ISS. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. The crew of STS-90, slated for launch in April, will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  11. KSC-97PC1718

    NASA Image and Video Library

    1997-11-12

    The Neurolab payload for STS-90, scheduled to launch aboard the Shuttle Columbia from Kennedy Space Center (KSC) on April 2, 1998, is installed in the Spacelab module by Boeing technicians in the Operations and Checkout Building at KSC. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90 will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  12. STS-89 M.S. Andrew Thomas, Ph.D., participates in TCDT

    NASA Technical Reports Server (NTRS)

    1998-01-01

    STS-89 Mission Specialist Andrew Thomas, Ph.D. gets ready to drive an M-113 armored personnel carrier as part of Terminal Countdown Demonstration Test (TCDT) activities. The TCDT is held at KSC prior to each Space Shuttle flight to provide crews with an opportunity to participate in simulated countdown activities. Standing inside the M-113 is Dr. Thomas while George Hoggard, a training officer with KSC Fire Services, sits atop the vehicle. The STS-89 mission will be the eighth docking of the Space Shuttle with the Russian Space Station Mir. After docking, Dr. Thomas will transfer to the space station, succeeding David Wolf, M.D., who will return to Earth aboard Endeavour. Dr. Thomas will live and work on Mir until June. STS-89 is scheduled for a Jan. 22 liftoff at 9:48 p.m.

  13. Top1 May Do More Than Relax DNA | Center for Cancer Research

    Cancer.gov

    Topoisomerase 1 (Top1) is an enzyme with a well known role in relaxing DNA supercoils by making reversible nicks in DNA. The ribonuclease (RNase) H class of enzymes is equally well known for removing ribonucleotides from hybrid duplex DNA when they are misincorporated during DNA replication. Recently, Shar-yin Huang, Ph.D., and Yves Pommier, M.D., Ph.D., in CCR’s Laboratory of Molecular Pharmacology teamed up with Sue Jinks-Robertson of Duke University’s Department of Molecular Genetics and Microbiology and Thomas Kunkel of the NIEHS, NIH to show that in yeast, Top1 can act like the RNase H class enzymes and convert misincorporated single ribonucleotides into irreversible single-strand breaks, an activity that produces deletion mutations.  They reported this discovery in Science.

  14. You are my teachers.

    PubMed

    Edlich, Richard F

    2005-01-01

    Dr. Owen Wangensteen reminded Dr. Edlich that the chief responsibility of a teacher is to create an atmosphere friendly to learning. Dr Wangensteen indicated that the role of professor has been defined as that of teacher, clinician, and investigator. He then indicated that two more responsibilities must be added: (1) sideline cheerleader and (2) regimental water carrier. Above all those enumerated functions, he believed that the most important concern of a professor is to create an atmosphere friendly to learning. He/she must have the willingness to recognize every type of talent and ability and to encourage men/women of promise. He must be the professor of the open door, easily accessible to students, residents, and associates. The major goal of Dr. Edlich's comments, as he receives the Distinguished Medical Alumni Award from The Minneapolis Medical Alumni Association (Minneapolis, Minnesota, USA) is to acknowledge his distinguished colleagues and friends who have served as his teachers during his academic career. They include the following individuals: Theodore J. Edlich, III, President of Total Action Against Poverty; Elizabeth C. Edlic, Cofounder/Chairman and Chief Executive Officer of OneWorldLive; Richard F. Edlich, Jr., President of Edlich Realty; Rachel C. Edlich, Executive Vice President and Cofounder of OneWorldLive; William B. Long, III, MD, President and Medical Director of Trauma Specialists LLP; William P. Magee, MD, Cofounder and Director of Operation Smile; John Barrow, President of Coolibar Incorporated; Mary M. Barrow, Cofounder of Coolibar Incorporated; Kathryne L. Winters, Website Manager and Senior Research Assistant; Lise Borel, DDS, Independent Pharmaceutical/Biotechnical Consultant; Mary Jude Cox, MD, Board Certified Glaucoma Specialist, Teaching Staff at Wills Eye Hospital Glaucoma Service; John Wish, PhD, Member of the Board of The Association of Air Medical Services, Director of the Research Committee; and Dr. Andrew J. Gear, Plastic Surgical Resident, University of Minnesota Medical School.

  15. Patterns of Care and Disparities in the Treatment of Early Breast Cancer

    DTIC Science & Technology

    2008-09-30

    renal impairment in heart failure : mortality in blacks versus whites. Circulation. 2005 Mar 15;111(10):1270-7. 19. Smith BD, Smith GL, Haffty BG...Lichtman JH, Krumholz HM. Functional status and quality of life in heart failure patients with renal impairment. Circulation 106(16):e76, 2002...Theses 1. Ph.D.: Smith GL. Renal Impairment in Heart Failure : Prevalence, Prognosis, and Detection. 2007. 41 2. M.D.: Smith GL. Patterns of

  16. The Role of Skp2 in the Prostate Tumorigenesis Following Rb and p53 Loss

    DTIC Science & Technology

    2014-10-01

    of Developmental and Molecular Biology Room 521 Ullmann 1300 Morris Park Avenue Bronx, NY 10461-1975 AND ADDRESS(ES) 8. PERFORMING...ORGANIZATION REPORT NUMBER rt t f l t l Molecular Biology Room 521 Ullmann 1300 Morris Park Avenue Bronx, NY 10461-1975...Congratulations! Mary Anne Clifford Tuesday , October 21, 2014 1:33 PM October 21, 2014 Hongling Zhao, M.D., Ph.D. Department of DMB Ullmann - 521 Dear

  17. Genomic and Expression Profiling of Benign and Malignant Nerve Sheath Profiling of Benign and Malignant Nerve Sheath

    DTIC Science & Technology

    2007-05-01

    Benign and Malignant Nerve Sheath Tumors in Neurofibromatosis Patients PRINCIPAL INVESTIGATOR: Matt van de Rijn, M.D., Ph.D. Torsten...Annual 3. DATES COVERED 1 May 2006 –30 Apr 2007 4. TITLE AND SUBTITLE 5a. CONTRACT NUMBER Genomic and Expression Profiling of Benign and Malignant Nerve...Award Number: DAMD17-03-1-0297 Title: Genomic and Expression Profiling of Benign and Malignant Nerve Sheath Tumors in Neurofibromatosis

  18. An Intervention Study on Screening for Breast Cancer Among Single African-American Women Aged 65 and Older

    DTIC Science & Technology

    1999-09-01

    Since the single constitute 75% of African-American women aged 65 and older , and the incidence and mortality of cancer are especially high in elderly ...Breast Cancer Among Single African-American Women Aged 65 and Older PRINCIPAL INVESTIGATOR: Kangmin Zhu, M.D., Ph.D. CONTRACTING ORGANIZATION: Meharry...to improve the breast screening behavior among single African-American women ages 65 and older . During the period, we (1) finished post-intervention

  19. EF5 PET of Tumor Hypoxia: A Predictive Imaging Biomarker of Response to Stereotactic Ablative Radiotherapy (SABR) for Early Lung Cancer

    DTIC Science & Technology

    2016-09-01

    Radiotherapy ( SABR ) for Early Lung Cancer PRINCIPAL INVESTIGATOR: Billy W. Loo, Jr., M.D., Ph.D CONTRACTING ORGANIZATION: Leland Stanford Junior University...CONTRACT NUMBER W81XWH-12-1-0236 Response to Stereotactic Ablative Radiotherapy ( SABR ) for Early Lung Cancer 5b. GRANT NUMBER 5c. PROGRAM...Distribution Unlimited 13. SUPPLEMENTARY NOTES 14. ABSTRACT Purpose and scope: Stereotactic ablative radiotherapy ( SABR ) has become a new standard

  20. Fyn: A Key Regulator of Metastasis in Prostate Cancer

    DTIC Science & Technology

    2013-06-01

    CSMC with Drs. Leland Chung, Michael Freeman, Neil Bhowmick, Beatrice Knudsen, Hyung Kim, Dolores DiVizio, Howard Sandler, and Stuart Holden... Heath EI, Posadas EM, Yu EY, Harrison MR, Bruce JY, Cho SY, Wilding GE, Fetterly GJ, Hangauer DG, Kwan MF, Dyster LM, Carducci MA. A phase 2 study of...assays of Fyn and Met Neil Bhowmick, PhD- cysteine as a biomarker in PCa (forthcoming clinical trial) Beatrice Knudsen, MD-PhD- MET/SRC/FYN

  1. An Annotated Bibliography of MANPRINT-Related Assessments and Evaluations Conducted by the U.S. Army, 2nd Edition: 1953 to 2009. Volume 2 - MANPRINT Assessment and Evaluations

    DTIC Science & Technology

    2010-02-01

    Research Laboratory Aberdeen Proving Ground, MD 21005-5425 ARL-SR-189 February 2010 An Annotated Bibliography of MANPRINT-Related...Middlebrooks, Ph.D. Human Research and Engineering Directorate, ARL Approved for public release; distribution...7. PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) U.S. Army Research Laboratory ATTN: RDRL-HRM-AV Fort Hood, TX 76544-5073 8. PERFORMING

  2. Use of the Photo-Electromyogram to Objectively Diagnose and Monitor Treatment of Post-TBI Light Sensitivity

    DTIC Science & Technology

    2013-10-01

    Eye Clinic are being seen by the PI (Randy Kardon MD PhD) in his VA and University of Iowa neuro -ophthalmology clinics. These patients are being...using the DSI wireless data transmission system. We have implanted a functional transmitter into a subcutaneous pocket beyond the scapulae on the...implant more so than smaller mice. Figure 7. Recovery of mouse chronically implanted with subcutaneous EMG electrodes and transmitter . There was

  3. Anthrax Vaccine does not affect semen Parameters, Embryo Quality, or Pregnancy Outcome in Couples with a Vaccinated Male Military Service Member

    DTIC Science & Technology

    2005-02-01

    concern that accination of predominantly reproductive-aged service- embers may result in deleterious effects on fertility or etal health (6). There are...requests: William H. Catherino, M.D., Ph.D., Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences, Building A...ORGANIZATION NAME(S) AND ADDRESS(ES) Uniformed Services University of the Health Sciences,Department of Obstetrics and Gynecology,4301 Jones Bridge Road

  4. The Potential Neurotoxic Effects of Low-Dose Sarin Exposure in a Guinea Pig Model

    DTIC Science & Technology

    2002-01-01

    1 THE POTENTIAL NEUROTOXIC EFFECTS OF LOW-DOSE SARIN EXPOSURE IN A GUINEA PIG MODEL Melinda R. Roberson, PhD, Michelle B. Schmidt...Proving Ground, MD 21010 USA ABSTRACT This study is assessing the effects in guinea pigs of repeated low-dose exposure to the nerve...COVERED - 4. TITLE AND SUBTITLE The Potential Neurotoxic Effects Of Low-Dose Sarin Exposure In A Guinea Pig Model 5a. CONTRACT NUMBER 5b

  5. A Knock-in Mouse Model of Human PHD2 Gene-associated Erythrocytosis Establishes a Haploinsufficiency Mechanism*

    PubMed Central

    Arsenault, Patrick R.; Pei, Fei; Lee, Rebecca; Kerestes, Heddy; Percy, Melanie J.; Keith, Brian; Simon, M. Celeste; Lappin, Terence R. J.; Khurana, Tejvir S.; Lee, Frank S.

    2013-01-01

    The central pathway for controlling red cell mass is the PHD (prolyl hydroxylase domain protein):hypoxia-inducible factor (HIF) pathway. HIF, which is negatively regulated by PHD, activates numerous genes, including ones involved in erythropoiesis, such as the ERYTHROPOIETIN (EPO) gene. Recent studies have implicated PHD2 as the key PHD isoform regulating red cell mass. Studies of humans have identified erythrocytosis-associated, heterozygous point mutations in the PHD2 gene. A key question concerns the mechanism by which human mutations lead to phenotypes. In the present report, we generated and characterized a mouse line in which a P294R knock-in mutation has been introduced into the mouse Phd2 locus to model the first reported human PHD2 mutation (P317R). Phd2P294R/+ mice display a degree of erythrocytosis equivalent to that seen in Phd2+/− mice. The Phd2P294R/+-associated erythrocytosis is reversed in a Hif2a+/−, but not a Hif1a+/− background. Additional studies using various conditional knock-outs of Phd2 reveal that erythrocytosis can be induced by homozygous and heterozygous knock-out of Phd2 in renal cortical interstitial cells using a Pax3-Cre transgene or by homozygous knock-out of Phd2 in hematopoietic progenitors driven by a Vav1-Cre transgene. These studies formally prove that a missense mutation in PHD2 is the cause of the erythrocytosis, show that this occurs through haploinsufficiency, and point to multifactorial control of red cell mass by PHD2. PMID:24121508

  6. KSC-98pc389

    NASA Image and Video Library

    1998-03-23

    KENNEDY SPACE CENTER, Fla. -- The Space Shuttle Columbia continues its morning rollout from the Vehicle Assembly Building to Launch Pad 39B in preparation for the STS-90 mission. The Neurolab experiments are primary payload on this nearly 17-day space flight. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, includes Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  7. KSC-98pc411

    NASA Image and Video Library

    1998-03-11

    KENNEDY SPACE CENTER, FLA. -- Swordtail fish (Xiphophorus helleri), like those that are part of the Neurolab payload on Space Shuttle Mission STS-90, are shown in their holding tanks in the Operations and Checkout Building. The fish will fly in the Closed Equilibrated Biological Aquatic System (CEBAS) Minimodule, a middeck locker-sized fresh water habitat, designed to allow the controlled incubation of aquatic species in a self-stabilizing, artifical ecosystem for up to three weeks under space conditions. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  8. KSC-98pc388

    NASA Image and Video Library

    1998-03-23

    KENNEDY SPACE CENTER, FLA. -- The Space Shuttle Columbia continues its rollout from the Vehicle Assembly Building to Launch Pad 39B in preparation for the STS-90 mission. The Neurolab experiments are the primary payload on this nearly 17-day space flight. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, includes Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  9. KSC-98pc387

    NASA Image and Video Library

    1998-03-23

    KENNEDY SPACE CENTER, FLA. -- The Space Shuttle Columbia begins its rollout from the Vehicle Assembly Building to Launch Pad 39B in preparation for the STS-90 mission. The Neurolab experiments are the primary payload on this nearly 17-day space flight. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, includes Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  10. KSC-98pc409

    NASA Image and Video Library

    1998-03-11

    KENNEDY SPACE CENTER, FLA. -- A water snail (Biomphalaria glabrata), like those that are part of the Neurolab payload on Space Shuttle Mission STS-90, is held up for inspection in the Operations and Checkout Building. The snails will fly in the Closed Equilibrated Biological Aquatic System (CEBAS) Minimodule, a middeck locker-sized fresh water habitat, designed to allow the controlled incubation of aquatic species in a self-stabilizing, artifical ecosystem for up to three weeks under space conditions. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, includes Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  11. KSC-98pc412

    NASA Image and Video Library

    1998-03-11

    KENNEDY SPACE CENTER, FLA. -- Swordtail fish (Xiphophorus helleri), like those that are part of the Neurolab payload on Space Shuttle Mission STS-90, are shown in their holding tank in the Operations and Checkout Building. The fish will fly in the Closed Equilibrated Biological Aquatic System (CEBAS) Minimodule, a middeck locker-sized fresh water habitat, designed to allow the controlled incubation of aquatic species in a self-stabilizing, artifical ecosystem for up to three weeks under space conditions. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  12. KSC-98pc408

    NASA Image and Video Library

    1998-03-11

    KENNEDY SPACE CENTER, FLA. -- Swordtail fish (Xiphophorus helleri), like those that are part of the Neurolab payload on Space Shuttle Mission STS-90, are shown in their holding tank in the Operations and Checkout Building. The fish will fly in the Closed Equilibrated Biological Aquatic System (CEBAS) Minimodule, a middeck locker-sized fresh water habitat, designed to allow the controlled incubation of aquatic species in a self-stabilizing, artifical ecosystem for up to three weeks under space conditions. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D.

  13. Swordtail fish fly on STS-90 as part of Neurolab

    NASA Technical Reports Server (NTRS)

    1998-01-01

    Swordtail fish (Xiphophorus helleri), like those that are part of the Neurolab payload on Space Shuttle Mission STS-90, are shown in their holding tank in the Operations and Checkout Building. The fish will fly in the Closed Equilibrated Biological Aquatic System (CEBAS) Minimodule, a middeck locker-sized fresh water habitat, designed to allow the controlled incubation of aquatic species in a self-stabilizing, artifical ecosystem for up to three weeks under space conditions. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D.

  14. Swordtail fish fly on STS-90 as part of Neurolab

    NASA Technical Reports Server (NTRS)

    1998-01-01

    Swordtail fish (Xiphophorus helleri), like those that are part of the Neurolab payload on Space Shuttle Mission STS-90, are shown in their holding tanks in the Operations and Checkout Building. The fish will fly in the Closed Equilibrated Biological Aquatic System (CEBAS) Minimodule, a middeck locker-sized fresh water habitat, designed to allow the controlled incubation of aquatic species in a self-stabilizing, artifical ecosystem for up to three weeks under space conditions. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D.

  15. STS-89 M.S. Dunbar and Sharipov chat under the orbiter after landing

    NASA Technical Reports Server (NTRS)

    1998-01-01

    STS-89 Mission Specialist Bonnie Dunbar, Ph.D., at left, discusses the mission with Mission Specialist Salizhan Sharipov of the Russian Space Agency under the orbiter Endeavour after it landed on Runway 15 at KSCs Shuttle Landing Facility Jan. 31. The 89th Space Shuttle mission was the 42nd (and 13th consecutive) landing of the orbiter at KSC, and STS-89 was the eighth of nine planned dockings of the orbiter with the Russian Space Station Mir. STS-89 Mission Specialist Andrew Thomas, Ph.D., succeeded NASA astronaut and Mir 24 crew member David Wolf, M.D., who was on the Russian space station since late September 1997. Dr. Wolf returned to Earth on Endeavour with the remainder of the STS-89 crew, including Commander Terrence Wilcutt; Pilot Joe Edwards Jr.; and Mission Specialists James Reilly, Ph.D.; Michael Anderson; Dr. Dunbar; and Sharipov. Dr. Thomas is scheduled to remain on Mir until the STS-91 Shuttle mission returns in June 1998. In addition to the docking and crew exchange, STS-89 included the transfer of science, logistical equipment and supplies between the two orbiting spacecrafts.

  16. KSC-99pp0453

    NASA Image and Video Library

    1999-04-27

    Under the eye of Capt. Steve Kelly (left), with Space Gateway Support, Commander Kent V. Rominger gets ready to practice driving the small armored personnel carrier that is part of emergency egress training during Terminal Countdown Demonstration Test (TCDT) activities. At the rear is Douglas Hamilton, a Canadian flight surgeon. The tracked vehicle could be used by the crew in the event of an emergency at the pad during which the crew must make a quick exit from the area. The TCDT also provides simulated countdown exercises and opportunities to inspect the mission payloads in the orbiter's payload bay. Other crew members taking part in the TCDT are Pilot Rick Douglas Husband, and Mission Specialists Ellen Ochoa (Ph.D.), Tamara E. Jernigan (Ph.D.), Daniel Barry (M.D., Ph.D.), Julie Payette and Valery Ivanovich Tokarev. Payette represents the Canadian Space Agency and Tokarev the Russian Space Agency. Mission STS-96, which is scheduled for liftoff on May 20 at 9:32 a.m., is a logistics and resupply mission for the International Space Station, carrying such payloads as a Russian crane, the Strela; a U.S.-built crane; the Spacehab Oceaneering Space System Box (SHOSS), a logistics items carrier; and STARSHINE, a student-led experiment

  17. KSC-99pp0458

    NASA Image and Video Library

    1999-04-27

    While Capt. Steve Kelly, with Space Gateway Support, keeps watch from the top of the vehicle, STS-96 Pilot Rick Douglas Husband practices driving the small armored personnel carrier that is part of emergency egress training during Terminal Countdown Demonstration Test (TCDT) activities. Behind them are (from left) Mission Specialist Daniel Barry (M.D., Ph.D.), Commander Kent V. Rominger and Mission Specialist Tamara E. Jernigan (Ph.D.). The tracked vehicle could be used by the crew in the event of an emergency at the pad during which the crew must make a quick exit from the area. The TCDT also provides simulated countdown exercises and opportunities to inspect the mission payloads in the orbiter's payload bay. Other crew members taking part in the TCDT are Mission Specialists Ellen Ochoa (Ph.D.), Julie Payette, with the Canadian Space Agency, and Valery Ivanovich Tokarev, with the Russian Space Agency. Mission STS-96, which is scheduled for liftoff on May 20 at 9:32 a.m., is a logistics and resupply mission for the International Space Station, carrying such payloads as a Russian crane, the Strela; a U.S.-built crane; the Spacehab Oceaneering Space System Box (SHOSS), a logistics items carrier; and STARSHINE, a student-led experiment

  18. KSC-99pp0449

    NASA Image and Video Library

    1999-04-27

    STS-96 Mission Specialist Julie Payette (right) practices driving a small armored personnel carrier that is part of emergency egress training during Terminal Countdown Demonstration Test (TCDT) activities. The tracked vehicle could be used by the crew in the event of an emergency at the pad during which the crew must make a quick exit from the area. The TCDT also provides simulated countdown exercises and opportunities to inspect the mission payloads in the orbiter's payload bay. At left are Mission Specialist Valery Ivanovich Tokarev, with the Russian Space Agency, and Pilot Rick Douglas Husband. Payette is with the Canadian Space Agency. Riding on the front of the carrier is Capt. Steve Kelly, with Space Gateway Support, who is assisting the crew with their training. Other crew members are Commander Kent V. Rominger and Mission Specialists Ellen Ochoa (Ph.D.), Tamara E. Jernigan (Ph.D.), and Daniel Barry (M.D., Ph.D.). Mission STS-96 is a logistics and resupply mission for the International Space Station, carrying such payloads as a Russian crane, the Strela; a U.S.-built crane; the Spacehab Oceaneering Space System Box (SHOSS), a logistics items carrier; and STARSHINE, a student-led experiment

  19. KSC-99pp0456

    NASA Image and Video Library

    1999-04-27

    Capt. Steve Kelly (left), with Space Gateway Support, explains to STS-96 Mission Specialist Valery Ivanovich Tokarev the use of the small armored personnel carrier that is part of emergency egress training during Terminal Countdown Demonstration Test (TCDT) activities. Behind him are Commander Kent V. Rominger and Mission Specialist Ellen Ochoa (Ph.D.). The tracked vehicle could be used by the crew in the event of an emergency at the pad during which the crew must make a quick exit from the area. The TCDT also provides simulated countdown exercises and opportunities to inspect the mission payloads in the orbiter's payload bay. Other crew members taking part in the TCDT are Pilot Rick Douglas Husband and Mission Specialists Tamara E. Jernigan (Ph.D.), Daniel Barry (M.D., Ph.D.), and Julie Payette, with the Canadian Space Agency. Tokarev is with the Russian Space Agency. Mission STS-96, which is scheduled for liftoff on May 20 at 9:32 a.m., is a logistics and resupply mission for the International Space Station, carrying such payloads as a Russian crane, the Strela; a U.S.-built crane; the Spacehab Oceaneering Space System Box (SHOSS), a logistics items carrier; and STARSHINE, a student-led experiment

  20. STS-96 Discovery night landing front view

    NASA Technical Reports Server (NTRS)

    1999-01-01

    Bright lights at KSC's Shuttle Landing Facility runway 15 illuminate the landing of Space Shuttle Discovery, which completes the 9-day, 19-hour, 13-minute and 1-second long STS-96 mission. A contrail streams from the wing. Main gear touchdown was at 2:02:43 EDT June 6 , landing on orbit 154 of the mission. Nose gear touchdown was at 2:02:59 a.m. EDT, and the wheels stopped at 2:03:39 a.m. EDT. At the controls were Commander Kent V. Rominger and Pilot Rick D. Husband. Also onboard the orbiter were Mission Specialists Ellen Ochoa (Ph.D.), Tamara E. Jernigan (Ph.D.), Daniel S. Barry (M.D., Ph.D.), Julie Payette and Valery Ivanovich Tokarev. Payette represents the Canadian Space Agency and Tokarev the Russian Space Agency. The crew returned from the second flight to the International Space Station on a logistics and resupply mission. This was the 94th flight in the Space Shuttle program and the 26th for Discovery, also marking the 47th at KSC, the 24th in the last 25 missions, 11th at night, and the 18th consecutive landing in Florida.

  1. STS-96 M.S. Dan Barry checks equipment during a CEIT

    NASA Technical Reports Server (NTRS)

    1999-01-01

    In the Orbiter Processing Facility bay 1, STS-96 Mission Specialist Daniel Barry, M.D., Ph.D., looks at one of the foot restraints used for extravehicular activity, or space walks. The STS-96 crew is at KSC to take part in a Crew Equipment Interface Test. The other crew members are Commander Kent V. Rominger, Pilot Rick Douglas Husband, and Mission Specialists Ellen Ochoa (Ph.D.), Tamara E. Jernigan (Ph.D.), Julie Payette and Valery Ivanovich Tokarev. Payette represents the Canadian Space Agency and Tokarev the Russian Space Agency. The primary payload of STS- 96 is the SPACEHAB Double Module. In addition, the Space Shuttle will carry unpressurized cargo such as the external Russian cargo crane known as STRELA; the Spacehab Oceaneering Space System Box (SHOSS), which is a logistics items carrier; and an ORU Transfer Device (OTD), a U.S.-built crane that will be stowed on the station for use during future ISS assembly missions. These cargo items will be stowed on the International Cargo Carrier, fitted inside the payload bay behind the SPACEHAB module. STS-96 is targeted for launch on May 24 from Launch Pad 39B.

  2. University Curricula in the Marine Sciences and Related Fields. Academic Years 1969-70 and 1970-71.

    DTIC Science & Technology

    1971-01-01

    Associate Professor Krause , Dale C., Associate Professor 112 McMaster, Robert L., Ph.D., Associate Professor Smayda, Theodore J., Dr., Philos...Associate Professor of Zoology Division of Physical Sciences Allison, Edwin C., Ph.D., Professor of Geology Berger, Wolfgang , Ph.D., Assistant Professor of

  3. Developing a Research Strategy for Suicide Prevention in the Department of Defense: Status of Current Research, Prioritizing Areas of Need, and Recommendations for Moving Forward

    DTIC Science & Technology

    2014-01-01

    Suicide Prevention Ursula S . Whiteside, Ph.D. Group Health Cooperative Central Hospital Civilians Population-based risk reduction/resilience...Use and Suicidality: Comparative Safety in Children and Adults Sebastian Schneeweiss, M.D. Brigham and Women’s Hospital Civilians Risk and...Recommendations for Moving Forward 5a. CONTRACT NUMBER 5b. GRANT NUMBER 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR( S ) 5d. PROJECT NUMBER 5e. TASK

  4. PTSD Trajectory, Comorbidity, and Utilization of Mental Health Services Among Reserves

    DTIC Science & Technology

    2009-10-01

    unemployed 4 Retired 5 A homemaker 6 A student 7 On maternity or paternity leave 8 On illness or sick leave 9 On disability 10 Other (SPECIFY...with ongoing civilian life . The central goal of this work is to identify the changeable factors that can improve resilient mental health outcomes...AUTHOR(S) 5d. PROJECT NUMBER Sandro Galea, M.D., PH.D. 5e. TASK NUMBER E-Mail: sgalea@umich.edu 5f. WORK UNIT NUMBER 7. PERFORMING

  5. Cellular Energy Pathways as Novel Targets for the Therapy of Autosomal Dominant Polycystic Kidney Disease

    DTIC Science & Technology

    2016-09-01

    AWARD NUMBER: W81XWH-15-1-0419 TITLE: Cellular Energy Pathways as Novel Targets for the Therapy of Autosomal Dominant Polycystic Kidney Disease...Polycystic Kidney Disease 5b. GRANT NUMBER W81XWH-15-1-0419 5c. PROGRAM ELEMENT NUMBER 6. AUTHOR(S) 5d. PROJECT NUMBER Michael J. Caplan, MD, PhD Kenneth...dominant polycystic kidney disease (ADPKD) is a common inherited disorder where patients, over the course of decades, develop large fluid filled

  6. Identification and Therapeutic Targeting of Paracrine Senescence Factors in the Prostate Tumor Microenvironment

    DTIC Science & Technology

    2011-10-01

    PROJECT NUMBER James P. Dean, M.D., Ph.D. 5e. TASK NUMBER E-Mail: amoreno@fhcrc.org 5f. WORK UNIT NUMBER 7. PERFORMING ORGANIZATION NAME(S...secretion of STC1 were defined, but multiple studies seeking to define the function of STC1 in the prostate were uniformly negative. A clinical trial...men in the United States - could be prevented with more effective treatments. Overcoming tumor cell resistance to the effects of androgen

  7. Human Behaviour in High Stress Situations in Aerospace Operations Conference Proceedings Held in The Hague, The Netherlands on 24-28 October 1988

    DTIC Science & Technology

    1989-06-01

    Continuously stimulating advances in the aerospace sciences relevant to strengthening the common defence posture; - Improving the co-operation among member...very stimulating symposium. vii KI-1 PREDICTION OF PERSONALITY Harald T. Andersen M.D., Ph.D., D.Sc,D.Av.Med. Director RNoAF Institute of Aviation...audio tape recorder which was connected to the aircraft communication system. This recorder provided a continuous auditory record of each mission so that

  8. Selection of Human Antibody Fragments Which Bind Novel Breast Tumor Antigens

    DTIC Science & Technology

    1997-09-01

    Human monoclonal antibody production: current status and future prospects. J. Immunol. Methods. 100: 5-. 16. Marks, J.D., Hoogenboom , H.R., Griffiths...16007-16010. 17. Hoogenboom , H.R., Marks, J.D., Griffiths, A.D., and Winter, G. (1992) Building antibodies from their genes. Immunol. Rev. 130: 41-68...Nature. 348: 552-4. page (21) Annual report, Grant No. DAMD17-94-J-4433 James D. Marks M.D., Ph.D. 19. Hoogenboom , H.R., Griffiths, A.D., Johnson, K.S

  9. In Remembrance of Robert J. Arceci, M.D., Ph.D. | Office of Cancer Genomics

    Cancer.gov

    It is with great sadness and a profound sense of loss that OCG recognizes the untimely passing of Dr. Robert J. Arceci. Dr. Arceci was a co-Principal Investigator for the Acute Myeloid Leukemia (AML) project within the TARGET initiative, which aims to discover novel, more effective treatments for childhood cancers. Dr. Arceci was passionate about the use of cancer genomics to both inform therapeutic approaches in the clinic and expand the field of precision medicine.

  10. Acceleration of Regeneration of Large Gap Peripheral Nerve Injuries Using Acellular Nerve Allografts plus amniotic Fluid Derived Stem Cells (AFS)

    DTIC Science & Technology

    2016-09-01

    AWARD NUMBER: W811XWH-13-1-0310 TITLE: Acceleration of Regeneration of Large-Gap Peripheral Nerve Injuries Using Acellular Nerve Allografts...plus amniotic Fluid Derived Stem Cells (AFS). PRINCIPAL INVESTIGATOR: Zhongyu Li, MD, PhD RECIPIENT: Wake Forest University Health Sciences...REPORT DATE September 2016 2. REPORT TYPE Annual 3. DATES COVERED 1Sep2015 - 31Aug2016 4. TITLE AND SUBTITLE Acceleration of Regeneration of Large

  11. EF5 PET of Tumor Hypoxia: A Predictive Imaging Biomarker of Response to Stereotactic Ablative Radiotherapy (SABR) for Early Lung Cancer

    DTIC Science & Technology

    2015-09-01

    SABR ) for Early Lung Cancer PRINCIPAL INVESTIGATOR: Billy W. Loo, Jr., M.D., Ph.D CONTRACTING ORGANIZATION: Stanford University Stanford, CA...CONTRACT NUMBER W81XWH-12-1-0236 Response to Stereotactic Ablative Radiotherapy ( SABR ) for Early Lung Cancer 5b. GRANT NUMBER 5c. PROGRAM...Unlimited 13. SUPPLEMENTARY NOTES 14. ABSTRACT Purpose and scope: Stereotactic ablative radiotherapy ( SABR ) has become a new standard of care for early

  12. Clinical Trial of Imipenem/Cilastatin in Severely Burned and Infected Patients

    DTIC Science & Technology

    1987-07-01

    34"OT FILE CO.Y CLINICAL TRIAL OF IMIPENEM /CILASTATIN IN SEVERELY BURNED AND INFECTED PATIENTS Gary R. Culbertson, M.D., Albert T. McManus, PH.D., D T...NOV 1 3 1987 San Antonio, Texas b H Imipenem /cilastatin was examined for safety and effi- ,-;Opportunistic organisms causing infections in cacy in a...All of the clinical failures were in the pulmonary in ec- imipenem /cilastatin, a novel thienamycin alti- tion group. No serious toxicity or side

  13. Development of Gutless Adenoviral Vectors Encoding Anti Angiogenic Proteins for Therapy of Prostate Cancer

    DTIC Science & Technology

    2005-01-01

    PRINCIPAL INVESTIGATOR: Calvin J. Kuo, M.D., Ph.D. CONTRACTING ORGANIZATION : Stanford University Stanford, California 94305-5401 REPORT DATE: January...cloned in between the I-Scel site and the T’. This extra DNA fragment is used as a stuffer DNA in order to increase the size of the viral genome up to...regularly increasing sizes above the 2 fragments specific for the virus left and right ends can only be explained by the phenomenon known as ’postreplicative

  14. Targeting histone abnormality in triple negative breast cancer

    DTIC Science & Technology

    2017-08-01

    ELEMENT NUMBER N/A 6. AUTHOR(S) 5d. PROJECT NUMBER N/A Yi Huang, M.D., Ph.D. 5e. TASK NUMBER N/A E -Mail:huangy2@upmc.edu 5f. WORK UNIT NUMBER...prevention. This funded Breast Cancer Breakthrough Award is initially a partnership between Dr. Yi Huang (initiating PI) and Dr. Nancy E . Davidson...partner PI). During the current funding period, Dr. Nancy E . Davidson moved to University of Washington at Seattle and transferred the Partnering PI to

  15. Developing Novel Therapeutic Approaches in Small Cell Lung Carcinoma Using Genetically Engineered Mouse Models and Human Circulating Tumor Cells

    DTIC Science & Technology

    2015-10-01

    xenograft models . 12-36 Dr. Engelman Subtask 3: Analyze CTCs for P-4EBP1, P-S6, BIM , Bcl-2, Bcl-xL, and Mcl-1 using ISH and IHC We propose...Using Genetically Engineered Mouse Models and Human Circulating Tumor Cells PRINCIPAL INVESTIGATOR: Jeffrey Engelman MD PhD CONTRACTING...reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions

  16. Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia.

    PubMed

    Yang, Chunzhang; Zhuang, Zhengping; Fliedner, Stephanie M J; Shankavaram, Uma; Sun, Michael G; Bullova, Petra; Zhu, Roland; Elkahloun, Abdel G; Kourlas, Peter J; Merino, Maria; Kebebew, Electron; Pacak, Karel

    2015-01-01

    We have investigated genetic/pathogenetic factors associated with a new clinical entity in patients presenting with pheochromocytoma/paraganglioma (PHEO/PGL) and polycythemia. Two patients without hypoxia-inducible factor 2α (HIF2A) mutations, who presented with similar clinical manifestations, were analyzed for other gene mutations, including prolyl hydroxylase (PHD) mutations. We have found for the first time a germ-line mutation in PHD1 in one patient and a novel germ-line PHD2 mutation in a second patient. Both mutants exhibited reduced protein stability with substantial quantitative protein loss and thus compromised catalytic activities. Due to the unique association of patients' polycythemia with borderline or mildly elevated erythropoietin (EPO) levels, we also performed an in vitro sensitivity assay of erythroid progenitors to EPO and for EPO receptor (EPOR) expression. The results show inappropriate hypersensitivity of erythroid progenitors to EPO in these patients, indicating increased EPOR expression/activity. In addition, the present study indicates that HIF dysregulation due to PHD mutations plays an important role in the pathogenesis of these tumors and associated polycythemia. The PHD1 mutation appears to be a new member contributing to the genetic landscape of this novel clinical entity. Our results support the existence of a specific PHD1- and PHD2-associated PHEO/PGL-polycythemia disorder. • A novel germ-l i n e PHD1 mutation causing heochromocytoma/paraganglioma and polycythemia. • Increased EPOR activity and inappropriate hypersensitivity of erythroid progenitors to EPO.

  17. Large Population-Based Study Reveals Disparities in Myeloma Precursor Disease | Center for Cancer Research

    Cancer.gov

    Multiple myeloma (MM) is a cancer of plasma cells, which are antibody-producing white blood cells. Patients with MM have a characteristic excess of monoclonal antibodies, so called M proteins, in their serum, urine, or both and plasma cell infiltration into their bone marrow at multiple sites. African Americans are more than twice as likely as whites to develop MM, but the reason for this higher prevalence is not entirely clear. Since MM is nearly always preceded by the premalignant condition monoclonal gammopathy of undetermined significance (MGUS), Ola Landgren, M.D., Ph.D., a Senior Investigator in CCR’s Lymphoid Malignancies Branch, and colleagues from NCI’s Division of Cancer Epidemiology and Genetics, the Mayo Clinic, and the Centers for Disease Control and Prevention (CDC), wanted to determine whether there were also disparities in MGUS prevalence or in biomarkers associated with a high risk of MGUS progression to MM.

  18. [Generation Y in ENT: leading a young generation of doctors].

    PubMed

    Schmidt, K; Meyer, J; Liebeneiner, J; Schmidt, C E; Hüttenbrink, K B

    2012-11-01

    The shortage of qualified doctors and nurses has led to a competition between hospitals. Analyzing the circumstances of the competition, nurses and doctors of so-called generation Y are important. These employees are mainly female and have different requirements compared to previous generations. Therefore, knowledge of these requirements will become a critical success factor for hospitals in the future. We interviewed medical students in Kiel and Hannover from 2005 to 2011 about the clinical department chosen, the criteria for choosing a specific clinic, and the importance of MD and PhD programs. In addition, we conducted an internet and Medline search for scientific studies on labor shortage, generation Y, and demographics. The data were sorted by main categories and relevance for hospitals. Statistical analyses were performed using descriptive measures. We received 1,097 answers which represents approx. 75% of all students. Sixty-seven percent of the students were female, 33% male. Preferences for departments revealed internal medicine, pediatrics, and anesthesiology as the top three. ENT followed at rank 10. The main criteria for choosing a clinic were working climate, structure and broadness of education, family friendliness, and respect. MD programs were rated 2.6, while PhD programs were rated 3.6. Staff members of Generation Y "live while working" and disagree with hierarchies. Internet and computers are part of their daily routine. Employees of Generation Y challenge leadership in hospitals by increasing demands. However, Generation Y can increase professionalization and competitiveness for hospitals significantly.

  19. The Road to Remarkable: Directed by Vision, Driven by Strength--2010 Five-Year Report of the Policy and Planning Board

    ERIC Educational Resources Information Center

    American Psychologist, 2011

    2011-01-01

    The 2010 Policy and Planning Board of the American Psychological Association (APA) was chaired by Elena J. Eisman, EdD. Other members of the board included Gwyneth M. Boodoo, PhD; G. Rita Dudley-Grant, PhD; Beverly Greene, PhD; Christopher W. Loftis, PhD; Michael J. Murphy, PhD; Paul D. Nelson, PhD; Kurt Salzinger, PhD; and Michael Wertheimer,…

  20. The Changing Landscape of Lung Cancer Research and Treatment

    Cancer.gov

    Along with the Lung Cancer Social Media (#LCSM) community, the National Cancer Institute will be co-hosting a lively and interactive Google Hangout on Air about the changing landscape of lung cancer research and treatment. During the chat, viewers will have the opportunity to pose questions to a panel of lung cancer experts including NCI's Dr. Shakun Malik, the head of thoracic oncology therapeutics, Roy S. Herbst, MD, PhD, Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven and David Tom Cooke MD FACS, Head, Section of General Thoracic Surgery University of California, Davis. You can also learn more and follow along on the #LCSM Chat page. The chat will be moderated by lung cancer advocate and #LCSM co-founder, Janet Freeman-Daily. To ask questions of our experts, simply use the #LCSM hashtag during the chat.

  1. A water snail catches a ride on STS-90 as part of Neurolab

    NASA Technical Reports Server (NTRS)

    1998-01-01

    A water snail (Biomphalaria glabrata), like those that are part of the Neurolab payload on Space Shuttle Mission STS-90, is held up for inspection in the Operations and Checkout Building. The snails will fly in the Closed Equilibrated Biological Aquatic System (CEBAS) Minimodule, a middeck locker-sized fresh water habitat, designed to allow the controlled incubation of aquatic species in a self-stabilizing, artifical ecosystem for up to three weeks under space conditions. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, includes Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D.

  2. KSC-98pc146

    NASA Image and Video Library

    1998-01-09

    STS-90 Mission Specialist Dafydd "Dave" Rhys Williams, M.D., with the Canadian Space Agency, and back-up Payload Specialist Chiaki Mukai, M.D., Ph.D., with the National Space Development Agency of Japan, examine items to be used during the Crew Equipment Interface Test (CEIT) in Kennedy Space Center's (KSC's) Operations and Checkout Building, where the Neurolab payload is undergoing processing. The CEIT gives astronauts an opportunity to get a hands-on look at the payloads with which they will be working on-orbit. STS-90 is scheduled to launch aboard the Shuttle Columbia from KSC on April 2. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system

  3. KSC-98pc553

    NASA Image and Video Library

    1998-05-03

    The orbiter Columbia touches down on Runway 33 of KSC's Shuttle Landing Facility to complete the nearly 16-day STS-90 mission. Main gear touchdown was at 12:08:59 p.m. EDT on May 3, 1998, landing on orbit 256 of the mission. The wheels stopped at 12:09:58 EDT, completing a total mission time of 15 days, 21 hours, 50 minutes and 58 seconds. The 90th Shuttle mission was Columbia's 13th landing at the space center and the 43rd KSC landing in the history of the Space Shuttle program. During the mission, the crew conducted research to contribute to a better understanding of the human nervous system. The crew of the STS-90 Neurolab mission include Commander Richard Searfoss; Pilot Scott Altman; Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  4. KSC-98pc410

    NASA Image and Video Library

    1998-03-11

    KENNEDY SPACE CENTER, FLA. -- Dr. Dirk Voeste, a scientist with Ruhr-University of Bochum, Germany, examines some swordtail fish (Xiphophorus helleri), like those that are part of the Neurolab payload on Space Shuttle Mission STS-90, in their holding tank in the Operations and Checkout Building. The fish will fly in the Closed Equilibrated Biological Aquatic System (CEBAS) Minimodule, a middeck locker-sized fresh water habitat, designed to allow the controlled incubation of aquatic species in a self-stabilizing, artifical ecosystem for up to three weeks under space conditions. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  5. KSC-98pc402

    NASA Image and Video Library

    1998-03-23

    KENNEDY SPACE CENTER, FLA. -- The Space Shuttle Columbia continues its morning rollout from the Vehicle Assembly Building to Launch Pad 39B in preparation for the STS-90 mission. The Neurolab experiments are the primary payload on this nearly 17-day space flight. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, includes Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  6. KSC-98pc390

    NASA Image and Video Library

    1998-03-23

    KENNEDY SPACE CENTER, FLA. -- The Space Shuttle Columbia continues its morning rollout from the Vehicle Assembly Building to Launch Pad 39B in preparation for the STS-90 mission. The Neurolab experiments are the primary payload on this nearly 17-day space flight. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, includes Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  7. KSC-98pc413

    NASA Image and Video Library

    1998-03-11

    KENNEDY SPACE CENTER, FLA. -- Ingo Ronny Wortmann (left) and Dr. Dirk Voeste, scientists with Ruhr-University of Bochum, Germany, examine swordtail fish (Xiphophorus helleri), like those that are part of the Neurolab payload on Space Shuttle Mission STS-90, in their holding tanks in the Operations and Checkout Building. The fish will fly in the Closed Equilibrated Biological Aquatic System (CEBAS) Minimodule, a middeck locker-sized freshwater habitat, designed to allow the controlled incubation of aquatic species in a self-stabilizing, artifical ecosystem for up to three weeks under space conditions. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  8. KSC-98pc415

    NASA Image and Video Library

    1998-02-27

    KENNEDY SPACE CENTER, FLA. -- An oyster toadfish (Opsanus tau), like those that are part of the Neurolab payload on Space Shuttle Mission STS-90, is shown in its holding tank in the Space Station Processing Facility. Each fish is between eight and 14 inches long. Toadfish live in an estuarine environment and are native to areas along the Northeast coast of the United States. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. This fish is an excellent model for looking at vestibular function because the architecture of its inner and middle ear are similar to those of mammals with respect to the vestibular apparatus. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, includes Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  9. KSC-98pc563

    NASA Image and Video Library

    1998-05-03

    The orbiter Columbia touches down on Runway 33 of KSC's Shuttle Landing Facility to complete the nearly 16-day STS-90 mission. Main gear touchdown was at 12:08:59 p.m. EDT on May 3, 1998, landing on orbit 256 of the mission. The wheels stopped at 12:09:58 EDT, completing a total mission time of 15 days, 21 hours, 50 minutes and 58 seconds. The 90th Shuttle mission was Columbia's 13th landing at the space center and the 43rd KSC landing in the history of the Space Shuttle program. During the mission, the crew conducted research to contribute to a better understanding of the human nervous system. The crew of the STS-90 Neurolab mission include Commander Richard Searfoss; Pilot Scott Altman; Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  10. KSC-98pc403

    NASA Image and Video Library

    1998-03-23

    KENNEDY SPACE CENTER, FLA. -- The Space Shuttle Columbia continues its morning rollout past the newly opened tour stop, the Launch Complex 39 Observation Gantry, to Launch Pad 39B in preparation for the STS-90 mission. The Neurolab experiments are the primary payload on this nearly 17-day space flight. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, includes Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  11. KSC-98pc414

    NASA Image and Video Library

    1998-02-27

    KENNEDY SPACE CENTER, FLA. -- An oyster toadfish (Opsanus tau), like those that are part of the Neurolab payload on Space Shuttle Mission STS-90, is shown in its holding tank in the Space Station Processing Facility. Each fish is between eight and 14 inches long. Toadfish live in an estuarine environment and are native to areas along the Northeast coast of the United States. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. This fish is an excellent model for looking at vestibular function because the architecture of its inner and middle ear are similar to those of mammals with respect to the vestibular apparatus. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, includes Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  12. KSC-98pc316

    NASA Image and Video Library

    1998-02-26

    Members of the STS-90 crew participate in the Crew Equipment Interface Test (CEIT) in Kennedy Space Center's Orbiter Processing Facility Bay 3. The CEIT gives astronauts an opportunity to get a hands-on look at the payloads with which they will be working on-orbit. Investigations during the STS-90 Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch in April, are, left to right, Pilot Scott Altman; Payload Specialist James Pawelczyk, Ph.D.; Commander Richard Searfoss; Mission Specialists Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire; Payload Specialist Jay Buckey, M.D.; and Mission Specialist Richard Linnehan

  13. KSC-98pc405

    NASA Image and Video Library

    1998-03-23

    KENNEDY SPACE CENTER, FLA. -- The Space Shuttle Columbia continues up the ramp to Launch Pad 39B in its morning rollout prior to STS-90. Leveling systems within the crawler-transporter underneath the Shuttle keep the platform level while negotiating the five percent ramp leading up to the pad surface. The top of the orbiter is kept vertical within plus or minus 10 minutes of arc, about the diameter of a basketball during the journey. The Neurolab experiments are the primary payload on this nearly 17-day space flight. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. The crew of STS-90, slated for launch April 16 at 2:19 p.m. EDT, includes Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  14. KSC-98pc315

    NASA Image and Video Library

    1998-02-26

    Members of the STS-90 crew participate in the Crew Equipment Interface Test (CEIT) in Kennedy Space Center's Orbiter Processing Facility Bay 3. The CEIT gives astronauts an opportunity to get a hands-on look at the payloads with which they will be working on-orbit. Investigations during the STS-90 Neurolab mission will focus on the effects of microgravity on the nervous system. Specifically, experiments will study the adaptation of the vestibular system, the central nervous system, and the pathways that control the ability to sense location in the absence of gravity, as well as the effect of microgravity on a developing nervous system. The crew of STS-90, slated for launch in April, will include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  15. KSC-98pc557

    NASA Image and Video Library

    1998-05-03

    The orbiter Columbia approaches touchdown on Runway 33 of KSC's Shuttle Landing Facility to complete the nearly 16-day STS-90 mission. Main gear touchdown was at 12:08:59 p.m. EDT on May 3, 1998, landing on orbit 256 of the mission. The wheels stopped at 12:09:58 EDT, completing a total mission time of 15 days, 21 hours, 50 minutes and 58 seconds. The 90th Shuttle mission was Columbia's 13th landing at the space center and the 43rd KSC landing in the history of the Space Shuttle program. During the mission, the crew conducted research to contribute to a better understanding of the human nervous system. The crew of the STS-90 Neurolab mission include Commander Richard Searfoss; Pilot Scott Altman; Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  16. KSC-98pc555

    NASA Image and Video Library

    1998-05-03

    The orbiter Columbia approaches touchdown on Runway 33 of KSC's Shuttle Landing Facility to complete the nearly 16-day STS-90 mission. Main gear touchdown was at 12:08:59 p.m. EDT on May 3, 1998, landing on orbit 256 of the mission. The wheels stopped at 12:09:58 EDT, completing a total mission time of 15 days, 21 hours, 50 minutes and 58 seconds. The 90th Shuttle mission was Columbia's 13th landing at the space center and the 43rd KSC landing in the history of the Space Shuttle program. During the mission, the crew conducted research to contribute to a better understanding of the human nervous system. The crew of the STS-90 Neurolab mission include Commander Richard Searfoss; Pilot Scott Altman; Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  17. Swordtail fish fly on STS-90 as part of Neurolab

    NASA Technical Reports Server (NTRS)

    1998-01-01

    Dr. Dirk Voeste, a scientist with Ruhr-University of Bochum, Germany, examines some swordtail fish (Xiphophorus helleri), like those that are part of the Neurolab payload on Space Shuttle Mission STS-90, in their holding tank in the Operations and Checkout Building. The fish will fly in the Closed Equilibrated Biological Aquatic System (CEBAS) Minimodule, a middeck locker- sized fresh water habitat, designed to allow the controlled incubation of aquatic species in a self-stabilizing, artifical ecosystem for up to three weeks under space conditions. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. The crew of STS- 90, slated for launch April 16 at 2:19 p.m. EDT, include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D.

  18. KSC-98pc564

    NASA Image and Video Library

    1998-05-03

    The orbiter Columbia approaches touchdown on Runway 33 of KSC's Shuttle Landing Facility to complete the nearly 16-day STS-90 mission. Main gear touchdown was at 12:08:59 p.m. EDT on May 3, 1998, landing on orbit 256 of the mission. The wheels stopped at 12:09:58 EDT, completing a total mission time of 15 days, 21 hours, 50 minutes and 58 seconds. The 90th Shuttle mission was Columbia's 13th landing at the space center and the 43rd KSC landing in the history of the Space Shuttle program. During the mission, the crew conducted research to contribute to a better understanding of the human nervous system. The crew of the STS-90 Neurolab mission include Commander Richard Searfoss; Pilot Scott Altman; Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  19. KSC-98pc554

    NASA Image and Video Library

    1998-05-03

    The orbiter Columbia touches down on Runway 33 of KSC's Shuttle Landing Facility to complete the nearly 16-day STS-90 mission. Main gear touchdown was at 12:08:59 p.m. EDT on May 3, 1998, landing on orbit 256 of the mission. The wheels stopped at 12:09:58 EDT, completing a total mission time of 15 days, 21 hours, 50 minutes and 58 seconds. The 90th Shuttle mission was Columbia's 13th landing at the space center and the 43rd KSC landing in the history of the Space Shuttle program. During the mission, the crew conducted research to contribute to a better understanding of the human nervous system. The crew of the STS-90 Neurolab mission include Commander Richard Searfoss; Pilot Scott Altman; Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  20. KSC-98pc556

    NASA Image and Video Library

    1998-05-03

    The orbiter Columbia touches down on Runway 33 of KSC's Shuttle Landing Facility to complete the nearly 16-day STS-90 mission. Main gear touchdown was at 12:08:59 p.m. EDT on May 3, 1998, landing on orbit 256 of the mission. The wheels stopped at 12:09:58 EDT, completing a total mission time of 15 days, 21 hours, 50 minutes and 58 seconds. The 90th Shuttle mission was Columbia's 13th landing at the space center and the 43rd KSC landing in the history of the Space Shuttle program. During the mission, the crew conducted research to contribute to a better understanding of the human nervous system. The crew of the STS-90 Neurolab mission include Commander Richard Searfoss; Pilot Scott Altman; Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  1. KSC-98pc558

    NASA Image and Video Library

    1998-05-03

    The orbiter Columbia approaches touchdown on Runway 33 of KSC's Shuttle Landing Facility to complete the nearly 16-day STS-90 mission. Main gear touchdown was at 12:08:59 p.m. EDT on May 3, 1998, landing on orbit 256 of the mission. The wheels stopped at 12:09:58 EDT, completing a total mission time of 15 days, 21 hours, 50 minutes and 58 seconds. The 90th Shuttle mission was Columbia's 13th landing at the space center and the 43rd KSC landing in the history of the Space Shuttle program. During the mission, the crew conducted research to contribute to a better understanding of the human nervous system. The crew of the STS-90 Neurolab mission include Commander Richard Searfoss; Pilot Scott Altman; Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., with the Canadian Space Agency, and Kathryn (Kay) Hire; and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D

  2. Swordtail fish fly on STS-90 as part of Neurolab

    NASA Technical Reports Server (NTRS)

    1998-01-01

    Ingo Ronny Wortmann (left) and Dr. Dirk Voeste, scientists with Ruhr-University of Bochum, Germany, examine swordtail fish (Xiphophorus helleri), like those that are part of the Neurolab payload on Space Shuttle Mission STS-90, in their holding tanks in the Operations and Checkout Building. The fish will fly in the Closed Equilibrated Biological Aquatic System (CEBAS) Minimodule, a middeck locker-sized freshwater habitat, designed to allow the controlled incubation of aquatic species in a self-stabilizing, artifical ecosystem for up to three weeks under space conditions. Investigations during the Neurolab mission will focus on the effects of microgravity on the nervous system. The crew of STS- 90, slated for launch April 16 at 2:19 p.m. EDT, include Commander Richard Searfoss, Pilot Scott Altman, Mission Specialists Richard Linnehan, D.V.M., Dafydd (Dave) Williams, M.D., and Kathryn (Kay) Hire, and Payload Specialists Jay Buckey, M.D., and James Pawelczyk, Ph.D.

  3. New Therapeutic Modalities of Retinal Laser Injury.

    DTIC Science & Technology

    1992-03-31

    Clawticarroni New Therapeutic Modalities for Retinal Laser Injury 1 2 . PERSONAL AUTHOR(S) Tim T.Lar. Ph.D., .and Mark Q.M. Tso. M.D. 13a. TYPE OF...Experimental treatment of retinal laser Injury 4 1.3: Clinical therapy 4 1.4: Our hypothesis and approaches 4 Chapter 2 : Accidental laser Injury to the...human retina 7 2.1: Introduction 7 2.2: Case 1 7 2.3: Case 2 8 2.4: General comments 9 2.5: Clinical course 10 2.6: Implications 10 Chapter 3: Sub

  4. Social Sciences Support to Military Personnel Engaged in Counter-Insurgency and Counter-Terrorism Operations (Soutien en sciences sociales apporte au personnel militaire engage dans des operations de contre-insurrection et de contre-terrorisme)

    DTIC Science & Technology

    2011-11-01

    Aleksanin, M.D., Ph.D., Director of the Nikiforov Russian Centre of Emergency and Radiation Medicine: Dr. Aleksanin has worked as a therapist and served as a...four components of being combat ready: psychological health, physical health, combat skills and physical training. The combat potential of the...clear that participation in armed conflict affects mental and physical health adversely. Studies have shown that certain personality changes take

  5. Galen Wagner, M.D., Ph.D. (1939-2016) as international mentor of young investigators in electrocardiology.

    PubMed

    Swenne, Cees A; Pahlm, Olle; Atwater, Brett D; Bacharova, Ljuba

    This paper describes a substantial part of the international mentoring network of students and young investigators in electrocardiology that developed around Dr. Galen Wagner (1939-2016), including many experiences of his mentees and co-mentors. The paper is meant to stimulate thinking about international mentoring as a means to achieve important learning experiences and personal development of young investigators, to intensify international scientific cooperation, and to stimulate scientific production. Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

  6. Proceedings of the Tri-Service Aeromedical Research Panel Fall Technical Meeting, 13-14 November 1984.

    DTIC Science & Technology

    1984-11-01

    P t -.1 41 N a ( d AUTOMATED VISUAL FIELD TESTING Chris A. Johnson, Ph.D. and John L. Keltner , M.D. Department of Ophthalmology University...and D . R. Griffin. 1947. The change in refractive power of the human eye in dim and bright light. J. Opt. Soc. Am. 37:321-336. 2. Leibowitz, H. W. and...Dover, New York (1962). 3. Maddox, E. E. 1893. The Clinical Use of Prisms, pp. 83-92. John Wright and Sons, Bristol, England. 4. Cogan,

  7. A Phase II Trial on the Effect of Low-Dose versus High-Dose Vitamin D Supplementation on Bone Mass in Adults with Neurofibromatosis 1 (NF1)

    DTIC Science & Technology

    2013-10-01

    MD, PhD CONTRACTING ORGANIZATION: University of Utah REPORT DATE : October 2013 TYPE OF REPORT: Annual PREPARED FOR: U.S...of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. 1. REPORT DATE ...October 2013 2. REPORT TYPE Annual 3. DATES COVERED 15 September 2012-14 September 2013 4. TITLE AND SUBTITLE A Phase II Trial on the Effect of

  8. Insights on unconventional natural gas development from shale: an interview with Anthony R. Ingraffea by Adam Law.

    PubMed

    Ingraffea, Anthony R

    2013-01-01

    Adam Law, M.D., interviewed Anthony R. Ingraffea, Ph.D., P.E., as part of a series of interviews funded by the Heinz Endowment. Dr. Ingraffea is the Dwight C. Baum Professor of Engineering at Cornell University, and has taught structural mechanics, finite element methods, and fracture mechanics at Cornell for 33 years. He discusses issues related to hydraulic fracturing, including inherent risks, spatial intensity, and the importance of a multi-disciplinary organization in establishing a chain of evidence.

  9. Undergraduate Training in the Epidemiology of Prostate Cancer with Focus on Genetics of Disease Progression and Quality of Life

    DTIC Science & Technology

    2014-08-01

    Brown’s Paper entitled “Pharmacogenomics and Prostate Cancer ” focused on the impact of cytochrome P450 genes such as CYP2C9, CYP 2D6, CYP 1A1 and CYP...Podophyllotoxins). Ms. Cobb’s paper focused on the pharmacogenetics of breast cancer and on the role of phase 1 and phase 2 hepatic enzymes on pharmacological... Cancer with Focus on Genetics of Disease Progression and Quality of Life PRINCIPAL INVESTIGATOR: Emanuela Taioli, MD, PhD CONTRACTING

  10. Defeating a rare, aggressive form of skin cancer with avelumab | Center for Cancer Research

    Cancer.gov

    For the one-year anniversary of the FDA’s approval of avelumab, CCR Communications caught up with Richard Mulcahy to share his success story as a clinical trial patient. Mulcahy was diagnosed with Merkel cell carcinoma in September of 2016. It’s been over a year since he received his first treatment of avelumab as part of a clinical trial led by Isaac Brownell, M.D., Ph.D., formerly an Investigator in the Dermatology Branch, at the National Cancer Institute (NCI) in Bethesda. Read more...

  11. Characterization of the Fusion and Attachment Glycoproteins of Human Metapneumovirus and Human Serosurvey to Determine Reinfection Rates

    DTIC Science & Technology

    2007-06-27

    Reinfection Rates" Name of Candidate: Julie Pavlin Doctor of Philosophy Degree 27 June 2007 Date Dissertation and Abstract Approved: (~ k( r (~~ t ~z-7...m s t e r R a b b it Rhesus macaque Cynomolgus macaque African green monkey Chimpanzee 75 Immunizations with sF and sG. Previous studies have...301�񔪔 J ge anco, Ph.D. V’ ion Systems, I c. ~~e~ David ReIman , M.D. Stanford University Committee Member (,/1.7 )07

  12. KSC-98pc259

    NASA Image and Video Library

    1998-01-31

    KENNEDY SPACE CENTER, FLA. -- STS-89 Commander Terrence Wilcutt, at left, shakes hands with Pilot Joe Edwards Jr. under the orbiter Endeavour after it landed on Runway 15 at KSC’s Shuttle Landing Facility Jan. 31. Kneeling in front of the wheel of the orbiter's nose, the commander and pilot congratulate each other on a perfect alignment of the wheel down the center of the runway. The 89th Space Shuttle mission was the 42nd (and 13th consecutive) landing of the orbiter at KSC, and STS-89 was the eighth of nine planned dockings of the orbiter with the Russian Space Station Mir. STS-89 Mission Specialist Andrew Thomas, Ph.D., succeeded NASA astronaut and Mir 24 crew member David Wolf, M.D., who was on the Russian space station since late September 1997. Dr. Wolf returned to Earth on Endeavour with the remainder of the STS-89 crew, including Commander Wilcutt; Pilot Edwards; and Mission Specialists James Reilly, Ph.D.; Michael Anderson; Bonnie Dunbar, Ph.D.; and Salizhan Sharipov of the Russian Space Agency. Dr. Thomas is scheduled to remain on Mir until the STS-91 Shuttle mission returns in June 1998. In addition to the docking and crew exchange, STS-89 included the transfer of science, logistical equipment and supplies between the two orbiting spacecrafts

  13. The STS-96 crew takes part in a Crew Equipment Interface Test at KSC

    NASA Technical Reports Server (NTRS)

    1999-01-01

    In the Orbiter Processing Facility bay 1, the STS-96 crew (foreground) looks into the payload bay of the orbiter Discovery. Standing in the bucket in the foreground are (left to right) Mission Specialists Daniel Barry (M.D., Ph.D.), Valery Ivanovich Tokarev, and Tamara E. Jernigan (Ph.D.), with a KSC worker at the controls of the bucket. In the background (center) pointing is Mission Specialist Julie Payette. Tokarev represents the Russian Space Agency and Payette the Canadian Space Agency. They are at KSC for a Crew Equipment Interface Test. The other crew members participating in the test are Commander Kent V. Rominger, Pilot Rick Douglas Husband and Mission Specialist Ellen Ochoa (Ph.D.). The primary payload of STS-96 is the SPACEHAB Double Module. In addition, the Space Shuttle will carry unpressurized cargo such as the external Russian cargo crane known as STRELA; the Spacehab Oceaneering Space System Box (SHOSS), which is a logistics items carrier; and an ORU Transfer Device (OTD), a U.S.-built crane that will be stowed on the station for use during future ISS assembly missions. These cargo items will be stowed on the International Cargo Carrier, fitted inside the payload bay behind the SPACEHAB module. STS-96 is targeted for launch on May 24 from Launch Pad 39B.

  14. The STS-96 crew takes part in a Crew Equipment Interface Test at KSC

    NASA Technical Reports Server (NTRS)

    1999-01-01

    In the Orbiter Processing Facility bay 1, STS-96 crew members look at the Canadian arm in the payload bay of the orbiter Discovery. Standing in a bucket controlled by a KSC worker, are (from left) Mission Specialist Tamara E. Jernigan (Ph.D), Daniel Barry (M.D., Ph.D.), and Valery Ivanovich Tokarev, who represents the Russian Space Agency. The STS-96 crew is at KSC to take part in a Crew Equipment Interface Test. The other crew members are Commander Kent V. Rominger, Pilot Rick Douglas Husband and Mission Specialists Ellen Ochoa (Ph.D.) and Julie Payette, with the Canadian Space Agency. The primary payload of STS-96 is the SPACEHAB Double Module. In addition, the Space Shuttle will carry unpressurized cargo such as the external Russian cargo crane known as STRELA; the Spacehab Oceaneering Space System Box (SHOSS), which is a logistics items carrier; and an ORU Transfer Device (OTD), a U.S.-built crane that will be stowed on the station for use during future ISS assembly missions. These cargo items will be stowed on the International Cargo Carrier, fitted inside the payload bay behind the SPACEHAB module. STS-96 is targeted for launch on May 24 from Launch Pad 39B.

  15. KSC-99pp0457

    NASA Image and Video Library

    1999-04-27

    STS-96 Mission Specialist Valery Ivanovich Tokarev practices driving the small armored personnel carrier that is part of emergency egress training during Terminal Countdown Demonstration Test (TCDT) activities. Riding the front of the carrier is Capt. Steve Kelly (left), with Space Gateway Support, who is assisting with the training. Behind them are Pilot Rick Douglas Husband (waving), and Mission Specialists Daniel Barry (M.D., Ph.D.) and Tamara E. Jernigan (Ph.D.) (waving). The tracked vehicle could be used by the crew in the event of an emergency at the pad during which the crew must make a quick exit from the area. The TCDT also provides simulated countdown exercises and opportunities to inspect the mission payloads in the orbiter's payload bay. Other crew members taking part in the TCDT are Commander Kent V. Rominger and Mission Specialists Ellen Ochoa (Ph.D.) and Julie Payette, with the Canadian Space Agency. Tokarev is with the Russian Space Agency. Mission STS-96, which is scheduled for liftoff on May 20 at 9:32 a.m., is a logistics and resupply mission for the International Space Station, carrying such payloads as a Russian crane, the Strela; a U.S.-built crane; the Spacehab Oceaneering Space System Box (SHOSS), a logistics items carrier; and STARSHINE, a student-led experiment

  16. KSC-99pp0454

    NASA Image and Video Library

    1999-04-27

    At right, STS-96 Mission Specialist Tamara E. Jernigan (Ph.D.) practices driving the small armored personnel carrier that is part of emergency egress training during Terminal Countdown Demonstration Test (TCDT) activities. At left is Capt. Steve Kelly, with Space Gateway Support, who is assisting with the training. At the rear of the carrier are (left) Mission Specialist Julie Payette, with the Canadian Space Agency, and Commander Kent V. Rominger (right). The tracked vehicle could be used by the crew in the event of an emergency at the pad during which the crew must make a quick exit from the area. The TCDT also provides simulated countdown exercises and opportunities to inspect the mission payloads in the orbiter's payload bay. Other crew members taking part in the TCDT are Pilot Rick Douglas Husband, and Mission Specialists Ellen Ochoa (Ph.D.), Daniel Barry (M.D., Ph.D.), and Valery Ivanovich Tokarev, who is with the Russian Space Agency. Mission STS-96, which is scheduled for liftoff on May 20 at 9:32 a.m., is a logistics and resupply mission for the International Space Station, carrying such payloads as a Russian crane, the Strela; a U.S.-built crane; the Spacehab Oceaneering Space System Box (SHOSS), a logistics items carrier; and STARSHINE, a student-led experiment

  17. KSC-pasts89-2

    NASA Image and Video Library

    1998-01-31

    The Space Shuttle orbiter Endeavour touches down on Runway 15 of the KSC Shuttle Landing Facility (SLF) to complete the nearly nine-day STS-89 mission. Main gear touchdown was at 5:35:09 p.m. EST on Jan. 31, 1998. The wheels stopped at 5:36:19 EST, completing a total mission time of eight days, 19 hours, 48 minutes and four seconds. The 89th Space Shuttle mission was the 42nd (and 13th consecutive) landing of the orbiter at KSC, and STS-89 was the eighth of nine planned dockings of the Space Shuttle with the Russian Space Station Mir. STS-89 Mission Specialist Andrew Thomas, Ph.D., succeeded NASA astronaut and Mir 24 crew member David Wolf, M.D., who was on the Russian space station since late September 1997. Dr. Wolf returned to Earth on Endeavour with the remainder of the STS-89 crew, including Commander Terrence Wilcutt; Pilot Joe Edwards Jr.; and Mission Specialists James Reilly, Ph.D.; Michael Anderson; Bonnie Dunbar, Ph.D.; and Salizhan Sharipov with the Russian Space Agency. Dr. Thomas is scheduled to remain on Mir until the STS-91 Shuttle mission returns in June 1998. In addition to the docking and crew exchange, STS-89 included the transfer of science, logistical equipment and supplies between the two orbiting spacecrafts

  18. KSC-398d1fr09

    NASA Image and Video Library

    1998-01-31

    The Space Shuttle orbiter Endeavour touches down on Runway 15 of the KSC Shuttle Landing Facility (SLF) to complete the nearly nine-day STS-89 mission. Main gear touchdown was at 5:35:09 p.m. EST on Jan. 31, 1998. The wheels stopped at 5:36:19 EST, completing a total mission time of eight days, 19 hours, 48 minutes and four seconds. The 89th Space Shuttle mission was the 42nd (and 13th consecutive) landing of the orbiter at KSC, and STS-89 was the eighth of nine planned dockings of the Space Shuttle with the Russian Space Station Mir. STS-89 Mission Specialist Andrew Thomas, Ph.D., succeeded NASA astronaut and Mir 24 crew member David Wolf, M.D., who was on the Russian space station since late September 1997. Dr. Wolf returned to Earth on Endeavour with the remainder of the STS-89 crew, including Commander Terrence Wilcutt; Pilot Joe Edwards Jr.; and Mission Specialists James Reilly, Ph.D.; Michael Anderson; Bonnie Dunbar, Ph.D.; and Salizhan Sharipov with the Russian Space Agency. Dr. Thomas is scheduled to remain on Mir until the STS-91 Shuttle mission returns in June 1998. In addition to the docking and crew exchange, STS-89 included the transfer of science, logistical equipment and supplies between the two orbiting spacecrafts

  19. KSC-pasts89-1

    NASA Image and Video Library

    1998-01-31

    The Space Shuttle orbiter Endeavour touches down on Runway 15 of the KSC Shuttle Landing Facility (SLF) to complete the nearly nine-day STS-89 mission. Main gear touchdown was at 5:35:09 p.m. EST on Jan. 31, 1998. The wheels stopped at 5:36:19 EST, completing a total mission time of eight days, 19 hours, 48 minutes and four seconds. The 89th Space Shuttle mission was the 42nd (and 13th consecutive) landing of the orbiter at KSC, and STS-89 was the eighth of nine planned dockings of the Space Shuttle with the Russian Space Station Mir. STS-89 Mission Specialist Andrew Thomas, Ph.D., succeeded NASA astronaut and Mir 24 crew member David Wolf, M.D., who was on the Russian space station since late September 1997. Dr. Wolf returned to Earth on Endeavour with the remainder of the STS-89 crew, including Commander Terrence Wilcutt; Pilot Joe Edwards Jr.; and Mission Specialists James Reilly, Ph.D.; Michael Anderson; Bonnie Dunbar, Ph.D.; and Salizhan Sharipov with the Russian Space Agency. Dr. Thomas is scheduled to remain on Mir until the STS-91 Shuttle mission returns in June 1998. In addition to the docking and crew exchange, STS-89 included the transfer of science, logistical equipment and supplies between the two orbiting spacecrafts

  20. KSC-98pasts89-1

    NASA Image and Video Library

    1998-01-31

    KENNEDY SPACE CENTER, FLA. -- The Space Shuttle orbiter Endeavour touches down on Runway 15 of the KSC Shuttle Landing Facility (SLF) to complete the nearly nine-day STS-89 mission. Main gear touchdown was at 5:35:09 p.m. EST on Jan. 31, 1998. The wheels stopped at 5:36:19 EST, completing a total mission time of eight days, 19 hours, 48 minutes and four seconds. The 89th Space Shuttle mission was the 42nd (and 13th consecutive) landing of the orbiter at KSC, and STS-89 was the eighth of nine planned dockings of the Space Shuttle with the Russian Space Station Mir. STS-89 Mission Specialist Andrew Thomas, Ph.D., succeeded NASA astronaut and Mir 24 crew member David Wolf, M.D., who was on the Russian space station since late September 1997. Dr. Wolf returned to Earth on Endeavour with the remainder of the STS-89 crew, including Commander Terrence Wilcutt; Pilot Joe Edwards Jr.; and Mission Specialists James Reilly, Ph.D.; Michael Anderson; Bonnie Dunbar, Ph.D.; and Salizhan Sharipov with the Russian Space Agency. Dr. Thomas is scheduled to remain on Mir until the STS-91 Shuttle mission returns in June 1998. In addition to the docking and crew exchange, STS-89 included the transfer of science, logistical equipment and supplies between the two orbiting spacecrafts

Some links on this page may take you to non-federal websites. Their policies may differ from this site.
Top